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ABSTRACT 
 
Following stroke, impairments in arm function are common motor deficits in 
survivors, affecting thousands of people each year. A useful technique used in clinical 
rehabilitation of patients with arm impairments is to force use of the impaired arm 
through constraint of WKHXQDIIHFWHGRUOHVVDIIHFWHGRQH7KHVXFFHVVRIWKLVµFRQVWUDLQW
LQGXFHGPRYHPHQW WKHUDS\¶&,07LVEHOLHYHG WREHGXH WRQHXURSODVWLFFKDQJHV WKDW
take place on a cellular level in surviving brain tissue, however, little is understood 
about the mechanisms involved. Appropriate animal models are necessary to study how 
rehabilitation affects neuroplasticity. Previous literature has described several models of 
forced use following stroke in rats which have resulted in varying success. Animal stress 
and lack of behavioural pressure may have contributed to the inconsistency of prior 
forced use models. 
The purpose of the research presented in this thesis was to optimize a surgical 
model of post-ischemic upper extremity impairment, determine whether it would be 
possible to force use of the impaired forelimb using a novel appetitively motivated 
protocol, and then to investigate the effects of this novel model on markers of 
neuroplasticity. First, the endothelin-1 (ET-1) model of focal unilateral ischemia was 
optimized by attempting a previously unpublished protocol of injections along the motor 
cortex and to the striatum. Male Sprague Dawley rats were subjected to ET-1 or sham 
surgery. Ensuing forelimb functional deficits were measured using a battery of 
behavioural tests, which were compared to intact sham surgical control performance. 
The stroke model resulted in reliable and reproducible lesions to forelimb motor regions 
of the brain, and deficits that lasted up to the end of the 21 day study period in some 
tests.  
Next, this ET-1 stroke surgery was used to evaluate a novel form of forced use 
rehabilitation in which rats engaged the impaired limb to move voluntarily in 
commercial pet activity balls. Animals were subjected to ET-1 or sham surgery, and then 
received either rehabilitation or a control treatment. Behavioural tests revealed that 
animals receiving rehabilitation recovered to sham levels of performance sooner than 
animals receiving the control treatment. Stroke, but not rehabilitation, affected the 
proportion of cells expressing brain derived neurotrophic factor (BDNF) and the 
presence of doublecortin-positive neuroblasts, but had no effect on the expression of the 
growth inhibiting protein NOGOA. 
Finally, the novel forced use model was developed further to more closely 
resemble clinical CIMT with the addition of a task-specific reaching component. 
Animals were subjected to either ET-1 followed by rehabilitation, ET-1 followed by a 
control treatment, or sham surgery. Again, behavioural tests revealed that animals that 
had undergone ET-1 surgery had significant deficits that recovered sooner in the group 
that received rehabilitation. Rehabilitation did not affect the proportion of BDNF-
expressing cells, but did appear to cause a shift in the cellular origin of the BDNF that 
was present. Further, rehabilitation resulted in more doublecortin-positive cells in the 
damaged hemisphere. This novel approach to rehabilitation represents a useful model of 
forced use therapy which results in accelerated functional recovery following ischemic 
injury. The mechanisms underlying this effect may be related to changes in BDNF 
expression and increased generation or survival of new born cells. 
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CHAPTER 1 
GENERAL INTRODUCTION 
 
 
 
 
 
 
 
³2QFHGHYHORSPHQWZDVHQGHGWKHIRXQWVRI
growth and regeneration ... dried up irrevocably. 
In adult centres the nerve paths are something 
fixed, ended, immutable. Everything may die, 
nothing may be regenerated. It is for the science 
of the future to change, if possible, this harsh 
GHFUHH´ 
 
 
-Santiago Ramón y Cajal (1852-1934) 
picture from http://spin.udg.edu/rn12/santiago-ramon-y-cajal/
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OVERVIEW 
 
)RUPXFKRIWKHWKFHQWXU\WKHZRUGVRIWKHUHYHUHGµIDWKHURIQHXURVFLHQFH¶
Santiago Ramón y Cajal (see page 1) were the dogma taught to generations of 
neuroscientists (Cajal, 1991). Fortunately, critical work in the last few decades has 
revealed the capacity of the brain to undergo regenerative processes, prompting a surge 
in research into neurorehabilitation of the nervous system following injury and disease.  
Stroke is a leading cause of death and disability (Hootman et al., 2009; Statistics 
Canada, 2000). While preventive therapies and lifestyle modifications can reduce the 
incidence of stroke (Bousser, 2012), countless people live with the devastating 
disabilities associated with the disease and require some form of rehabilitation to 
recover. A particularly common and pervasive disability in survivors of stroke is 
decreased sensorimotor function of the contralateral arm (Kelly-Hayes et al., 1998). An 
increasingly popular rehabilitative technique that is being developed to increase use and 
improve function of the impaired arm is constraint induced movement therapy (CIMT) 
(Nijland et al., 2011). During CIMT, the affected arm is constrained, forcing patients to 
use their impaired arm. CIMT has been shown to improve functional outcome (Bonaiuti 
et al., 2007; Nijland et al., 2011; Sawaki et al., 2008; Wittenberg et al., 2003; Wolf et 
al., 2011), even when administered to patients with chronic deficits (Liepert et al., 
2000).  
The mechanisms underlying CIMT-associated improvements in recovery are not 
well understood (Sawaki et al., 2008). This has SURPSWHGLQWHUHVWLQPRGHOOLQJµIRUFHG
XVH¶ rehabilitation in animals in order to more closely examine resulting changes in the 
brain. To date, animal models of forced use therapies have had varying success at 
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producing functional improvements. The purpose of the work described in this thesis 
was to develop and evaluate the efficacy of a novel animal model of voluntary forced 
use on recovery of forelimb function, and to investigate resulting alterations in the 
expression of markers associated with neuroplasticity in the brain.  
 
1.1 STROKE 
 
Approximately 850,000 North Americans are clinically diagnosed with stroke 
each year (Heart and Stroke Foundation, 2012; Hootman et al., 2009; Roger et al., 2011; 
Statistics Canada, 2000) and many more may experience transient ischemic attacks 
7,$V NQRZQ DV µVLOHQW VWURNHV¶ (Roger et al., 2011). In addition to a high mortality 
rate, the majority of survivors are left with motor disabilities (Heart and Stroke 
Foundation, 2012). Patients can remain chronically impaired for months to years 
following a stroke, which vastly impacts quality of life and is associated with a higher 
rate of post-stroke depression (Burvill et al., 1997; Ramasubbu et al., 1998). As a result, 
it has been suggested that stroke has a greater disability impact than any other chronic 
disease (Adamson et al., 2004). 
There are two types of stroke: ischemic, which involves vessel occlusion, and 
hemorrhagic, associated with vessel rupture. At least 80% of strokes diagnosed in North 
America are ischemic (Heart and Stroke Foundation, 2012; Roger et al., 2011). 
Occlusion affecting blood supply to the entire brain results in global ischemia, while 
focal ischemia occurs when only part of the brain is affected. Ischemic episodes may be 
permanent or temporary, wherein dissolution of the clot leads to a period of reperfusion 
to the affected area. During the ischemic episode, lack of oxygen exchange to the 
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affected region ultimately leads to the development of an infarct (Hertz, 2008), as 
described below. Because of its high prevalence, temporary focal ischemia is the focus 
of the work in this thesis. 
 
1.2 THE PATHOLOGY OF ISCHEMIA 
 
Once vessel occlusion occurs, a complex series of multiple cellular events is 
rapidly set in motion, as described below (summarized in Figure 1.1; numbers on Figure 
correspond to description below) (Hertz, 2008; Teasell et al., 2005). The brain is 
comprised of several cell types, including neurons, astrocytes, oligodendrocytes, and 
endothelial cells. Each of these is vulnerable to the effects of ischemia, albeit to varying 
degrees (Denes et al., 2010), and together they comprise an intricately intertwined 
network system. Hence, when a subpopulation of cells is injured, the effects are not 
constrained to a particular cell type or group; there will be ramifications to the 
surrounding microenvironment, and to remote connected regions.  
Initially, lack of blood (and, therefore, oxygen and glucose exchange) results in 
energy depletion, which impairs cellular ion pumps (1) leading to cell depolarization (2). 
If energy depletion is excessive, both apoptotic and necrotic pathways are initiated and 
cell death occurs (3) (Lee et al., 2000). Both depolarization and cell death lead to the 
release of glutamate, an excitatory amino acid, into the surrounding extracellular space, 
while glutamate sequestering systems are disrupted (4). Glutamate can then stimulate 
surrounding cells, resulting in N-methyl-D-aspartate (NMDA) and non-NMDA receptor-
mediated excitotoxicity (5) (Durukan and Tatlisumak, 2007; Lee et al., 2000). 
Excitotoxicity results in massive calcium (Ca2+) influx, mitochondrial dysfunction, 
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Figure 1.1. General overview of 
pathological events in the 
ischemic cascade. In this 
example, a blood clot results in 
reduced transport of oxygen and 
glucose, which results in cellular 
energy deprivation and a number 
of downstream effects involving 
Ca2+, free radical production, and 
excitotoxicity, and can result in 
apoptosis, necrosis, and altered 
gene expression. See text for 
stepwise description of numbers. 
Figure created by J. Livingston-
Thomas, from information 
contained in references cited in 
Section 1.2. 
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and the formation of reactive oxygen species, which inhibit energy production and attack 
cellular components (6). Moreover, induction of inducible nitric oxide synthase (iNOS) 
leads to increased release of nitric oxide (NO) which enhances oxidative damage and 
can contribute to further cell death (7) (Forman et al., 1998). 
Because of the self-perpetuating and outwardly spreading nature of this process, 
the damage that occurs following stroke evolves over time, initially consisting of a 
necrotic region resulting from the death of cells in the immediately affected area (the 
core), and a surrounding peri-infarct region (the penumbra). In the core, the excitotoxic 
overload and bio-energetic depletion described above results in immediate necrotic and 
apoptotic cell death, while the penumbral region experiences moderate sub-lethal 
ischemia, due to less-intensive damage or partial blood supply from collateral vessels 
(Hertz, 2008). While this moderate reduction in blood flow can become sufficient to 
cause the loss of electrical excitability, these cells can maintain membrane potential and 
ion gradients temporarily. The penumbra is considered reversibly compromised, because 
tissue can be affected by further damage spreading from the core but is also sensitive to 
appropriate interventions (Hossmann, 1994). Damage in the penumbra can occur for up 
to three days following the ischemic incident (Hata et al., 2000; Hossmann, 1994). The 
timing of the spectrum of ischemic cascade events varies depending on infarct size, 
duration of ischemia, and timing and effectiveness of reperfusion, if applicable. Figure 
1.2 generalizes the events into those that occur within minutes, hours, and days. 
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Figure 1.2. Timeline of events following ischemia. Ischemia results in the initiation of 
both protective and detrimental processes. These are generalized into those that take 
place within minutes, hours, and days. Immediately, energy failure and subsequent 
excitotoxicity occur. Secondary damage processes including edema and diaschisis peak 
after hours. Eventually, a dynamic growth environment results in repair processes, 
including regeneration of axons and dendrites and formation of synapses. The role of 
inflammation is complicated, and believed to include both damaging and reparative 
processes, therefore it appears on both sides of the spectrum. Figure adapted from 
(Endres et al., 2008; Wieloch and Nikolich, 2006). 
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1.3 POST-ISCHEMIC MOTOR DEFICITS: MECHANISMS OF 
RECOVERY  
 
The middle cerebral artery (MCA) is most commonly affected in ischemic stroke 
(Ng et al., 2007). The MCA supplies blood to areas of the cortex and striatum, including 
the primary motor and sensory areas of the hand and arm (Traystman, 2003). Disruption 
of blood flow to these regions largely results in motor and sensorimotor deficits in 
contralateral forelimb function (Feys et al., 1998; Modo et al., 2000). These impairments 
are common in survivors of stroke (Kelly-Hayes et al., 1998). 
Initial post-stroke impairments are usually followed by some degree of 
spontaneous (unaided) recovery, after which remaining deficits may last years without 
further improvement. Generally, the degree of spontaneous recovery is minor, and 
occurs soon after the initial insult. Spontaneous recovery in humans is partly attributed 
to the resolution of secondary injury processes that are produced by the initial trauma, 
and which resolve within the first days and weeks following ischemia (see Figure 1.2). 
These include edema, diaschisis, and inflammation, described below. The degree of both 
spontaneous and later long-term recovery is highly variable, and depends on the severity 
of the infarct and demographic characteristics such as age, gender, and prior health 
status (Braeuninger and Kleinschnitz, 2009; Huang et al., 2012, 2009; Johansson, 2000).  
Two forms of edema normally follow ischemic injury. Cytotoxic edema occurs 
due to cellular swelling in response to ionic imbalance resulting from ischemia (Durukan 
and Tatlisumak, 2007; Hossmann, 2008), while vasogenic edema occurs due to the 
breakdown of the blood brain barrier (Hossmann, 2008; Watanabe et al., 1977a). Edema 
gradually resolves over the first days following injury, restoring some function to 
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affected neurons (Teasell et al., 2005). Diaschisis is the state of depressed neurological 
function resulting from the interruption of input from remote but neuroanatomically 
connected brain regions. Resolution of diaschisis within the first hours and days 
following the insult can result in the return of neurological function to affected areas 
(Teasell et al., 2005). Inflammation, which is initiated soon after onset of ischemia, may 
play several roles. Microglia and other cell types involved in the immune response are 
believed to have both harmful (Iadecola and Anrather, 2011) and beneficial effects on 
the post-injury brain (Faustino et al., 2011; Iadecola and Anrather, 2011; Madinier et al., 
2009), but in general the resolution of early inflammatory processes is believed to 
contribute to early spontaneous recovery (Denes et al., 2010). 
Humans experience little short-term recovery before reaching a plateau at which 
remaining deficits may be chronic (Krakauer, 2005). However, in rodent models of 
stroke, unassisted recovery occurs more quickly, and can result in more complete 
functional recovery, depending on the evaluation used. For example, reflexive and gross 
motor deficits often recover to baseline levels within one month without intervention 
(Hume, 2009; Leasure and Grider, 2010; Schallert et al., 2000a), whereas dextrous 
motor function remains impaired for much longer or does not recover within the 
reported time frame (Biernaskie and Corbett, 2001; Ploughman et al., 2009; Soleman et 
al., 2010). 
 
1.4 NEUROPLASTICITY 
 
Once considered a largely static organ following development, the adult brain is 
now known to be structurally and functionally dynamic. The ability to reorganize by 
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forming and sculpting new neural connections throughout life is a phenomenon called 
µneuroplasticity¶. In the healthy adult brain, much of this plasticity occurs during 
learning and memory processes. However, following injury to the nervous system 
including stroke, post-ischemic neuroplastic processes are initiated. A better 
understanding of these inherent repair mechanisms could result in substantial advances 
in post-stroke recovery. 
 
1.4.1 Neuroplasticity in the injured brain 
 
Injury to the central nervous system is a potent trigger of plasticity (Chopp et al., 
2008; Ohab et al., 2006; Schallert et al., 2000b). In human patients, examination of 
motor maps by functional magnetic resonance imaging (fMRI) reveals altered activation 
patterns following stroke that evolve over time. For example, during a particular motor 
task that normally requires the brain region that is damaged, patients with poor initial 
recovery are more likely to recruit brain regions in the contralesional hemisphere. As 
more complete recovery is observed, there is increased activation of ipsilesional brain 
areas (Bastings et al., 2002; Cramer, 2004; Teasell et al., 2005; Ward et al., 2003). A 
similar positive correlation between recovery and ipsilesional activation is observed in 
rats (Dijkhuizen et al., 2003). Such alterations in functional activity maps are attributed 
to the recruitment of previously unrelated pathways in the brain, and to neuroplastic 
processes that take place on a cellular level (Nudo et al., 2001). These processes include 
axonal regeneration (Carmichael and Chesselet, 2002; Carmichael et al., 2005; 
Dancause et al., 2005), dendritic growth (Hsu and Jones, 2006; Jones and Schallert, 
11 
 
1992), and neurogenesis (Jin et al., 2001; Leasure and Grider, 2010; Ohab et al., 2006; 
Wang et al., 2007).  
 
1.4.2 Regeneration 
 
 As discussed previously, following ischemic stroke, a necrotic core of 
tissue develops which is surrounded by the penumbra (Hossmann, 2008). Cells in the 
penumbra retain the capacity to sustain membrane potentials, while being subjected to 
spreading glutamate excitotoxicity and other pathological processes (see Section 1.2). 
Elevation of intracellular Ca2+ concentrations in these cells ultimately results in the 
modulation of gene expression by affecting the phosphorylation of transcription factor 
cAMP-response-element-binding protein (CREB) (see Figure 1.1) (Di Filippo et al., 
2008; Ohab et al., 2006). Various genes can be affected, including pro- and  anti-
apoptotic genes, as well as those involved in inflammation, neuroprotection, and cell 
growth (Li and Carmichael, 2006; Raghavendra Rao et al., 2002) Consequently, 
ischemia can lead not only to cell damage and death, but alternatively, to a dynamic 
growth-modulating microenvironment.  
Post-ischemic neuroplastic changes have been described in both the injured and 
intact hemispheres. In ipsilesional tissue, there is an immediate degeneration of axons, 
dendritic spines, and synapses in the first days following injury, followed by axonal 
sprouting as early as the third day post-injury and synaptogenesis 1-2 weeks later 
persisting up to 12 weeks (Ito et al., 2006; Nudo et al., 2001). Similarly, in the 
contralesional hemisphere, dendritic overgrowth begins in the first few days following 
injury, followed later by dendritic pruning and increased synapse formation (Jones and 
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Schallert, 1992). By 30 days post-injury, there are more multiple synaptic boutons and 
perforated postsynaptic densities (Kleim et al., 2003; Nudo et al., 2001). These 
structural changes at a cellular levHO XQGHUOLH WKH EUDLQ¶V DELOLW\ WR UHRUJDQL]H DQG
presumably, to recover function. 
 
1.4.3 Growth-associated proteins 
 
Ischemia alters the expression of several genes (Mizutani et al., 2011; 
Raghavendra Rao et al., 2002), including those associated with cellular growth, division, 
and apoptosis. Carmichael et al. (2005) performed a detailed analysis that demonstrated 
the temporally-defined patterns of expression of various genes over the first month post-
ischemia (Carmichael et al., 2005)/DWHUWHUPHGµJHQHH[SUHVVLRQZDYHV¶(Carmichael, 
2006), the patterns of several of these growth-associated genes are summarized in Figure 
1.3 (Carmichael et al., 2005; Li and Carmichael, 2006). This gene regulation is linked to 
the differential expression of various proteins involved with promoting and inhibiting 
growth (Abe, 2000). Of particular relevance to this thesis are brain derived neurotrophic 
factor (BDNF), and the growth-inhibitory protein NOGOA. 
 
1.4.3.1 Brain derived neurotrophic factor 
 
Growth factors are proteins that have the capacity to stimulate cell growth, 
differentiation, and proliferation. Neurotrophins are a family of growth factors that 
influence the survival of neurons. BDNF, one of the most intensively studied of these, 
has been implicated in post-ischemic neuroplastic events, described in more detail 
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below. Other growth factors, such as the glial cell-line derived neurotrophic factor 
(GDNF) family, and non brain-specific proteins such as insulin growth factor (IFG)-1 
and basic fibroblast growth factor (bFGF)-2, are also implicated in post-ischemic 
neuroplasticity (Greenberg and Jin, 2006; Horinouchi et al., 2007), although not the 
focus of the present work. 
BDNF belongs to the neurotrophin family, consisting of structurally-related 
nerve growth factor (NGF), neurotrophin-3, neurotrophin-4/5, all of which modulate cell 
survival (Lu, 2003). BDNF is a well-characterized neurotrophic factor that has been 
implicated in numerous post-injury recovery processes including neurogenesis, dendritic 
growth, and synaptic modulation (Greenberg et al., 2009; Nagappan and Lu, 2005). 
BDNF expression is activity-dependent (Nagappan and Lu, 2005); it is upregulated 
during long term potentiation (Greenberg et al., 2009; Lu, 2003; Vaynman and Gomez-
Pinilla, 2005) and exercise (Griesbach et al., 2009; Kim et al., 2005; Ploughman et al., 
2009). Thus, the increased neuronal activation that takes place in the penumbral zone 
may modulate BDNF expression (Di Filippo et al., 2008). 
Produced as a precursor peptide, pro-BDNF is cleaved primarily by extracellular 
proteases including metalloproteinases and plasmin. The product is mature BDNF 
protein, which binds to the tropomyosin-related kinase B (TrkB) receptor (Lu, 2003). 
TrkB receptor autophosphorylation then activates downstream signal transduction 
pathways including 0$3.3/&ȖDQG3,.7KLVVLJQDOOLQJOHDGVWR WKHDFWLYDWLRQRI
transcription factors that can alter expression of a number of growth-associated genes 
such as those regulating growth associated protein GAP43 (associated with neuronal 
sprouting), synaptophysin (associated with syntaptogenesis), and further BDNF 
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expression (Figure 1.4) (Jovanovic et al., 2000; Lu, 2003; Madinier et al., 2009; 
Vaynman et al., 2004). 
There is compelling evidence to suggest that BDNF plays a critical role in post-
ischemic reorganization and recovery. Post-stroke interventions that improve functional 
recovery can be associated with increased BDNF (Ke et al., 2011; Kim et al., 2005; 
MacLellan et al., 2011), and exogenously administered BDNF facilitates motor recovery 
(Müller et al., 2008; Schabitz et al., 2004). Conversely, interfering with BDNF by using 
antisense oligonucleotides (Ploughman et al., 2009) or by blocking TrkB receptors 
(Griesbach et al., 2009) reduces neuroplasticity and attenuates recovery. However, a 
study using BDNF +/- mice reported that after permanent ischemia, mice with deficient 
BDNF production recovered sooner than wild types (Nygren et al., 2006), suggesting a 
potential detrimental role of BDNF to post-stroke plasticity. 
Despite this controversial role in recovery, endogenous post-stroke BDNF 
expression has been poorly investigated (Béjot et al., 2011; Madinier et al., 2013). 
Recently, Béjot et al. (2011) found that BDNF expression in both the ipsi- and 
contralateral hemisphere increased following embolic stroke. Furthermore, several cell 
types in the brain (neurons, astrocytes, microglia, endothelial, and ependymal cells) were 
responsible for BDNF expression, emphasizing the potential importance of non-neuronal 
cells (as well as neurons) in neuroplastic processes. 
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1.4.3.2 NOGOA  
 
NOGOA belongs to a small family of proteins which inhibit neuronal sprouting 
(Schwab, 2004). NOGOA binds to the NOGO receptor NgR1, which activates the RhoA 
pathway and Rho kinase. This leads to microtubule depolymerization and actin 
contraction, leading to growth cone collapse and failed neural regeneration (Figure 1.5) 
(Carmichael, 2010).  
Following central nervous system (CNS) injury, neuronal NOGOA expression is 
increased, which may represent an endogenous attempt to inhibit spontaneous axonal 
remodelling that could worsen functional recovery (Cheatwood et al., 2008). Cheatwood 
et al. (2008) performed detailed analyses of NOGOA expression following middle 
cerebral artery occlusion (a stroke model described below, in Section 1.6), and reported 
dynamic changes in NOGOA expression over time and in various brain regions, 
including the cortex (Cheatwood et al., 2008). In the ipsilesional hemisphere, the protein 
was highly expressed in the forelimb sensorimotor cortex immediately following 
ischemia, and up to 28 days post-injury. In the contralateral hemisphere, there was an 
initial decrease in NOGOA expression following ischemia, which returned to baseline 
levels a week later (Cheatwood et al., 2008).  
Using a similar stroke model, Papadopoulos et al. (2002) found that post-
ischemic neuroplasticity and functional recovery could be enhanced by neutralizing the 
effects of NOGOA using an antibody to the protein. Similarly, following ischemia, Fang 
et al. (2010) used a NOGOA antagonist combined with rehabilitation to successfully 
promote functional recovery. These results suggest that NOGOA plays an important role 
in post-ischemic neuroplastic remodelling. 
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Figure 1.5. Overview of NOGOA signalling. NOGOA plays an important role in post-
ischemic neuroplasticity though interaction with the Nogo receptor NgR1, which 
activates RhoA signalling and Rho kinase (ROCK), ultimately blocking axon growth 
through growth cone collapse (Carmichael, 2010). 
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1.4.3.3 Neurogenesis 
 
While it has long been recognized that many adult non-nervous system tissues 
have the capacity to be renewed through the production of stem cells (SC), it was widely 
accepted that the brain did not possess this ability. In recent decades, the discovery that 
the adult brain does produce neural SCs represented a major breakthrough in the study 
of neurodegenerative disease, because of the potential for therapeutic manipulation of 
this process to promote brain repair (Altman, 1962; Eriksson et al., 1998; Reynolds and 
Weiss, 1992). In the healthy brain, SCs are constantly being formed in two main regions: 
the subgranular zone (SGZ) of the dentate gyrus and the subventricular zone (SVZ) 
adjacent to the lateral ventricles (Lois and Alvarez-Buylla, 1994; Zhang et al., 2001). In 
the healthy adult brain, the SCs originating in the SGZ become integrated into the 
granule cell layer, while the SCs originating in the SVZ follow a rostral migratory 
stream to the olfactory bulb (Lois and Alvarez-Buylla, 1994). Neural SCs are 
multipotent and give rise to various neural cell types (neurons, astrocytes, and 
oligodendrocytes) (Momma et al., 2000). 
Several studies have shown that ischemia results in reactive neurogenesis in the 
SVZ, and migration of new cells toward the site of lesion (Gu et al., 2000; Jiang et al., 
2001; Jin et al., 2001; Leasure and Grider, 2010; Parent et al., 2002; Wang et al., 2007; 
Xiong et al., 2010; Zhang et al., 2001). While the role of these endogenous newborn 
neural cells remains unclear, they likely contribute to functional recovery, because 
attenuation of neurogenesis by genetic ablation (Jin et al., 2010; Sun et al., 2012) or 
irradiation (Raber et al., 2004) worsens functional outcome following ischemia. 
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Evaluations of the efficacy of SC transplantation following stroke are ongoing. 
Several paradigms have been reported using SCs from various sources, including human 
umbilical cord blood (Chen et al., 2001), bone marrow (Chen et al., 2003; Li et al., 
2001), embryonic tissue (Bühnemann et al., 2006a; Hicks et al., 2009), and hNT cells 
derived from human teratocarcinoma cell line (Bliss et al., 2006), which have been 
administered via the blood stream (Chen et al., 2001, 2003; Li et al., 2001) or grafted 
intracerebrally (Bliss et al., 2006; Bühnemann et al., 2006a; Hicks et al., 2009) [see 
Smith and Gavins (2012) for review]. Unfortunately, there is evidence that grafted SCs 
may not exhibit long-term survival, develop normally, express neurotransmitters, or 
integrate into existing neural networks (Arvidsson et al., 2002; Bühnemann et al., 
2006b; Hicks et al., 2009), possibly due to suboptimal experimental conditions. 
Furthermore, there are a number of additional challenges associated with stem cell 
transplantation including graft rejection, the use of relatively invasive procedures, and 
ethical concerns (e.g. if SCs are obtained from human fetal tissue) (Liu et al., 2009). 
Interestingly, various forms of experimental post-stroke rehabilitation strategies have 
been shown to enhance endogenous neurogenesis (Hicks et al., 2007; Mizutani et al., 
2011; Nilsson et al., 1999; Wurm et al., 2007). However, the long-term fate of newly 
born SCs, and their contribution to functional recovery, remains unclear (Arvidsson et 
al., 2002).  
 
1.5 TREATING STROKE 
 
Despite advances in the diagnosis and management of acute ischemic stroke in 
recent decades, it remains a leading cause of mortality and disability (Hootman et al., 
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2009; Statistics Canada, 2000). Because cells in the ischemic core die within minutes 
(see Figure 1.2), the primary goal of acute stroke therapy is to salvage tissue in the 
penumbra. The current standard of care involves the use of a thrombolytic compound, 
recombinant tissue plasminogen activator (tPA), to restore blood flow resulting from a 
clot. It is presently the only approved drug for administration following stroke, but can 
only be administered within 4.5 hours of stroke onset (Stemer and Lyden, 2010), and 
requires prior confirmation that the stroke is ischemic rather than hemorrhagic (Madden, 
2002; Stemer and Lyden, 2010). In most cases, this time frame is insufficient for patients 
to seek medical help, undergo clinical assessment, and be administered the drug. As a 
result, it has been estimated that fewer than 5% of stroke victims receive tPA (Reeves et 
al., 2005). These limitations have fuelled the search for other therapeutic options 
including alternative thrombolytic agents (Balami et al., 2013), adjuvant compounds that 
could extend the time window for treatment [e.g. atorvastatin; (Zhang et al., 2010)], and 
neuroprotectants [e.g. PSD95 inhibitors; (Sun et al., 2008)].  
More than 1,000 candidate strategies for treating stroke have failed in clinical 
trials 2¶&ROOLQVet al., 2006), likely due to the inability of current preclinical models to 
adequately mimic clinical stroke (Radermacher et al., 2012). Many different therapeutic 
approaches have been explored, including the use of free radical scavengers, excitatory 
amino acid antagonists, hypothermia, barbiturates, calcium channel blockers, and growth 
factors (STAIR, 1999). However, despite the fact that many of these approaches have 
shown promise in preclinical experimentation, none have been successful in clinical 
trials (Fisher et al., 2¶&ROOLQVet al., 2006; STAIR, 1999). 
During ischemia, cells are subject to excitotoxic events largely mediated by the 
binding of excess glutamate to NMDA receptors (see Figure 1.1). Thus, one obvious 
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neuroprotective strategy is to block NMDA receptors. Unfortunately, conventional 
extracellular antagonism of NMDA receptor activation results in severe dose-limiting 
side effects because of the essential role of glutamatergic signalling in the brain. A 
promising alternative approach currently being explored is to specifically target 
intracellular NMDA receptor-related cytotoxic events following ischemia without 
affecting normal function, thereby preventing damage while avoiding detrimental side 
effects (Aarts et al., 2002; Cook et al., 2012; Sun et al., 2008). 
Other alternative approaches to treating stroke include targeting downstream 
processes such as inflammation (Endres et al., 2008). The role of inflammation 
following stroke is complicated, and it is believed to have both beneficial and 
detrimental effects on brain recovery (Denes et al., 2010; Faustino et al., 2011; Iadecola 
and Anrather, 2011; Madinier et al., 2009). Cytokines such as interleukins (e.g. IL-ȕ
IL-6) and tumour necrosis factor alpha (TNF)-ĮDUHUHOHDVHGGXULQJ LQIODPPDWLRQDQG
have been shown to contribute to brain damage following ischemia (Relton and 
Rothwell, 1992). Thus, an emerging therapeutic approach to limit damage is to interfere 
with the inflammatory response, either alone (Pradillo et al., 2012) or as an adjuvant to 
other pharmacotherapy (Sumbria et al., 2013). While this may represent an effective 
early strategy, inflammation may play a vital role in assisting neuroplastic processes in 
the weeks following ischemia (Denes et al., 2010; Madinier et al., 2009; Narantuya et 
al., 2010) . 
While these approaches currently show promise in preclinical studies, the clinical 
efficacy of such treatments has not been established. Consequently, tPA administration 
remains the only presently available treatment for those experiencing a stroke. Because 
of logistical issues described earlier, many patients do not receive tPA and are left with 
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brain damage and resultant disability. These patients must rely on treatments aimed at 
improving recovery of function, the further development of which requires clinically 
predictive animal models. 
 
1.6 ANIMAL MODELS OF STROKE 
 
As described earlier, cellular death and damage in ischemic stroke is a complex 
process involving a variety of cell types and cellular mediators (see Section 1.2). As 
such, in-depth investigation into the processes underlying ischemic damage and 
subsequent functional recovery requires the use of whole animals. Addressing all aspects 
of the disease using any given animal model may be impossible, but several models have 
contributed to our understanding of the mechanisms involved. To date, a variety of 
animal models including pigs (Imai et al., 2006) and non-human primates (Watanabe et 
al., 1977b) have been explored, but rat models of stroke are the most common choice for 
researchers. This is largely due to the similar pattern of neurovascular branching to 
humans (Macrae, 1992; Yamori et al., 1976), relatively low cost (Durukan and 
Tatlisumak, 2007), and the high number of validated behavioural tests of functional 
outcome in the rat (Durukan and Tatlisumak, 2007; Macrae, 1992; Tamura et al., 1981). 
In the case of forelimb rehabilitation studies, rats are especially useful because of the 
similarity of their limb movement patterns to that of humans (Whishaw et al., 2002).  
 The following section summarizes the most common rat models of stroke used to 
study post-stroke rehabilitation, including the model chosen for the present research 
(summarized in Table 1.1). There are several other models of focal ischemia that are 
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Stroke Model Advantages Disadvantages References 
Devascularization -Models permanent ischemia; 
-Relatively good control over lesion size 
location; 
-Low mortality rates 
-Requires removal of skull tissue; 
-Mechanical damage can occur to 
surrounding tissue and vessels; 
-Can produce surface damage only; 
 
(Gonzalez and Kolb, 2003; 
Kleim et al., 2007; Metz and 
Whishaw, 2002; Whishaw, 
2000) 
Photothrombosis -Models permanent ischemia; 
-Low mortality rate;  
-Precise control over lesion size and 
location;  
-Full craniectomy can be avoided 
 
-Can only produce cortical damage; 
-Penumbra area different from that 
observed following stroke 
(Carmichael, 2005; 
Carmichael et al., 2004; 
Markgraf et al., 1993; 
Müller et al., 2008; Shanina 
et al., 2006; Watson et al., 
1985) 
 
MCAo -Models transient or permanent ischemia; 
-Results in cortical and striatal damage 
-Widely used and well-characterized 
 
-Large and variable infarcts;  
-Collateral damage to non-targeted 
vasculature; 
-Feeding problems may occur;  
-Some mortality 
 
(Boyko et al., 2010; Gerriets 
et al., 2004; Lipsanen and 
Jolkkonen, 2011; Longa et 
al., 1989)  
Endothelin-1 -Models transient ischemia;  
-Can produce cortical and striatal 
damage;  
-Ability to control precise variables 
resulting in localized lesions;  
-Can be used to model lacunar infarcts 
-Low mortality rate 
-Requires removal of some skull 
tissue;  
-Mechanism of vessel occlusion not 
well elucidated 
-Unknown nonspecific effects due 
to presence of ETR on non-vascular 
cells 
(Adkins et al., 2008; Fuxe et 
al., 1997; Sharkey et al., 
1993; Windle et al., 2006) 
Table 1.1. Common animal stroke models. A summary of advantages and disadvantages of commonly used animal models of focal 
ischemic stroke used in animal rehabilitation research. 
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widely used for other aspects of stroke research, such as embolization and spontaneous 
infarction using hypertensive rats (Yamori et al., 1976). There are also a number of 
models of multi-focal and global ischemia, as well as hemorrhagic models. A detailed 
discussion of these is beyond the scope of this thesis; for comprehensive reviews see 
(Hossmann, 2008; Kleim et al., 2007).  
 
1.6.1 Devascularization 
 
 Complete ischemia by eradication of blood supply to brain tissue can be 
achieved by devascularisation. In this approach, vasculature on the surface of the brain is 
physically removed, for example by rubbing with a cotton swab (Gonzalez and Kolb, 
2003; Metz and Whishaw, 2002; Whishaw, 2000), or by electrocoagulation (Humm et 
al., 1998, 1999; Kozlowski et al., 1996). This method generally produces focal cortical 
damage that extends from the pia to the white matter (Kleim et al., 2007). However, it 
does not produce striatal damage that is often associated with clinical stroke (Cramer, 
2003). Furthermore, devascularisation cannot model temporary ischemia, a common 
clinical presentation of stroke. Mechanical damage to surrounding tissue can also occur, 
resulting in hemorrhage and non-targeted damage (Kleim et al., 2007).  
 
1.6.2 Photothrombosis 
 
Photothrombotic stroke models induce cortical damage by the systemic injection 
of a photoactive dye (e.g. Rose Bengal) followed by irradiation of blood vessels by a 
light beam, usually through the skull (Watson et al., 1985). This damages the 
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vasculature and causes ischemia. This method can be used to produce widespread 
damage by targeting a major artery such as the MCA (Markgraf et al., 1993; Yao and 
Nabika, 2011; Yao et al., 2003), or to create a more localized lesion by directly targeting 
the vasculature in a particular brain area (Müller et al., 2008; Shanina et al., 2006; 
Watson et al., 1985). Focal photothrombosis allows the experimenter to easily target 
precise cortical regions, results in relatively reproducible lesions, and is associated with 
a low mortality rate (Markgraf et al., 1993). However, as photoactivation usually occurs 
through the skull, resulting damage is only cortical, and reperfusion is not possible. 
Furthermore, photothrombosis does not produce a penumbral region resembling that 
which is observed in clinical stroke (Carmichael, 2005), potentially affecting the cellular 
processes that follow, thereby limiting the translational value of this model.  
 
1.6.3 Middle cerebral artery occlusion 
 
As previously highlighted, the MCA is often affected in ischemic stroke 
(Madden, 2002), hence the development of the most commonly used animal stroke 
model: middle cerebral artery occlusion (MCAo) (Koizumi et al., 1986). The MCA can 
be occluded via the internal (Boyko et al., 2010) or external (Longa et al., 1989) carotid 
artery, which are accessed at a ventral midline incision point. Occlusion can be 
temporary (Belayev et al., 1996) or permanent (Pena-Tapia et al., 2004). Transient 
MCAo is usually achieved by temporary insertion of a filament into the MCA. The 
filament is later removed, resulting in restoration of blood flow. Permanent MCAo 
involves leaving the filament in the MCA, or using a clip or cauterization to permanently 
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occlude blood flow. Occlusion results in infarction of both cortical and striatal regions, 
resembling pathology commonly observed following human stroke (Cramer, 2003). 
However, there are several aspects to this stroke model that detract from its 
clinical relevance. Because of the vast territory supplied by the MCA, inadvertent 
damage often occurs (Lipsanen and Jolkkonen, 2011; Trueman et al., 2011), resulting in 
unintended behavioural impairments (Gerriets et al., 2004). Furthermore, while rats can 
often survive the large infarcts that are produced using MCAo, humans are unlikely to 
survive an injury of comparable extent (Carmichael, 2005). The acute nature of the 
occlusion, and if applicable the resolution, are also not representative of the 
corresponding clinical events, which are typically more progressive in nature (Kleim et 
al., 2007). Moreover, unless alterations are made to traditional MCAo procedures 
(Boyko et al., 2010), complications such as loss of blood supply (or direct damage) to 
the muscles of the mouth (Dittmar et al., 2005) can result in misinterpretation of post-
surgical morbidity and/or the appearance of behavioural outcomes that result from 
surgical side effects rather than ischemia (Trueman et al., 2011). The procedure also 
carries a considerable risk of hemmorhage (Braeuninger and Kleinschnitz, 2009; 
Lipsanen and Jolkkonen, 2011), and even subtle variations in surgical technique can 
impact outcome and contribute to the variability inherent in the model (Trueman et al., 
2011). 
 
1.6.4 Endothelin-1 
 
Endothelin-1 is a 21-amino acid peptide that acts through specific receptors to 
cause potent and long-lasting vasoconstriction. First described in 1988, there are three 
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forms of endothelin, designated ET-1, ET-2, and ET-3 (Inoue et al., 1989; Shah, 2007). 
The most potent vasoconstrictor, ET-1, is produced mainly by endothelial cells, but can 
also be produced by neuronal and glial cells throughout the CNS (Kuwaki et al., 1997; 
Naidoo et al., 2004; Nakagomi et al., 2000).  
Endothelins act on one of two G-protein coupled receptors, designated ETRA and 
ETRB, that are predominantly expressed on smooth muscle cells (Naidoo et al., 2004; 
Shah, 2007)3UHFXUVRUSURWHLQµELJ(7-¶LVFRQYHUWHGWR(7-1 by endothelin converting 
enzyme (Shah, 2007). ET-1 binds irreversibly to ETRA (Rubanyi and Polokoff, 1994), 
resulting in increased intracellular Ca2+ and rapid and sustained vasoconstriction 
(Bourque et al., 2011; Shah, 2007); the precise mechanism of this process is not known 
(Kuwaki et al., 1997). Normal tension can be restored upon eventual endocytosis of the 
ET-receptor complex (Shah, 2007). The role of ETRB remains controversial, because 
selective activation of the receptor can induce either vasodilation or constriction 
(Chuquet et al., 2002). 
Because of its potent vasoconstricting properties, ET-1 can be used to induce 
localized ischemia when applied topically (Adkins et al., 2008; Fuxe et al., 1992), 
injected intracerebrally (Windle et al., 2006), or injected proximal to the MCA (Sharkey 
et al., 1993). ET-1 affects immediately proximal arteries, causing a rapid and temporary 
reduction in blood flow. The occlusion begins within 5-20 minutes (Fuxe et al., 1997; 
Macrae et al., 1993) and can last several hours (Macrae, 1992). The somewhat slower 
onset of ischemia resulting from ET-1 administration may be more representative of the 
clinical condition in stroke compared to the acute occlusion and reperfusion associated 
with MCAo (Kleim et al., 2007). A further advantage of this model is the greater degree 
of control over the infarct volume produced, afforded by adjusting the concentration, 
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volume, and stereotactic placement of the microinjections. Therefore, infarcts achieved 
using this model can be more localized and uniform than those resulting from traditional 
MCAo, which often produces large infarcts of questionable clinical relevance.  
ET-1 has been used to produce ischemic injury to forelimb sensorimotor brain 
regions in both mouse (Horie et al., 2008) and rat (Adkins et al., 2004; Allred and Jones, 
2004; Frost et al., 2006; Gilmour et al., 2004; Hughes et al., 2003; Soleman et al., 2010; 
Windle and Corbett, 2005; Windle et al., 2006) models. Windle et al. (2006) 
demonstrated that clinically relevant lesions could be produced by combining 
intracortical and intrastriatal injections of ET-1 (Figure 1.6). Resulting behavioural 
deficits have been shown to last from one week to more than a month (Adkins et al., 
2004; Allred and Jones, 2004; Frost et al., 2006; Gilmour et al., 2004; Soleman et al., 
2010; Windle and Corbett, 2005; Windle et al., 2006). A more detailed discussion of 
behavioural tests used to measure forelimb function will follow in Section 1.8. 
While other stroke models discussed in this Section can result in similar 
behavioural outcomes, the ET-1 model was chosen for the research described in this 
thesis. The use of ET-RIIHUVµIDFHYDOLGLW\¶DQGLQFUHDVHVWKHOLNHOLKRRGRISURGXFLQJ
neuroplastic responses similar to those associated with clinical stroke (Gilmour et al., 
2004). This permits the examination of the dynamic relationship between functional 
recovery and neuroplastic processes. Specifically, intracerebral (cortical + striatal) 
injections allow for control of lesion placement to target discrete functional areas while 
retaining sufficient intact neural tissue to act as a substrate for the putative cellular 
changes responsible for neuroplasticity. 
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Figure 1.6. Ischemic damage caused by endothelin-1. Typical damage associated with 
select ET-1 model variations, manifested in coronal sections from approximately +3.8 to 
-2.0 (mm A/P) from bregma. The present study targeted cortical and striatal damage, as 
depicted in the first set of sections, as these areas are commonly damaged following 
clinical stroke [adapted from (Windle et al., 2006)]. Another variation of the ET-1 
model is MCAo-proximal administration, which results in larger, more variable, and less 
forelimb-specific damage (second set of sections).  
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1.7 INFLUENCING NEUROPLASTICITY WITH REHABILITATION 
 
The physical and emotional consequences of stroke can take an immense toll on 
patients and caretakers, while the economic burden of caring for patients represents a 
significant strain on health care budgets. Thus, basic and clinical scientists have long 
sought effective treatments to restore function following stroke. The discovery that a 
number of processes are involved in post-injury neuroplasticity, and that behavioural 
experience can be a potent modulator of these processes, has led to a significant shift in 
the field of rehabilitation therapy. However, activity-dependent changes can also be 
maladaptive. Compensation [the use of alternative behavioural strategies to perform a 
task (Whishaw, 2000)], as well as disuse (the absence of any post-injury activity) can 
lead to detrimental cellular changes in the brain (Benowitz and Carmichael, 2010). As 
such, rehabilitation aims to optimize behavioural experiences and influence 
neuroplasticity in a positive way, with the goal of normalization of function rather than 
compensation.  
 
1.7.1 Constraint Induced Movement Therapy (CIMT) 
 
One of the rehabilitative techniques that has been developed to increase use and 
improve function of the upper limb in survivors of stroke is CIMT (Nijland et al., 2011). 
7KH WKHUDS\ GLVFRXUDJHV µOHDUQHG QRQ-XVH¶ ILUVW GHVFULEHG E\ 7DXE et al. (2006a). 
Learned non-use is a phenomenon whereby movement is initially suppressed due to 
failure and other adverse consequences encountered when a subject attempts to use the 
affected limb. This results in persistent compensatory behaviours and subsequent 
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suppression of use of the impaired limb, perpetuating the negative consequences (Figure 
1.7). Through constraint of the unaffected limb and subsequent forced use of the affected 
RQH &,07 HQFRXUDJHV SRVLWLYH IHHGEDFN DERXW WKH OLPE¶V IXQFWLRQDO SRWHQWLDO
Generally, a constraint device (e.g. a large mitten or sling) is worn for up to 90% of 
waking hours during a two week period (Richards et al., 2006; Sawaki et al., 2008; 
Wittenberg et al., 2003; Wolf et al., 2011), and is accompanied by intensive repetitive 
task practice (RTP) performed daily using the impaired limb. During RTP, patients 
engage in meaningful and increasingly difficult functional activities for which they 
receive positive feedback. In addition, other behavioural techniques such as home 
practice and problem solving sessions are used to aid in the transfer of functional gains 
to the performance of daily activities (Morris et al., 2006). 
CIMT has been shown in the clinic to improve functional outcome (Bonaiuti et 
al., 2007; Nijland et al., 2011; Sawaki et al., 2008; Wittenberg et al., 2003; Wolf et al., 
2011), even when administered to patients with chronic deficits (Liepert et al., 2000). 
However, the therapy presents several obstacles. CIMT is expensive, due the intensive 
therapy presently requiring specialized professionals. Furthermore, despite the fact that 
subjects are required to sLJQDµEHKDYLRXUDOFRQWUDFW¶GHVLJQHGWRLQFUHDVHLQFHQWLYHDQG
ensure motivation (Taub and Uswatte, 2003; Wolf et al., 2011), CIMT is a demanding 
therapy for stroke patients who have diminished physical capacity. This raises concerns 
about compliance (Page et al., 2002), and several modifications of the therapy have been 
investigated in an attempt to reduce the prescribed intensity (Page et al., 2005; Sterr et 
al., 2002; Wolf et al., 2011). While results of these studies are promising, further 
confirmatory research is required. CIMT has only been developed for, and tested in, 
patients that retain some level of function, according to general inclusion/exclusion  
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criteria such as the ability to initiate finger movements (Wolf et al., 2011), and extension 
movement of at least 20 degrees in the wrist and fingers (Richards et al., 2006; Sawaki 
et al., 2008; Taub et al., 2006b). This limits the generalization of study results to more 
disabled patients (Mark and Taub, 2004; Sterr and Saunders, 2006).
 Unfortunately, clinical evaluation of CIMT is limited by the inability to control 
experimental variables. Size, location, and severity of the infarct, as well as co-
morbidities and prior health status are all important variables that can affect treatment 
outcome (Duncan et al., 1992). There are also obvious challenges with respect to 
studying changes on a tissue and cellular level in the human stroke survivor population. 
Thus, clinical investigation into rehabilitation-driven neuroplasticity is challenging, 
highlighting the importance of developing valid, clinically relevant animal models of 
forced use rehabilitation. 
 
1.7.2 Animal models of forced use rehabilitation 
 
Valid experimental models are essential for the development of rehabilitative 
therapies to treat survivors of stroke. By modelling CIMT in animals, it may be possible 
to elucidate underlying processes responsible for functional benefits, and eventually to 
manipulate these processes to accelerate or enhance post-stroke recovery. Indeed, there 
have been several attempts at the development of animal models of rehabilitation that 
resemble CIMT (described below and summarized in Table 1.2) (Bland et al., 2000; 
DeBow et al., 2003; Humm et al., 1998; Leasure and Schallert, 2004; Müller et al., 
2008; Schabitz et al., 2004). These have provided important insight into the 
development of rehabilitation paradigms that best model particular and
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Table 1.2. Common animal models of forced use rehabilitation. A summary of advantages and disadvantages of several animal 
models of forced use rehabilitation. 
Rehab Model Advantages Disadvantages References 
Constraint -Most direct model of CIMT;  
-May allow constraint for 
specific durations, thereby 
allowing more complete 
evaluation 
-Conducive to studies of 
unilateral forced use 
-Constraint devices may be 
stressful, confounding results; 
-Lack of behavioural pressure 
to use paretic arm despite 
constraint 
(DeBow et al., 2003; Leasure and Grider, 
2010; Müller et al., 2008; Schabitz et al., 2004) 
Forcing use 
with locomotion 
-Stimulates use of the paretic 
limb in a less aversive paradigm 
-Can be stressful (involuntary 
forced use) or lack control over 
intensity (voluntary forced 
use);  
-Involves bilateral forced use 
(Auriat et al., 2006; DeBow et al., 2003; Kim 
et al., 2005; Maldonado et al., 2008; Marin et 
al., 2003; Ploughman et al., 2009; Yang et al., 
2003) 
Encouraging 
use with 
environmental 
enrichment 
-Stimulates use of the paretic 
limb in a less aversive paradigm 
-Complicated by other, non-
forced use therapy components 
such as cognitive stimulation;  
-Involves bilateral forced use 
(Auriat and Colbourne, 2009; Auriat et al., 
2010; Biernaskie and Corbett, 2001; Biernaskie 
et al., 2004; MacLellan et al., 2011) 
Task specific 
exercises 
-An addition to rehabilitation 
that models task specific shaping 
exercises of CIMT 
-Requires the desire of animals 
to participate in a demanding 
task 
(Auriat and Colbourne, 2009; Auriat et al., 
2010; Biernaskie and Corbett, 2001; Biernaskie 
et al., 2004; DeBow et al., 2003; Maldonado et 
al., 2008; Ploughman et al., 2009) 
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appropriate aspects of the regimen. CIMT involves constraint of the intact limb for most 
waking hours, which forces use of the impaired limb for daily tasks as well as intensive 
therapist-led RTP exercises (see Section 1.7.1). In rats, this presents a challenge. The 
affected forelimb can be constrained (DeBow et al., 2003; Leasure and Schallert, 2004; 
Schabitz et al., 2004), but increased animal stress (Ke et al., 2011; Yanagita et al., 2007) 
and lack of behavioural pressure to rely on the impaired forelimb (DeBow et al., 2003) 
can be problematic. Some researchers have opted to shift focus away from constraint per 
se and toward forced use. Many also incorporate task-specific exercises to model the 
573 DVVRFLDWHG ZLWK &,07 +RZHYHU WKLV UHVXOWV LQ D µWUDGH RII¶ RI DVSHFWV RI WKH
rehabilitation, in an attempt to replicate specific components of therapy. For example, 
experimental rehabilitation may require implementing less intense but voluntary 
paradigms to reduce animal stress and increase behavioural incentive. Taub and Uswatte 
(2003) KDYHHPSKDVL]HG WKDW WKH µFRQVWUDLQW¶XVHG LQ&,07 LV LQWHQGHGDV DPHDQV WR
induce patients to use the affected extremity for a large proportion of the time and for a 
variety of activities, thus other strategies that induce similar pressures are likely to result 
in similar use-dependent reorganization and functional benefit (Taub and Uswatte, 
2003). 
 
1.7.2.1 Forcing use by constraint  
 
The principle behind this approach is straightforward, and involves direct 
constraint of the unaffected forelimb, which forces use of the impaired forelimb. This 
strategy can be achieved by permanent plaster casting (Bland et al., 2000; DeBow et al., 
2004; Humm et al., 1998; Kozlowski et al., 1996; Leasure and Schallert, 2004; Müller et 
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al., 2008; Schabitz et al., 2004), bandaging (DeBow et al., 2004), or use of a constraint 
jacket (DeBow et al., 2003). 
Plaster casting and bandage wrapping have been used to model immediate and 
permanent constraint of the intact forelimb following electrolysis (Humm et al., 1998; 
Kozlowski et al., 1996), artery occlusion (Bland et al., 2000, 2001), photothrombosis 
(Müller et al., 2008; Schabitz et al., 2004) and devascularisation (DeBow et al., 2004). 
However, rather than leading to improved functional recovery, a number of studies have 
reported that this form of rehabilitation in rats results in use-dependent exaggeration of 
infarct volume (DeBow et al., 2004; Humm et al., 1998; Kozlowski et al., 1996) and 
either no functional improvement (Schabitz et al., 2004) or worsening of behavioural 
deficits (Bland et al., 2000, 2001; DeBow et al., 2004; Humm et al., 1998; Kozlowski et 
al., 1996; Müller et al., 2008). A possible explanation for these findings is the potential 
stress associated with complete constraint. Stress can decrease phosphorylation of CREB 
and inhibit BDNF production (Schaaf et al., 1998; Ueyama et al., 1997), thereby 
potentially attenuating plasticity (see Figure 1.4). Other explanations for the 
exacerbation of damage may involve excitotoxicity (Humm et al., 1999) and 
hyperthermia (DeBow et al., 2004) in perilesional tissue. 
Debow et al. (DeBow et al., 2003) employed a sleeveless constraint jacket, 
which was worn around the upper torso of the rat and could be attached to a separate 
metal wrist bracelet to restrict forelimb movement. An advantage of this paradigm over 
plaster casting is the ability to control the duration of the constraint. This more closely 
resembles the clinical administration of CIMT. However, the authors reported that 
constraint (for 6h/day) using this paradigm did not produce functional benefit. As above, 
a possible explanation of the failure of this seemingly clinically relevant model of CIMT 
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is that the continuous wearing of the jacket, or the constraint period used, could 
exacerbate animal stress and attenuate neuroplastic processes. A further explanation for 
the absence of improvement using this model may be the lack of behavioural pressure to 
use the impaired forelimb. In the same study, when animals were further engaged by 
performing additional rehabilitative exercises with the damaged limb (resembling RTP), 
functional recovery was effectively promoted (DeBow et al., 2003). 
 
1.7.2.2 Encouraging use with activity: enriched environment 
 
In 1947, Canadian neuroscientist Donald Hebb noted that laboratory rats that had 
been taken home as pets had better learning and problem-solving skills that those who 
lived in standard laboratory conditions (Hebb, 1947), suggesting that an enriched 
environment (EE) may affect neuroplasticity. Since then, research into exposure to EEs 
has shown that EEs are effective at improving post-stroke functional recovery (Auriat 
and Colbourne, 2009; Auriat et al., 2010; Biernaskie and Corbett, 2001; Janssen et al., 
2010; MacLellan et al., 2011), in a time-dependent manner (Biernaskie et al., 2004). 
Exposure of rats to enriched environments provides ample opportunity for 
engagement in voluntary nonspecific activity, because a major component of these 
environments is the presence of novel objects and climbing apparatuses. As such, 
general voluntary movement is encouraged in a way that stimulates use of the impaired 
forelimb, which may contribute to activity-dependent plasticity. While the precise 
contribution of the motor enrichment component of EE to functional recovery has yet to 
be determined, this environment represents a basic voluntary use paradigm that has 
shown significant positive results (Hicks et al., 2007; Janssen et al., 2010).  
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1.7.2.3 Forcing use by locomotion  
 
Locomotion presents an alternative approach to encourage use-dependent 
plasticity, by exploiting the fact that animals need to engage the impaired forelimb in 
order to run or walk. This form of rehabilitation can be forced, using motorized running 
wheels or treadmills (Auriat et al., 2006; Kim et al., 2005; Ploughman et al., 2009; Yang 
et al., 2003), or voluntary, by allowing free access to running wheels (Maldonado et al., 
2008; Marin et al., 2003). The intensity of such therapies has varied from < 1km to 7 
kms per day, and lasted 3-5 weeks (Auriat et al., 2006; DeBow et al., 2003; Kim et al., 
2005; Maldonado et al., 2008; Ploughman et al., 2009; Yang et al., 2003).  
The use of locomotion appears to be a promising approach, and both forced (Kim 
et al., 2005; Leasure and Grider, 2010; Ploughman et al., 2009; Yang et al., 2003) and 
voluntary (Ke et al., 2011; Mizutani et al., 2011) locomotion can improve functional 
recovery following administration of ET-1 topically (Leasure and Grider, 2010), directly 
proximal to the MCA (Ploughman et al., 2009), and following MCAo using the 
intraluminal thread method (Ke et al., 2011; Kim et al., 2005; Mizutani et al., 2011; 
Yang et al., 2003). Additionally, unlike direct constraint methods described above, 
infarct volume is not affected (Leasure and Grider, 2010; Ploughman et al., 2009) or is 
even decreased in animals receiving locomotor rehabilitation (Yang et al., 2003). The 
mechanisms underlying functional recovery in these studies may involve increased 
expression of BDNF (Ke et al., 2011; Kim et al., 2005), because blocking BDNF 
production attenuates the functional recovery induced by exercise (Ploughman et al., 
2009). Conversely, several groups have reported that voluntary (Maldonado et al., 2008; 
Marin et al., 2003) and forced (Auriat et al., 2006) exercise exerts no beneficial effect on 
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functional recovery (although, notably, without exacerbating damage). The reason for 
this discrepancy could be variations in the paradigms of both forced and voluntary 
exercise that have been studied, and the use of different outcome measures.  
Ke et al. (2011) showed that voluntary exercise (access to voluntary wheel 
running for 23 hours per day) is more beneficial than forced exercise (30 minutes of 
daily treadmill exercise). This study demonstrated that forced exercise resulted in 
increased levels of corticosterone, a typical marker of stress, which can inhibit BDNF 
expression (Schaaf et al., 1998). Similar results were reported by Yanagita et al. (2007) 
who demonstrated that following voluntary wheel running, animals exhibited fewer 
neurons containing corticotrophin-releasing hormone compared to forced treadmill 
exercise controls. However, a drawback to voluntary exercise is that the experimenter 
has less control over the intensity of the rehabilitation (Ke et al., 2011; Maldonado et al., 
2008; Mizutani et al., 2011). 
 
1.7.2.4 Forcing use with task specific exercises 
 
Clinical CIMT includes RTP exercises that involve grasping, gripping, and 
manipulating objects (Sawaki et al., 2008; Wittenberg et al., 2003). Therefore, many 
preclinical researchers combine one of the forms of rehabilitation described above with a 
task specific exercise (Auriat et al., 2010; Biernaskie and Corbett, 2001; Biernaskie et 
al., 2004; DeBow et al., 2003; Fang et al., 2010; Maclellan et al., 2005; Maldonado et 
al., 2008; Ploughman et al., 2009). Experimentally, RTP exercises are often modelled 
using pellet reaching tasks. Animals are provided palatable sucrose pellets that require 
reaching with the impaired limb. This can be achieved by placing pellets on the 
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appropriate side of a tray, shelf, or well (Auriat et al., 2010; Fang et al., 2010; 
Maldonado et al., 2008) or by using a modified staircase apparatus (Auriat and 
Colbourne, 2009; Biernaskie and Corbett, 2001; Biernaskie et al., 2004). 
 
1.7.2.5 Initiating rehabilitation: considerations 
 
While CIMT is generally initiated as soon as the patient is medically stable, it is 
still effective when initiated several years post-insult (Liepert et al., 2000). Some animal 
studies have shown that initiation of rehabilitation immediately after surgery can result 
in larger infarcts and worse functional outcome (DeBow et al., 2004; Humm et al., 
1998). However, unlike humans, rats exhibit spontaneous recovery on many functional 
tests in a relatively short time frame (< 1 month), so delayed rehabilitation may result in 
a missed opportunity to accelerate recovery. Thus, rehabilitation in rat models is 
generally initiated between post surgical day 3 and 7 (Auriat et al., 2010; Biernaskie et 
al., 2004; DeBow et al., 2003; MacLellan et al., 2011; Maldonado et al., 2008; 
Ploughman et al., 2009). Considering that post-ischemic neuroplastic processes are 
dynamic and may depend on the severity of the initial insult, the ideal time to initiate a 
particular rehabilitation model likely varies. 
 
1.8 MEASURING FUNCTIONAL DEFICIT AND RECOVERY 
 
When evaluating post-stroke deficits and subsequent recovery in animal models, 
it is recommended that a battery of tests be used (Kleim et al., 2007; Schaar et al., 2010; 
STAIR, 1999). Several considerations that must be made when choosing behavioural 
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tests include the sensitivity of the test to the damage being observed, the time required to 
pre-train and test animals, and the possible confounding properties of the tests and 
testing schedule chosen. The latter is especially important in studies of rehabilitation, in 
which performance of the tests themselves can affect activity-dependent neuroplasticity, 
and therefore, be potentially rehabilitative (Kleim et al., 2007).  
An ongoing challenge for both clinical and experimental researchers is how to 
DSSURSULDWHO\GHILQHDQGDVVHVVµUHFRYHU\¶,QRUGHUWRPHDVXUHIXQFWLRQUHVHDUFKHUVUHO\ 
RQDYDULHW\RIGLIIHUHQW WHVWVDQGVFDOHV6RPHWLPHVZKDWDSSHDUV WREH µUHFRYHU\¶ LV
simply the subject (human or animal) compensating for lost function in a way that 
allows them to attain a performance on the test that resembles normal function. This is 
an important distinction; if using a scoring system such as a scale that measures 
competency on activities of daily living, a patient who has learned to carry out daily 
living tasks using their other limb would show improved scoring despite lack of any 
actual recovery. Incorporation of a variety of functional tests decreases the chance of 
compensatory action to confound the result. 
Several behavioural tests of forelimb function have been well characterized in rat 
stroke models, and the tests chosen for the present research are summarized in Table 1.3. 
These tests range from those that measure acquired sensorimotor behaviours (i.e. skilled 
movements, which generally require training) to those that measure pre-existing 
behaviours (i.e. unskilled movements and reflexes requiring very little training). 
Detailed descriptions of the methodological details are presented in Chapters 2, 3, and 4 
(see Sections 2.2.4, 3.2.4, and 4.2.4). 
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Test Description Evaluating behaviour Selected references 
Forelimb 
flexion 
The rat is suspended above the home cage and the position of the 
impaired forelimb is scored from 0 to 2 wherein 0 = no flexion, 1 
= flexion of the forelimb, and 2 = forelimb flexion with twisting 
of the torso.  
Basic neurological 
function  
(Bederson et al., 1986; Riek-
Burchardt et al., 2004; Sun et 
al., 2008) 
Forelimb 
placing  
The rat is held by the torso with all but the testing limb secured. 
The vibrissae or wrist of the animal is brushed against the edge of 
a table. The number of successful responses (placing the paw in 
response to the simulation) is recorded.  
Sensorimotor 
capacity  
(Leasure and Schallert, 2004; 
De Ryck et al., 1989; Schallert 
et al., 2000a) 
Cylinder The animal is placed into a transparent plastic cylinder which 
encourages vertical exploration. He is then video recorded while 
rearing and exploring. The percent usage of the impaired forelimb 
is determined by slow motion video analysis. 
Preference for 
intact limb for 
postural support 
during movements  
(Auriat and Colbourne, 2009; 
Hicks et al., 2009; MacLellan et 
al., 2011; Schallert et al., 2000a; 
Soleman et al., 2010; Windle et 
al., 2006) 
Horizontal 
ladder 
Animals cross a horizontal ladder of variably spaced rungs to 
escape aversive stimuli (noise and light). The average number of 
foot slips made is determined by video analysis. 
Coordination and 
sensorimotor 
function  
(Auriat et al., 2006, 2010; 
Biernaskie et al., 2004; DeBow 
et al., 2003; Metz and Whishaw, 
2002; Soleman et al., 2010) 
Staircase Animals are placed into an apparatus consisting of an elevated 
platform with descending steps on either side. Each step is baited 
with multiple palatable sucrose pellets, at progressively deeper 
levels. Dexterous movements requiring motor function and 
sensory feedback are required to obtain pellets. 
Assesses forelimb 
sensorimotor 
capacity, dexterity, 
and coordination  
(Auriat and Colbourne, 2009; 
Biernaskie et al., 2004; DeBow 
et al., 2003; MacLellan et al., 
2011; Montoya et al., 1991) 
Table 1.3. Behavioural tests of animal forelimb function. A summary of the behavioural tests used in this thesis. Methods are 
described in more detail in Chapters 2, 3, and 4, under Methods and Materials. 
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1.9 SUMMARY 
 
With an aging population, high incidence of stroke, and few effective medical 
interventions, it is vital to gain a better understanding of the mechanisms underlying 
functional recovery in order to refine existing rehabilitative therapies and to develop 
new techniques. In order to understand the mechanisms underlying rehabilitation, 
clinically relevant animal models are important. Addressing all aspects of human stroke 
using any single animal model may never be possible, but many animal models have 
contributed to our understanding of the mechanisms underlying ischemic and 
neuroplastic processes. 
Modelling rehabilitation presents a major challenge and remains fundamentally 
different from rehabilitation in a clinical setting. Stroke patients undergoing CIMT 
receive supervised, assisted, and highly-motivated rehabilitation with trained experts. 
Experimental rehabilitation is largely hands-off, and animals are more difficult to 
motivate. The validity of any model may vary with respect to a particular aspect of the 
therapy. However, cortical reorganization and functional recovery may share underlying 
processes with the mechanisms responsible for the benefits of CIMT. In the clinic, 
constraint is simply considered the tool that induces the beneficial use of the impaired 
limb, discourages learned non-use, and encourages beneficial neuroplastic processes to 
occur (Taub and Uswatte, 2003). 
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1.10 EXPERIMENTAL OBJECTIVES OF THE THESIS 
 
The research described in this thesis was performed to investigate post-ischemic 
functional recovery and neuroplasticity in response to a novel model of voluntary forced 
use of the impaired forelimb. It was hypothesized that a novel model of voluntary 
forced use movement therapy would result in improved functional recovery as 
measured using a battery of behavioural tests. It was further hypothesized that this 
rehabilitation would alter the expression of a number of markers of neuroplasticity. 
These hypotheses were tested by addressing the following specific aims:  
1. Refine an endothelin-1 model of focal ischemic stroke in the rat, in order 
to obtain reproducible focal lesions to forelimb motor representation 
areas of the brain.  
ET-1 was injected into the brain at a set of previously unpublished 
stereotaxic coordinates corresponding to the forelimb motor cortex and 
striatum. The animals were assessed on a number of behavioural tests to 
determine the magnitude and duration of deficit. Tissue was analysed to 
determine the placement, spread, and volume of the resulting lesion. 
2. Conduct a preliminary evaluation of a novel model of voluntary forced 
use movement therapy on functional recovery and markers of 
neuroplasticity. 
Animals were treated with a novel rehabilitation model wherein they were 
allowed to voluntarily engage in the movement of pet activity balls, which 
forced use of the impaired forelimb using an appetitively motivated 
approach. They were again assessed on a number of behavioural tests (those 
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used in specific aim 1, as well as an additional test) to determine whether 
there was a benefit of rehabilitation on recovery profile. Tissue was analysed 
to determine whether rehabilitation affected the infarct volume, and whether 
there was any effect on several markers of neuroplasticity: BDNF, NOGOA, 
and the presence of nascent neurons. 
3. Evaluate a refined model of voluntary forced use movement therapy 
based on functional measures and markers of neuroplasticity. 
Animals were treated with a refined rehabilitation model wherein they were 
subjected to both activity ball therapy as well as a task specific exercise 
intended to model RTP that accompanies CIMT. Functional recovery was 
assessed using a number of behavioural tests (some of which were used in the 
previous specific aims, as well as an additional test). Tissue was analysed for 
infarct volume, presence of nascent neurons, and the level and cellular origin 
of BDNF. 
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CHAPTER 2: 
DEVELOPMENT OF THE ENDOTHELIN-1 MODEL OF POST-ISCHEMIC 
UPPER EXTREMITY IMPAIRMENT1 
 
 
 
 
 
 
 
 
³The brain can reorganize to compensate for 
loss; it is enormously plastic.´ 
 
-Paul Bach y Rita (1934-2006) 
picture from http://just-one-
question.com/Site/joq_pers_paul.html 
                                                 
1
 The majority of data presented in this chapter are published in: A novel approach to 
induction and rehabilitation of deficits in forelimb function in a rat model of 
ischemic stroke. Acta Pharmacol Sin. 2012, 34(1): 104-112. JLT contributed to 
experimental design, performed surgeries, behavioural testing, and histology, and 
prepared the manuscript. 
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SUMMARY 
 
Stroke commonly results from impaired circulation through the MCA, which 
supplies blood to sensorimotor regions in the striatum and cortex. Research into 
rehabilitation of motor function necessitates the use of an appropriate stroke model. 
Because recovery of function is largely attributed to numerous neuroplastic changes on a 
cellular level, it is especially important to ensure sufficient unaffected or salvageable 
tissue remains to act as a substrate for recovery processes. One surgical stroke model 
used in rodents is intracerebral injection of a vasoconstrictor, ET-1. By constricting 
blood vessels in surrounding tissue, ET-1 models the events of a temporary ischemic 
episode in a clinically relevant manner. Some research groups have published variations 
of the ET-1 model to produce localized ischemic damage, however no surgical standard 
exists for creating lesions specific to forelimb motor areas of the brain. In the study 
presented in this Chapter, adult male rats were randomly assigned to receive ET-1 
microinjections at a series of previously unreported stereotaxic coordinates, or sham 
surgery. Animals were then assessed over a period of 21 days using a battery of 
sensorimotor tests to determine deficit and subsequent spontaneous recovery. Following 
the study, animals were then euthanized and infarct volume was measured. This ET-1 
protocol resulted in reproducible, well-defined lesions, accompanied by deficits that 
lasted up to 21 days post-surgery. This surgical protocol was therefore deemed to be 
appropriate to use for studying the effects of post-ischemic rehabilitation in the 
following Chapters of this thesis. 
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2.1 INTRODUCTION 
 
Stroke commonly results from impaired circulation through the MCA (Madden, 
2002) which supplies blood to motor regions in the striatum and cortex (Yamori et al., 
1976). In humans, arm impairment is a particularly debilitating and pervasive functional 
deficit following stroke (Williams et al., 1999), and proper function of the arm and hand 
is important for achieving post-stroke independence (Burvill et al., 1997). While some 
spontaneous recovery of deficits occurs in the early post-stroke period (Krakauer, 2005), 
this is largely attributed to the resolution of secondary injury processes, and chronic 
deficits can remain for years in the absence of rehabilitative intervention (see Section 
1.3). In order to investigate processes underlying post-ischemic neuroplasticity, and to 
properly evaluate models of rehabilitation, it is essential to begin with an appropriate 
stroke model.  
While several animal models of stroke exist, rat models remain the most popular 
choice for researchers. This is largely due to the similarity between rat and human 
neurovasculature (Macrae, 1992; Yamori et al., 1976), the relatively low cost and ease 
of use (Durukan and Tatlisumak, 2007), the large number of validated functional tests 
(Kleim et al., 2007; Tamura et al., 1981), and the documented similarities between rat 
and human limb movements (Whishaw et al., 2002).  
All experimental stroke models are associated with inherent variability in the 
lesion that is produced. Because recovery of function is largely attributed to numerous 
neuroplastic changes at a cellular level (Dobkin, 2004; Jones et al., 2009; Wieloch and 
Nikolich, 2006) (see Section 1.4), it is especially important to ensure that sufficient 
unaffected or salvageable tissue remains to act as a substrate for recovery processes. 
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Furthermore, consideration should be given to complications of the model that can have 
a direct impact on behavioural outcome. For example, poor overall health due to loss of 
body weight, infections, and collateral damage to non-targeted areas can all affect 
performance on functional outcome measures. 
Occlusion of the MCA is presently one of the most commonly used models of 
stroke in the rat (Durukan and Tatlisumak, 2007; Kleim et al., 2007) (see Section 1.6.3). 
Variations on the model include permanent occlusion (using a clip or suture) (Sun et al., 
2012) or temporary occlusion (the insertion and later removal of an intraluminal 
filament, allowing reperfusion) (Belayev et al., 1996). However, both methods often 
result in large, inconsistently placed lesions, rendering them inadequate for studying 
specifically localized deficits. Additionally, they are commonly associated with 
relatively high mortality (Lindner et al., 2003) unless accompanied by labour-intensive 
post-operative care (Sun et al., 2008). Furthermore, mechanical occlusion and 
reperfusion are instantaneous, unlike the more gradual processes that take place during 
clinical stroke (Kleim et al., 2007).  
Alternative models of focal stroke have been developed in an attempt to more 
effectively control lesion location and reproducibility, and to produce marked deficits 
specific to forelimb function. Non-ischemic focal lesioning techniques such as 
devascularisation (Gonzalez and Kolb, 2003) and photothrombosis (Shanina et al., 2006) 
can result in precise and discrete lesions, however these affect surface tissue only 
(without accompanying damage to subcortical areas), do not allow for restoration of 
blood flow to the ischemic region, and may not result in the same post-ischemic 
processes as vessel occlusion. 
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An alternative method is to reversibly constrict local vessels pharmacologically, 
through administration of a vasoconstricting peptide, ET-1. Endothelin-1 causes a rapid, 
temporary, and dose-dependent constriction of affected arteries, resulting in interruption 
in blood flow within minutes, followed by reperfusion over several hours (Fuxe et al., 
1997; Macrae, 1992; Nikolova et al., 2009). Depending on the brain regions being 
targeted, ET-1 can be applied to the MCA (Robinson et al., 1990; Sharkey et al., 1993), 
or to the cortical surface (Fuxe et al., 1997), injected intracerebrally (Gilmour et al., 
2004), or administered as a combination of intracerebral and topical application 
(Soleman et al., 2010; Windle et al., 2006). Intracerebral microinjections, in which 
lesion placement can be carefully controlled and subcortical areas can be affected, 
represent a promising model for studying clinically relevant recovery and rehabilitation 
(see Figure 1.6). While variations on the model have been reported (Gilmour et al., 
2004; Hewlett and Corbett, 2006; Windle et al., 2006), no surgical standard presently 
exists.  
Previous work in our laboratory aimed to develop a variation of the ET-1 model 
that would result in reproducible unilateral ischemic lesions to the forelimb sensorimotor 
cortex and dorsolateral striatum, as well as functional forelimb impairments with an 
associated measurable recovery period (Hume, 2009). The specific aim of the current 
study was to further optimize the surgical technique using an injection protocol of four 
cortical injections (1µl each) and one striatal injection (0.5µl) of a 400 pmol/µl ET-1 
solution.
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2.2 METHODS 
 
2.2.1 Experimental animals 
 
Adult male Sprague-Dawley rats (N=20) were purchased from Charles River 
Laboratories (Montreal, Canada) and single housed on a 12 hr light/dark cycle (lights on 
at 08:00; off at 20:00). Animals had ad libitum access to food and water, and weighed 
between 300-350 g at the time of surgery. All procedures were conducted in accordance 
with the guidelines of the Canadian Council for Animal Care and were approved in 
advance by the University of Prince Edward Island Animal Care Committee. 
 
2.2.2 Endothelin-1 preparation 
 
One day prior to surgeries, lyophilized ET-1 (Calbiochem, Germany) was 
dissolved in sterile H2O at a concentration of 400 pmol/µl. The prepared ET-1 was then 
stored as aliquots at -20oC until use, up to a maximum of 12 days.  
 
2.2.3 Surgical procedure 
 
Forelimb sensorimotor coordinates for ET-1 injections were determined using 
the Paxinos and Watson Rat Brain Atlas (Paxinos and Watson, 2007). Prior to the study, 
injection locations were verified using injections of cresyl violet dye into the chosen 
coordinates using a separate set of animals (n=2). Before surgery, rats were randomly 
allocated to the Sham or Stroke group. At the time of surgery, rats were placed into an 
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induction chamber filled with 3.5% isoflurane in oxygen for 8 minutes; anaesthesia was 
subsequently maintained during the surgery using 2% isoflurane in oxygen (or as 
required). Once anesthetised, animals were mounted onto a stereotaxic apparatus (David 
Kopf Instruments, USA). The scalp was shaved, topical anaesthetic (Xylocaine; 
AstraZeneca, Canada) was applied, a midline incision was made, and the scalp was 
retracted with clamps. The surface of the skull was cleared of all tissue, the skull was 
confirmed to be level between bregma and lambda, and injection coordinates were 
marked (Table 2.1). Small holes were drilled through the skull at each injection location 
using a stereotaxically mounted drill (Stoelting Co., USA). At each location, a 26 gauge 
ȝOV\ULQJHZDVORZHUHGLQWREUDLQWLVVXHDQGOHIWXQGLVWXUEHGIRUPLQ(QGRWKHOLQ-1 
was then injected at a flow rate of 0.5µl/minute (injection volumes in Table 2.1), after 
which the needle was left undisturbed for 4 minutes before being slowly retracted from 
the brain. Following all injections, the scalp was sutured and the incision site was treated 
with topical anaesthetic. Body temperature was monitored regularly and maintained at 
36.0 ± 0.2°C for the duration of surgery using a heating pad. Following surgery, animals 
were given subcutaneous injections of butorphanol (2.0 mg/kg), returned to their home 
cage, and allowed to recover. A heating pad remained under the home cage for 1 hour 
post-surgery. Sham-operated rats received the same surgical procedure up to but not 
including the drill holes, remained anesthetised for the same amount of time as the ET-1 
animals, and received the same post-operative medication (n=14 stroke; n=6 sham).  
73 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1 ET-1 injection coordinates. Endothelin-1 microinjection locations (in mm from bregma) used in this study. Coordinates 
determined using (Paxinos and Watson, 2007). AP = anterior/posterior; ML = medial/lateral; DV = dorsal/ventral. A visual 
representation of the injection coordinates approximately shows the cortical injections along the forelimb motor representation of the 
cortex (solid dots) and the deeper striatal injection location (star) 
 Stereotaxic coordinates  
(mm from bregma) Volume 
(µl) 
  AP ML DV 
Cortex injection 1  +2.5 -2.8 -2.5 1.0 
Cortex injection 2  +1.6 -2.8 -2.5 1.0 
Cortex injection 3  +0.9 -2.8 -2.5 1.0 
Cortex injection 4  +0.4 -2.8 -2.5 1.0 
Striatum injection  +0.9 -3.7 -6.0 0.5 
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2.2.4 Behavioural testing 
 
Several behavioural tests commonly employed to determine sensorimotor 
deficits were used in this study. For three weeks prior to surgery, animals were handled 
daily and acclimated to all tests, then pre-surgical scores were recorded. Following 
surgery, animals were tested regularly until the end of the study at post surgical day 
36'  :KHQ HYDOXDWLQJ EHKDYLRXU µGHILFLW¶ ZDV GHILQHG DV D PHDQ SRVW-surgical 
stroke group performance significantly worse than mean sham control performance and 
µUHFRYHU\¶ ZDV FRQVLGHUHG WKH SRLQW DW ZKLFK WKH PHDQ stroke group score was not 
significantly different from mean sham performance. In any instance where the stroke 
group had recovered at a particular time point, then had subsequent testing days with 
LPSDLUHG SHUIRUPDQFH µUHFRYHU\¶ ZDV FRQVLGHUHG WKH ODWHVW WLPH SRLQW DW ZKLFK WKH\
consistently performed at sham level. All performance evaluations were conducted by an 
experimenter blind to the surgical condition. 
 
2.2.4.1 Forelimb placing tests 
 
 Two tests of forelimb placing were employed daily post-surgery: tactile-
stimulated forelimb placing (TFP) and vibrissae-stimulated forelimb placing (VFP). Rats 
were held by their torso, with 3 limbs secured and the forelimb to be tested hanging free. 
For TFP, the distal portion of the unrestrained forelimb was brushed against the edge of 
a table. For VFP, the rat was moved horizontally toward the table edge until the 
vibrissae came in contact with the surface (Figure 2.1). For each forelimb, the deficit  
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Figure 2.1. Forelimb placing tests. Vibrissae and tactile-stimulated forelimb placing 
testing was performed by constraining three limbs (except the forelimb to be tested) and 
gently brushing the vibrissae or wrist of the rat against a table edge. In response, the rat 
would place a forepaw onto the table when stimulated. Following stroke surgery, this 
response was disabled. 
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was determined based on the number of failed responsive forelimb placements on the 
table top out of 5 attempts. Attempts that missed the tabletop or did not place within 2 
seconds of stimulation were considered unsuccessful. Testing took place during the light 
cycle, but under red light conditions in order to diminish the influence of visual input on 
placing success. The order of ipsilateral/contralateral forelimb testing was alternated. 
 
2.2.4.2 Forelimb postural reflex test 
 
The forelimb postural reflex test was performed daily. Rats were suspended by 
the base of the tail 50 cm above their home cage. The position of the contralesional 
forelimb was scored as follows: normal vertical reaching toward the surface (score = 0; 
no deficit), >90o forelimb extension at the shoulder or adduction of the forelimb to the 
torso (score = 1; mild-moderate deficit), or extension/adduction accompanied by torso 
twisting (score = 2; severe deficit). 
 
2.2.4.3 Cylinder test 
 
 Animals were tested for limb preference and asymmetry in postural weight 
support during exploratory activity using the Schallert cylinder test (Schallert et al., 
2000) on PSD 1, 3, 6, 10, 14, 18 and 21. Rats were placed inside a clear open-ended 
cylinder (25cm diameter x 30cm height) and allowed to rear and explore the cylinder 
walls during 15 rears (Figure 2.2). A camera was stationed above the top of the cylinder 
to record forepaw usage during exploratory behaviour. Videos were then analyzed to 
determine the number of forelimb wall contacts made. The percentage use of the  
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Figure 2.2. Cylinder test. Animals were placed into a clear plastic cylinder, and 
allowed to rear several times while being filmed from above. Intact animals would use 
each forelimb for approximately half of all exploratory and weight bearing movements, 
thus a post-injury measure of asymmetry can be obtained by testing animals following 
stroke surgery. 
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impaired forelimb was determined using the following formula: [(# contralesional 
touches + ½ # bilateral touches) / total # touches] *100.  
 
2.2.5 Histology and infarct quantification 
 
Following behavioural testing, rats were deeply anesthetised with sodium 
pentobarbital (240 ml/kg; Euthansol, Schering, Canada) and decapitated. Brains were 
quickly removed to 250 ml of 10% phosphate buffered neutral formalin for 72 hours, 
sectioned (150 µm) using a Vibratome 1000 Plus (Vibratome Co. St. Louis, USA), 
mounted on slides, and stained using 0.1% cresyl violet solution. Photographs (Canon 
EOS DS6041 camera) oI HYHU\ VHFRQG VHFWLRQ LH ȝPDSDUWZHUH WKHQXVHG IRU
quantifying infarct damage using Image J software (National Institutes of Health [NIH], 
USA) by overlaying each experimental section onto a corresponding template section, 
and tracing the area of injury. Ischemic injury was defined as pallor or lack of cresyl 
violet staining (Luke et al., 2004). The total volume of brain injury was determined by 
summing the area of damage from each section and multiplying that value by the 
distance between the measured sections (Swanson et al., 1990). 
 
2.2.6 Statistical analyses 
 
Statistical analyses were performed using PAWS Statistics (v. 18; SPSS Inc., 
USA). Behavioural data were analysed using repeated measures analysis of variance 
(RM ANOVA). Where the sphericity assumption was violated (Mauchly's test; p<0.05) 
the Greenhouse±Geisser correction was applied (Geisser and Greenhouse, 1958). This 
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alters the degrees of freedom such that the critical F-value remains unchanged while the 
Type 1 error that results from violating sphericity is decreased (degrees of freedom are 
reported to the nearest integer). Independent two-tailed t-tests were used to determine 
differences between groups on specific days. Significance was considered p<0.05. 
Values are expressed as mean ± SEM.  
 
2.3 RESULTS 
 
2.3.1 Behavioural tests 
 
2.3.1.1 Forelimb placing tests 
 
Prior to surgery, all animals were able to successfully place 5/5 times in response 
to both tactile and vibrissae stimulation. Following ET-1 surgery, the ipsilateral placing 
response remained intact (data not shown). For tactile-stimulated placing on the 
contralesional side, there was a significant effect of group (F1,18=15.53; p=0.01), an 
effect of time, and a significant interaction of group x time (F4,69=3.79; p=0.008). Stroke 
animals remained impaired until PSD 20 (p=0.013) (Figure 2.3A). 
In the vibrissae-stimulated forelimb placing test, there was a significant group 
effect (F1,18 =15.53; p=0.001), and a significant effect of time as well as interaction of 
group x time (F4,68 =5.72; p=0.001). Stroke resulted in a significant impairment in 
contralateral forelimb placing in response to vibrissae stimulation that lasted for the 
duration of the study (p=0.030) (Figure 2.3B). 
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Figure 2.3. Performance on the forelimb placing tests. (A) Contralesional tactile-
stimulated forelimb placing function was impaired following ET-1 surgery, but not 
Sham surgery. The deficit was significant until 20 days post surgery. (B) Vibrissae-
stimulated forelimb placing function was impaired following ET-1 surgery but not Sham 
surgery. The deficit was significant until 21 days post surgery. n=14/stroke n=6/sham. 
A. 
B. 
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2.3.1.2 Forelimb postural reflex test 
 
Prior to surgery, animals in both the Stroke and Sham groups all received a score 
of 0 in the forelimb postural reflex test. Following surgery, statistical analysis revealed a 
significant difference between groups (F1,18=10.8; p=0.004), a significant effect of time, 
and an interaction of group x time (F5,86= 3.26; p=0.011). Postural reflex remained 
impaired in ET-1 animals for the duration of the study (p= 0.002) (Figure 2.4). 
 
2.3.1.3 Cylinder test 
 
To assess differences in the spontaneous use of the contralateral forelimb during 
exploration, the cylinder test was used to evoke and analyze percent forelimb usage. 
Sham and Stroke groups performed similarly prior to surgery, relying on the 
contralesional forelimb for exploring and weight bearing approximately half of the time 
(51.5 ± 2.8% for Sham and 49.1 ± 3.8% for Stroke). Following surgery, animals that 
received ET-1 demonstrated a consistent tendency to rely less on their contralesional 
forelimb compared to shams (PSD 1 = 39.1 ± 4.7% vs 48.4 ± 2.6%), although there was 
no significant difference between groups (F1,18=1.978; p=0.177) (Figure 2.5). 
 
2.3.2 Histology and infarct quantification 
 
A total of five intracerebral injections of ET-1 were administered in this study, 
targeting brain regions known to be responsible for forelimb sensorimotor function, 
including sensorimotor cortex and dorsolateral striatum (Figure 2.6A). Brains were 
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Figure 2.4. Performance on the forelimb postural reflex test. Postural reflex was 
determined by observing the position of the impaired forelimb while suspending the 
animal above a flat surface. The reflex was impaired in animals that received ET-1, but 
not sham surgery. The deficit lasted the duration of the study. n=14/stroke n=6/sham. 
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Figure 2.5. Performance on the cylinder test. The Schallert (Schallert et al., 2000) 
cylinder test of forelimb asymmetry was not significantly impaired following ET-1 
surgery compared to Sham surgery. n=14/stroke n=6/sham. 
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sectioned for complete analysis of the infarct at various stereotaxic levels; a 
representation of typical damage at each level is presented in Figure 2.6A. The average 
volume of ischemic damage resulting from this injection protocol was 21.31 ± 4.81 mm3 
(cortical) and 13.36 ± 3.36 mm3 (striatal), giving a combined total damage volume of 
37.2 ± 7.69 mm3 (Figure 2.6B). The infarct spread and volume at each stereotaxic level 
is presented in Figure 2.6C. 
 
2.4 DISCUSSION 
 
Mechanistic studies of post-stroke plasticity and rehabilitation require the use of 
a stroke model that results in consistent, well-defined lesions, with preservation of 
sufficient neural substrate to support neuroplastic processes. Other groups have 
evaluated the use of distinct variations of the ET-1 model to generate permanent 
histopathological damage to forelimb regions of the brain and associated functional 
impairment (Gilmour et al., 2004; Hewlett and Corbett, 2006; Soleman et al., 2010; 
Windle et al., 2006). However, no surgical standard currently exists.  
 The objective of this experiment was to evaluate a modified ET-1 microinjection 
protocol using tests of forelimb function and histological assessment of the resulting 
infarct. Stroke often results in a combination of cortical and striatal injury (Cramer, 
2003), therefore a combination of cortical and striatal injections were performed. 
Assessment of the infarct at various stereotaxic levels showed that damage was well-
confined to targeted brain regions responsible for forelimb function (Figure 2.6). Infarct 
variability was lower than that reported using similar ET-1 injection protocols (Hewlett 
and Corbett, 2006; Hume, 2009; Windle et al., 2006), despite the use of more injections. 
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This could be due to the use of lower overall injection volumes of a similarly 
concentrated solution, using more numerous injections [5 injections totalling 4.5 µl of 
400 pmol/µl ET-1 in the present study, compared to 3 injections totalling 5 µl (Hewlett 
and Corbett, 2006) or 6 µl (Windle et al., 2006) of a similarly concentrated solution 
previously reported]. 
In addition to measuring infarct volume, characterizing functional deficits that 
accompany brain injury is important when evaluating a stroke model (Corbett and 
Nurse, 1998). The results showed that the present injection protocol resulted in forelimb 
functional deficits that were measurable up to 21 days before recovery occurred (Figure 
2.3-2.4). This duration of deficit is similar to previous literature employing these tests 
(Leasure and Schallert, 2004; Schallert et al., 2000), and longer lasting than previous 
injection protocols attempted in our laboratory (Hume, 2009).  
Interestingly, there was no deficit detected on the cylinder test in this study, 
similar to previous reports using both rat (Fang et al., 2010) and mouse (Tennant and 
Jones, 2009) intracerebral ET-1 injection protocols, but contrary to several other studies 
of both ischemic (Hume, 2009; Schallert et al., 2000; Soleman et al., 2010; Windle et 
al., 2006) and non-ischemic (Schallert et al., 2000) damage to similar brain regions. The 
reason for this is unclear; previous cylinder impairments have been reported in the same 
strain of rat (Hume, 2009; Schallert et al., 2000) thereby ruling out a strain-specific 
issue. The test is easy to score with a high inter-rater reliability even when administered 
by inexperienced researchers (Schallert et al., 2000), excluding experimenter error. One 
SRVVLEOH H[SODQDWLRQ LV WKH DGPLQLVWUDWLRQ RI WKH F\OLQGHU WHVW GXULQJ WKH DQLPDOV¶ OHVV
active light cycle. Rats are nocturnal, which could affect motivation to explore in the 
cylinder during the day (Schallert and Woodlee, 2005). Occasionally, experimenter 
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LQWHUYHQWLRQV ZHUH UHTXLUHG WR VWLPXODWH WKH DQLPDOV¶ FXULRVLW\ WR REWDLQ WKH WDUJHW 
rears (e.g. lightly tapping the top of the cylinder, momentarily turning off the lights, 
etc.). It is possible that these interventions resulted in non-representative bi-tactile 
rearing responses that may have masked a more robust underlying deficit. However, 
interventions to motivate performance are suggested by Schallert and Woodlee (2005), 
and are not believed to affect the limb-use asymmetry score. Nonetheless, for future 
studies, cylinder testing took place during the dark cycle to eliminate this possibility (see 
Chapters 3 and 4). 
Further issues to note in this study are the ET-1 vehicle used, and the definition 
of Sham surgery. The current study used sterile water as a vehicle for dissolved ET-1, as 
has been previously reported (Hewlett and Corbett, 2006; Hicks et al., 2007; Ploughman 
et al., 2009) including in our laboratory (Hume, 2009). Other appropriate vehicle 
choices used previously include saline (Hughes et al., 2003; Soleman et al., 2010) and 
artificial cerebral spinal fluid (Fuxe et al., 1997; Ueki et al., 1993). However, to my 
knowledge, no systematic comparison of these ET-1 vehicles appears in the literature. In 
the present study, Sham surgeries did not include craniectomies or injections, similar to 
others (Kozlowski et al., 1996). Previous literature has shown that even when sham 
animals undergo skull removal, or skull removal followed by vehicle injection, there is 
no detectable effect on behaviour (Frost et al., 2006; Gilmour et al., 2004; Hume, 2009; 
Windle et al., 2006) nor significantly quantifiable lesion volume (Gilmour et al., 2004). 
Therefore, it is unlikely that the use of other sham surgical procedures would have 
significantly affected the results of this study. 
The ET-1 injection protocol described herein resulted in reproducible lesions to 
forelimb motor regions, and significant forelimb functional impairments. As such, this 
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injection protocol was deemed useful for studying post-stroke neuroplasticity and 
rehabilitation, by preserving more neural tissue to support potential neuroplastic changes 
than traditional stroke models. 
89 
 
2.5  REFERENCES 
Belayev, L., Alonso, O.F., Busto, R., Zhao, W., and Ginsberg, M.D. (1996). Middle 
cerebral artery occlusion in the rat by intraluminal suture. Neurological and 
pathological evaluation of an improved model. Stroke 27, 1616±1622. 
Burvill, P., Johnson, G., Jamrozik, K., Anderson, C., and Stewart-Wynne, E. (1997). 
Risk factors for post-stroke depression. Int J Geriatr Psychiatry 12, 219±226. 
Corbett, D., and Nurse, S. (1998). The problem of assessing effective neuroprotection in 
experimental cerebral ischemia. Prog Neurobiol 54, 531±548. 
Cramer, S.C. (2003). Clinical issues in animal models of stroke and rehabilitation. ILAR 
J 44, 83±84. 
Dobkin, B.H. (2004). Neurobiology of rehabilitation. Ann N Y Acad Sci 1038, 148±170. 
Durukan, A., and Tatlisumak, T. (2007). Acute ischemic stroke: overview of major 
experimental rodent models, pathophysiology, and therapy of focal cerebral 
ischemia. Pharmacol Biochem Behav 87, 179±197. 
Fang, P.C., Barbay, S., Plautz, E.J., Hoover, E., Strittmatter, S.M., and Nudo, R.J. 
(2010). Combination of NEP 1-40 treatment and motor training enhances 
behavioral recovery after a focal cortical infarct in rats. Stroke 41, 544±549. 
Frost, S.B., Barbay, S., Mumert, M.L., Stowe, A.M., and Nudo, R.J. (2006). An animal 
model of capsular infarct: endothelin-1 injections in the rat. Behav Brain Res 
169, 206±211. 
Fuxe, K., Bjelke, C.A.B., Andbjer, B., Grahn, H., Rimondini, R., Agnati, L.F., and 
Bjelke, B. (1997). Endothelin-1 induced lesions of the fronto- parietal cortex of 
the rat . A possible model of focal cortical ischemia. Neuroreport 8, 2623±2629. 
*HLVVHU6DQG*UHHQKRXVH6:$QH[WHQVLRQRI%R[¶VUHVXOWVRQWKHXVHRI
the F distribution in multivariate analysis. Ann Math Statist 29, 885±891. 
*LOPRXU*,YHUVHQ6'2¶1HLOO0)DQG%DQQHUPDQ'07KHHIIHFWVRI
intracortical endothelin-1 injections on skilled forelimb use: implications for 
modelling recovery of function after stroke. Behav Brain Res 150, 171±183. 
Gonzalez, C.L., and Kolb, B. (2003). A comparison of different models of stroke on 
behaviour and brain morphology. Eur J Neurosci 18, 1950±1962. 
90 
 
Hewlett, K.A., and Corbett, D. (2006). Delayed minocycline treatment reduces long-
term functional deficits and histological injury in a rodent model of focal 
ischemia. Neuroscience 141, 27±33. 
Hicks, A.U., Hewlett, K., Windle, V., Chernenko, G., Ploughman, M., Jolkkonen, J., 
Weiss, S., and Corbett, D. (2007). Enriched environment enhances transplanted 
subventricular zone stem cell migration and functional recovery after stroke. 
Neuroscience 146, 31±40. 
Hughes, P.M., Anthony, D.C., Ruddin, M., Botham, M.S., Rankine, E.L., Sablone, M., 
Baumann, D., Mir, A.K., and Perry, V.H. (2003). Focal lesions in the rat central 
nervous system induced by endothelin-1. J Neuropathol Exp Neurol 62, 1276±
1286. 
Hume, A. (2009). Evaluation of NMDA receptor-mediated neuroprotection in the 
endothelin-1 model of upper extremity impairment in stroke. MSc Thesis, 
University of Prince Edward Island. 
-RQHV7$$OOUHG53$GNLQV'/+VX-(2¶%U\DQW$DQG0DOGRQDGR0$
(2009). Remodelling the brain with behavioral experience after stroke. Stroke 40, 
S136±138. 
Kleim, J.A., Boychuk, J.A., and Adkins, D.L. (2007). Rat models of upper extremity 
impairment in stroke. ILAR J 48, 374±384. 
Kozlowski, D.A., James, D.C., and Schallert, T. (1996). Use-dependent exaggeration of 
neuronal injury after unilateral sensorimotor cortex lesions. J Neurosci 16, 4776±
4786. 
Krakauer, J.W. (2005). Arm function after stroke: from physiology to recovery. Semin 
Neurol 25, 384±395. 
Leasure, J.L., and Schallert, T. (2004). Consequences of forced disuse of the impaired 
forelimb after unilateral cortical injury. Behav Brain Res 150, 83±91. 
Lindner, M.D., Gribkoff, V.K., Donlan, N.A., and Jones, T.A. (2003). Long-lasting 
functional disabilities in middle-aged rats with small cerebral infarcts. J Neurosci 
23, 10913±10922. 
Luke, L.M., Allred, R.P., and Jones, T.A. (2004). Unilateral ischemic sensorimotor 
cortical damage induces contralesional synaptogenesis and enhances skilled 
reaching with the ipsilateral forelimb in adult male rats. Synapse 54, 187±199. 
Macrae, I. (1992). New models of focal cerebral ischaemia. Br J Clin Pharmacol 34, 
302±308. 
91 
 
Madden, K. (2002). Optimal timing of thrombolytic therapy in acute ischaemic stroke. 
CNS Drugs 16, 213±218. 
Nikolova, S., Moyanova, S., Hughes, S., Bellyou-Camilleri, M., Lee, T.Y., and Bartha, 
R. (2009). Endothelin-1 induced MCAO: dose dependency of cerebral blood 
flow. J Neurosci Methods 179, 22±28. 
Paxinos, G., and Watson, C. (2007). The Rat Brain in Stereotaxic Coordinates (San 
Deigo: Academic Press). 
Ploughman, M., Windle, V., MacLellan, C.L., White, N., Dore, J.J., and Corbett, D. 
(2009). Brain-derived neurotrophic factor contributes to recovery of skilled 
reaching after focal ischemia in rats. Stroke 40, 1490±1495. 
Robinson, M.J., Macrae, I.M., Todd, M., Reid, J.L., and McCulloch, J. (1990). 
Reduction of local cerebral blood flow to pathological levels by endothelin-1 
applied to the middle cerebral artery in the rat. Neurosci Lett 118, 269±272. 
Schallert, T., and Woodlee, M. (2005). The Behaviour of the Laboratory Rat (Oxford: 
Oxford University Press). 
Schallert, T., Fleming, S., Leasure, J., Tillerson, J., and Bland, S. (2000). CNS plasticity 
and assessment of forelimb sensorimotor outcome in unilateral rat models of 
stroke, cortical ablation, parkinsonism and spinal cord injury. 
Neuropharmacology 39, 777±787. 
Shanina, E. V, Schallert, T., Witte, O.W., and Redecker, C. (2006). Behavioral recovery 
from unilateral photothrombotic infarcts of the forelimb sensorimotor cortex in 
rats: role of the contralateral cortex. Neuroscience 139, 1495±1506. 
Sharkey, J., Ritchie, I.M., and Kelly, P.A. (1993). Perivascular microapplication of 
endothelin-1: a new model of focal cerebral ischaemia in the rat. J Cereb Blood 
Flow Metab 13, 865±871. 
Soleman, S., Yip, P., Leasure, J.L., and Moon, L. (2010). Sustained sensorimotor 
impairments after endothelin-1 induced focal cerebral ischemia (stroke) in aged 
rats. Exp Neurol 222, 13±24. 
Sun, F., Wang, X., Mao, X., Xie, L., and Jin, K. (2012). Ablation of neurogenesis 
attenuates recovery of motor function after focal cerebral ischemia in middle-
aged mice. PloS One 7, e46326. 
Sun, H.S., Doucette, T.A., Liu, Y., Fang, Y., Teves, L., Aarts, M., Ryan, C.L., Bernard, 
P.B., Lau, A., Forder, J.P., et al. (2008). Effectiveness of PSD95 inhibitors in 
permanent and transient focal ischemia in the rat. Stroke 39, 2544±2553. 
92 
 
Swanson, R.A., Morton, M.T., Tsao-Wu, G., Savalos, R.A., Davidson, C., and Sharp, 
F.R. (1990). A semiautomated method for measuring brain infarct volume. J 
Cereb Blood Flow Metab 10, 290±293. 
Tamura, A., Graham, D.I., McCulloch, J., and Teasdale, G.M. (1981). Focal cerebral 
ischaemia in the rat: 1. Description of technique and early neuropathological 
consequences following middle cerebral artery occlusion. J Cereb Blood Flow 
Metab 1, 53±60. 
Tennant, K., and Jones, T. (2009). Sensorimotor behavioral effects of endothelin-1 
induced small cortical infarcts in C57BL/6 mice. J Neurosci Methods 181, 18±
26. 
Ueki, A., Rosen, L., Andbjer, B., Agnati, L.F., Hallstrom, A., Goiny, M., Tanganelli, S., 
Ungerstedt, U., and Fuxe, K. (1993). Evidence for a preventive action of the 
vigilence-promoting drug modafinil against straital ischemic injury induced by 
endothelin-1 in the rat. Exp Brain Res 96, 89±99. 
Whishaw, I.Q., Suchowersky, O., Davis, L., Sarna, J., Metz, G.A., and Pellis, S.M. 
(2002). Impairment of pronation, supination, and body co-ordination in reach-to-
JUDVSWDVNVLQKXPDQ3DUNLQVRQ¶VGLVHDVH3'UHYHDOVKRPRORJ\WRGHILFLWVLQ
animal models. Behav Brain Res 133, 165±176. 
Wieloch, T., and Nikolich, K. (2006). Mechanisms of neural plasticity following brain 
injury. Curr Opin Neurobiol 16, 258±264. 
Williams, L.S., Weinberger, M., Harris, L.E., Clark, D.O., and Biller, J. (1999). 
Development of a Stroke-Specific Quality of Life Scale. Stroke 30, 1362±1369. 
Windle, V., Szymanska, A., Granter-Button, S., White, C., Buist, R., Peeling, J., and 
Corbett, D. (2006). An analysis of four different methods of producing focal 
cerebral ischemia with endothelin-1 in the rat. Exp Neurol 201, 324±334. 
Yamori, Y., Horie, R., Handa, H., Sato, M., and Fukase, M. (1976). Spontaneously 
Hypertensive Rats and Humans. Stroke 7, 46±53.  
93 
 
 
 
 
 
CHAPTER 3: 
EVALUATING A NOVEL MODEL OF VOLUNTARY FORCED USE 
MOVEMENT THERAPY ON POST-ISCHEMIC FUNCTIONAL RECOVERY 
AND MARKERS OF NEUROPLASTICITY2 
 
 
 
 
 
 
  
 
 
 
 
 
³>&,07@LVKDUGZRUNEXWLI\RXSXW the 
ZRUNLQWKHUH¶VDOPRVWQROLPLWWRWKH
DPRXQWRIUHFRYHU\WKDW\RXFDQKDYH´ 
 
 
Edward Taub (1931-present) 
picture from http://www.newswise.com/articles/remodelling-the-brainrehab-therapy-causes-
increase-in-gray-matter 
                                                 
2
 The majority of data presented in this chapter are published in: A novel approach to 
induction and rehabilitation of deficits in forelimb function in a rat model of 
ischemic stroke. Acta Pharmacol Sin. 2012, 34(1): 104-112, with the exception 
of doublecortin analysis (Results, 3.3.4.3). JLT contributed to experimental 
design, performed all surgeries, behavioural testing, histology, 
immunohistochemistry, and prepared the manuscript. 
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SUMMARY 
 
CIMT is a clinically effective form of rehabilitation. However, modelling CIMT 
therapy in animals has proven challenging, perhaps due to the use of inappropriate 
stroke models, animal stress, and lack of behavioural pressure to use the impaired limb. 
The study performed in Chapter 2 demonstrated that multiple low volume injections of 
the vasoconstrictor ET-1 to specific stereotaxic coordinates resulted in well-defined and 
reproducible infarcts and reliable contralesional forelimb impairments. The purpose of 
the study presented in this Chapter was to test whether a novel appetitively motivated 
form of forced forelimb use would affect recovery profile, lesion volume, and 
expression of proteins associated with neuroplasticity in this model of stroke. Following 
stroke or sham surgery, adult male rats were assigned to receive either daily 
rehabilitation or a control therapy beginning on PSD 5. Rehabilitation consisted of 30 
minutes of voluntary forced use movement sessions using plastic pet activity balls. Rats 
were tested periodically for 21 days to assess deficit and recovery of forelimb function, 
and then euthanized for tissue analysis. All animals that received stroke surgery had 
significant impairments in all functional tests. The rehabilitation therapy resulted in a 
small but consistent acceleration of forelimb recovery in several functional tests. Stroke 
increased the proportion of cells expressing the neurotrophin BDNF, as well as the 
number of doublecortin (Dcx)-expressing cells (indicative of migrating neuroblasts), but 
these effects were not altered by rehabilitation. There was no change in the expression of 
the growth inhibiting protein NOGOA. This model of voluntary forced use of the 
impaired limb warrants further development. 
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3.1 INTRODUCTION 
 
In addition to being the third leading cause of mortality of North America, the 
majority of people who survive stroke are left with disabilities (Heart and Stroke 
Foundation, 2012; Roger et al., 2011). Patients can remain chronically impaired for 
months to years following a stroke, which vastly impacts quality of life and is associated 
with a higher rate of post-stroke depression (Burvill et al., 1997; Ramasubbu et al., 
1998). While preventive therapies and lifestyle modifications are known to reduce the 
incidence of the disease (Bousser, 2012), the only effective drug presently available to 
treat someone experiencing a stroke is tPA. TPA only works in the event of ischemic 
stroke, by dissolving the offending blood clot to restore blood flow and prevent further 
ischemic damage. However, it is effective only in a fraction of stroke patients (Zhang 
and Chopp, 2009) due in part to a narrow therapeutic time window (Madden, 2002; 
Stemer and Lyden, 2010). Neuroprotective drugs are effective in experimental settings, 
but to date none have proven clinically effective 2¶&ROOLQVet al., 2006; STAIR, 1999). 
As such, many stroke patients continue to rely critically on post-stroke rehabilitation of 
impairments, and continued efforts toward progression of rehabilitative techniques is 
warranted to treat the devastating effects of a stroke. 
One rehabilitative technique that has been developed to increase use and improve 
function of upper limbs in survivors of stroke is CIMT. The therapy discourages 
µOHDUQHGQRQ-XVH¶WKURXJKFRQVWUDLQWRIWKHXQaffected limb and subsequent forced use of 
the impaired one for both daily living tasks and intense RTP exercises performed with 
therapist guidance (Page et al., 2005; Sawaki et al., 2011; Sterr et al., 2002; Taub et al., 
2006; Wittenberg et al., 2003; Wolf et al., 2011). A seemingly effective technique 
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(Nijland et al., 2011), the mechanisms responsible for CIMT-induced recovery of 
function are not well understood. Valid experimental models are essential for further 
investigation into this phenomenon.  
In recent years, several creative animal models of forced use therapies have been 
developed (Auriat et al., 2006, 2010; Biernaskie and Corbett, 2001; Biernaskie et al., 
2004; DeBow et al., 2003; Fang et al., 2010; Kim et al., 2005; Leasure and Schallert, 
2004; Maclellan et al., 2005; Maldonado et al., 2008; Müller et al., 2008; Ploughman et 
al., 2009; Schabitz et al., 2004; Yang et al., 2003). These have provided important 
insights into the numerous variables that need to be considered, including the use of 
paradigms that best model particular and appropriate aspects of CIMT. A major 
challenge faced by researchers when modelling forced use in animals is that of subject 
motivation. A main component of CIMT is constraint of the nonparetic limb for most 
waking hours. Similarly, the intact forelimb can be constrained in rats (DeBow et al., 
2003; Leasure and Schallert, 2004; Schabitz et al., 2004), although increased animal 
stress (Ke et al., 2011; Yanagita et al., 2007) and lack of behavioural pressure to use the 
impaired forelimb (DeBow et al., 2003) may be problematic. Because of this, some 
researchers have opted to shift focus away from constraint and toward forced use by 
other means. 
Chapter 2 described the development of an ET-1 stroke method that resulted in 
reproducible, well-placed lesions, and damage reasonably confined to targeted forelimb 
motor regions of the brain (see Figure 2.6). Using this procedure, the present experiment 
evaluated the efficacy of a novel method of appetitively forcing use of the impaired 
forelimb, intended to circumvent animal stress and behavioural pressure issues. The 
effects of this therapy on functional recovery, lesion volume, expression of 
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neuroplasticity-associated proteins (BDNF and NOGOA), and a marker of migrating 
neuroblasts (Dcx) were investigated. 
 
3.2 METHODS 
 
3.2.1 Experimental animals 
 
Adult male Sprague-Dawley rats (N=46) were purchased from Charles River 
Laboratories (Montreal, Canada) and single housed on a 12 hr reverse light/dark cycle 
OLJKWV RII DW  RQ DW  ,W ZDV IRXQG WKDW DFWLYLW\ OHYHOV DIIHFWHG DQLPDOV¶
participation in the rehabilitation, as shown by others (MacLellan et al., 2011), therefore 
all procedures (surgery, rehabilitation, and behavioural testing) took place during the 
dark cycle. Animals had ad libitum access to food and water, and weighed between 300-
350 g at the time of surgery. All procedures were conducted in accordance with the 
guidelines of the Canadian Council for Animal Care and were approved in advance by 
the University of Prince Edward Island Animal Care Committee. 
 
3.2.2 Surgical procedure 
 
The ET-1 surgical procedure was performed as described in Chapter 2 (see 
Section 2.2.3). Briefly, rats were placed into an induction chamber filled with isoflurane 
to induce anaesthesia, which was maintained during surgery at 2%. Once deeply 
anesthetised, animals were mounted onto a stereotaxic apparatus (David Kopf 
Instruments, USA), and the scalp was incised and retracted. Small holes were drilled 
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through the skull at each injection location (see Table 2.1) using a stereotaxically 
mounted drill (Stoelting Co., USA). Endothelin-1 (Calbiochem, Germany) was injected 
at each coordinate at a flow rate of 0.5µl/minutes. The scalp was then sutured and the 
incision site was treated with topical anaesthetic. Body temperature was checked 
regularly and maintained at 36.0 ± 0.2°C for the duration of surgery using a heating pad. 
Following surgery, animals were given subcutaneous injections of butorphanol (2.0 
mg/kg), returned to their home cage, and allowed to recover. A heating pad was placed 
under the cage for 1 hour. Sham-operated rats received the same surgical procedure up 
to but not including the drill holes, and remained anesthetised for the same amount of 
time as the ET-1 animals (n=11 for each stroke group; n=12 for each sham group). 
 
3.2.3 Rehabilitation 
 
Animals were acclimated to and trained to use commercially available clear 
plastic pet activity balls (29 cm diameter; Super Pet, USA) (Figure 3.1). Prior to the 
initiation of the study, pre- and post-stroke ability to move the balls was observed in a 
separate set of animals, to verify that all ball movement (initiating, propelling, changing 
direction, and stopping) required the use of both forelimbs. Therefore, animals were 
forced to evoke use of the impaired forelimb to engage in the post-surgical 
rehabilitation. Training took place with six exposures over two weeks, and began with 
exposure to balls that were held stationary on foam docks, then gradually progressed to 
increasing non-stationary periods of time, and resulted in a final verification of the 
DQLPDO¶VDELOLW\WRHQJDJHLQWKHUHKDbilitation. 
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Figure 3.1. Forced use movement therapy model. Appetitively motivated forced use 
movement therapy was modelled using clear plastic pet activity balls. Rehabilitation 
sessions lasted for 30 minutes daily, in a 90 sq ft arena. Control therapy consisted of 
placing animals into stationary activity balls for 30 minutes daily. 
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 Training was followed by a wash out period of at least 5 days to eliminate any 
potential neuroprotective effects of this mild exercise (Ploughman et al., 2007). A small 
number of animals (n=4) were not able to manipulate the balls following the training 
regimen and were subsequently disqualified from being assigned to a rehabilitation 
group (randomly assigned instead to either sham or stroke surgery, followed by control 
therapy). 
Following surgery, rats from both surgical groups were randomly assigned to 
receive voluntary forced use movement therapy (Rehab; n=11 stroke; n=12 sham), or 
Control therapy (n=11 stroke; n=12 sham) beginning on PSD 5. Rehabilitation sessions 
lasted for 30 minutes daily, during which the animals were free to move voluntarily 
around an enclosed 90 sq ft arena (4-6 animals per arena at a time). Sessions were video 
recorded and later analysed to determine the amount of time each rat spent moving 
during each 30 minute period. Time spent moving was scored manually by an 
experimenter blind to the surgical condition and to the test day of each animal. Control 
therapy consisted of placing rats into stationary balls for 30 minutes each day. 
 
3.2.4 Behavioural testing 
 
For three weeks prior to surgery, animals were handled daily and acclimated to 
all tests, then pre-surgery scores were recorded. Following surgery, animals were tested 
regularly as described below until the end of the study at PSD 21. As in Chapter 2, 
µGHILFLW¶ZDVGHILQHGDVDPHDQSRVW-surgical performance significantly worse than the 
PHDQ VKDP JURXS SHUIRUPDQFH DQG µUHFRYHU\¶ ZDV Fonsidered the point at which the 
mean performance of animals in each experimental group returned to mean sham 
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performance. In any instance where animals had recovered at a particular time point, 
WKHQKDGVXEVHTXHQWWHVWLQJGD\VZLWKLPSDLUHGSHUIRUPDQFHµUHFRYHU\¶ZDVFRQVLGHUHG
the latest time point at which they consistently performed at sham level. All performance 
evaluations were conducted by an experimenter blind to the surgical condition and, 
when possible, to the post surgical testing day. 
Several behavioural tests employed in Chapter 2 were used in this study as 
previously described (see Section 2.2.4; summarized below). Forelimb placing tests 
(both TFP and VFP) and forelimb postural reflex tests were performed daily under red 
lights. The cylinder test was performed on PSD 1, 6, 10, 14, 18, and 21. Briefly, for TFP 
and VFP, the distal portion of the unrestrained forelimb or the corresponding vibrissae 
was gently brushed against the edge of a table, to measure the ability of the animal to 
respond by placing its forelimb onto the surface. Functional deficit was determined 
based on the number of failed forelimb placements on the tabletop out of 5 attempts. 
Forelimb postural reflex was measured by suspending the animal by the tail and 
observing the position of the forelimb. A score was assigned from 0 (no deficit) to 2 
(abnormal forelimb flexion combined with torso twisting). The cylinder test was 
performed by placing animals into a clear plastic cylinder and determining the percent 
usage of the contralateral limb during rearing behaviour. 
 
3.2.4.1 Horizontal ladder test 
 
In the current study, the horizontal ladder test was used to measure forelimb 
coordination on PSD 1, 6, 10, 14, 18, and 21. Rats were provoked to run across a ladder 
(1.5 m long) with unevenly spaced rungs (1-3 cm apart) by using a bright light (470 lux) 
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and white noise (78 dB) at one end of the ladder and an escape box at the other end 
(Figure 3.2). On each testing day, animals were video recorded during 3 trials, and the 
average number of foot slips made with the contralesional forelimb was determined by 
slow motion video analysis. 
 
3.2.5 Histology and infarct quantification 
 
At the end of the study, rats were transcardially perfused with 120 mls phosphate 
buffered saline (PBS), followed by 120 mls 4% paraformaldehyde in PBS, both at a flow 
rate of 20 mls/min. Brains were extracted, post-fixed for a further 24 hours in 4% 
paraformaldehyde, then permeated with 30% sucrose in PBS for 72 hours (or until they 
were no longer floating in the solution). They were then cryoprotected with Cryomatrix 
(Thermo Scientific, USA), and stored at -80oC until use. Some brains (n= 4/group) were 
sectioned (10µm) for immunohistochemical analyses using a Cryostat (Thermo 
Scientific, USA). Sections were taken from intact tissue caudal and rostral to the 
damage, as well as anterior, middle, and posterior regions of the infarct itself (in total, at 
+4.1, +2.3, +0.5, -1.3, -3.1 mm from bregma). Remaining tissue was sectioned at 100 
µm and used for infarct quantification using cresyl violet staining. Remaining brains 
were sectioned at 100 µm for cresyl violet staining only. Tissue was mounted on slides, 
dried overnight, and stored at -20oC until use.  
Infarct quantification was performed as described previously (see Section 2.2.5). 
PKRWRJUDSKVRIHYHU\WKLUGVHFWLRQLHȝPDSDUWZHUHDVVHVVHGIRULQIDUFWGDPDJH
using Image J software (NIH, USA) by tracing the area of injury as defined by lack of 
cresyl violet staining (Luke et al., 2004). The total volume of brain injury was
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Figure 3.2. Horizontal ladder test. Animals were provoked to run across a horizontal 
ladder of unevenly spaced rungs by placing aversive stimuli at one end and an escape 
box at the other. Slow motion video analysis was used to determine the number of foot 
slips made with the impaired forelimb. 
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determined by summing the area of damaged tissue recorded from each section and 
multiplying that value by the distance between the measured sections. 
 
3.2.6 Immunohistochemistry 
 
8QOHVVRWKHUZLVHVWDWHGȝPVHFWLRQVIURPWKHEUDLQUHJLRQVLQGLFDWHGDERYH
were used for immunohistochemical analyses. Before each protocol, tissue was 
subjected to antigen retrieval by heating at 90oC for 20 minutes in sodium citrate buffer 
(pH 6.0). Negative controls were prepared by omitting the primary antibodies. 
Slides were rinsed in PBS, incubated with 3% H2O2 for 20 minutes, followed by 
blocking solution (5% goat serum in PBS) for 2 hours at room temperature. They were 
then incubated with rabbit anti-BDNF (1:500; #AB1779, Millipore, USA) for 48 hours 
or rabbit anti-NOGOA (1:1000; #sc-25660, Santa Cruz, USA) for 24 hours at 4oC. 
Following incubation with primary antibody, sections were washed in PBS (3 x 15 
minutes), and incubated with secondary antibody (1:200; biotinylated goat-anti-rabbit 
IgG; Vector, USA) for 1 hour at room temperature. Slides were then incubated with 
avidin biotin complex (ABC; Vector Laboratories, USA) for 30 minutes and visualized 
XVLQJDVROXWLRQRI¶-diaminobenzidine tetrahydrochloride and H2O2 (DAB; Vector 
Laboratories, USA). Following immunohistochemical staining, slides were 
counterstained with hematoxylin to visualize the cell nuclei. 
Sections (10 µm) from +2.3, +0.5, and -1.3 mm relative to bregma only were 
processed for the presence of Dcx+ cells, indicative of newly generated neurons. This 
subset of sections was chosen from the larger sample of 5 sections, because they would 
include infarcted tissue based on infarct spread observed in Chapter 2 (see Figure 2.6). 
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Sections were incubated in 3% H2O2 for 20 minutes, then in blocking solution (10% 
horse serum in 0.2% Triton X-100 in PBS) for 1 hour at room temperature, followed by 
goat anti-Dcx (1:250; #c-18, Santa Cruz Biotechnologies, USA) at 4°C for 24 hours. The 
following day, they were incubated in the presence of secondary antibody (1:200; 
biotinylated horse anti-goat IgG, Vector, USA) for 1 hour, then ABC for 30 minutes. 
Following washing, bound antibody was visualized with a solution of DAB and H2O2; 
sections were then counterstained with hematoxylin to visualize cell nuclei.  
 
3.2.7 Cell counting 
 
BDNF and NOGOA expression in various regions of interest (ROI) in the 
ipsilesional and contralesional hemisphere (and corresponding regions of sham sections) 
was quantified by calculating the percentage of cells in each region expressing the 
protein of interest [e.g. (# BDNF positive cells/total # cells) X 100]. Counting was 
performed at 400 x magnification (each ROI measuring 0.35 x 0.25 mm) in three regions 
along the visible lesion boundary, one in the ipsilesional striatum, and 4 equivalent 
regions of the contralesional hemisphere (see Figure 3.3A). 
The number of Dcx-positive cells was determined by counting ROIs on the 
lesion border, ipsilesional striatum and SVZ, and corresponding contralesional cortex, 
striatum and SVZ (see Figure 3.3B). Photographs were taken at 200 x magnification and 
ROIs measured 0.67 x 0.54 mm. All counting was performed by an observer blind to 
treatment group. 
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Figure 3.3. Immunohistochemistry regions of interest. (A) BDNF and NOGOA 
expression were examined from 8 ROIs (0.35 x 0.25 mm) as indicated by the red boxes. 
(B) Doublecortin expression was examined from 6 ROIs (0.70 x 0.56 mm). Scale bars = 
100 µm. 
A. 
B. 
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3.2.8 Statistical analyses 
 
Statistical analyses were performed using PAWS Statistics (v. 18; SPSS inc., 
Chicago, USA). Behavioural data were analysed using RM 2-way ANOVA. Where the 
assumptions of sphericity were violated (Mauchly's test; p<0.05) the Greenhouse±
Geisser correction was applied (degrees of freedom are reported to the nearest integer; 
see Section 2.2.6). Subsequent Bonferroni post-hoc tests were used to determine 
differences between groups on specific days. Immunohistochemistry was analysed using 
2 way ANOVAs (for surgical condition and rehabilitation group). Infarct volumes were 
compared using independent t-tests. Values are expressed as mean ± SEM. 
 
3.3 RESULTS 
 
3.3.1 Rehabilitation 
 
While Rehab was an independent variable in the present study, it was of interest 
to compare the overall activity levels of Stroke/Rehab and Sham/Rehab animals. All 
animals spent an equal amount of time moving during the 30 minute rehabilitation 
sessions on any given day (p > 0.05), however the amount of time declined steadily over 
the course of the study from an average of 18 minutes on PSD 5 to an average of 12 
minutes by PSD 21 in both groups (20% decrease; p <0.0001) (Figure 3.4). 
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Figure 3.4. Voluntary rehabilitation intensity. Intensity of voluntary rehabilitation 
was analysed as time spent moving for each daily rehabilitation session. There were no 
significant differences between Sham and Stroke animals on any day. Rehabilitation 
intensity declined over the course of the study. n=11-12/ group 
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3.3.2 Behavioural tests 
 
3.3.2.1 Forelimb placing tests 
 
Prior to surgery, all animals had equivalent performance on both the TFP and 
VFP tests, scoring 5/5 without error. Following surgery, there was no ipsilesional 
impairment in any group. On the contralesional tactile-stimulated forelimb placing test, 
there was a significant effect of group (F3,42=43.8; p<0.0005), time (F8,335=23.0; 
p<0.0005), and interaction of group x time (F24,335=7.46; p<0.0005). Post hoc analysis 
revealed that both ischemia groups had a significant deficit following stroke surgery. 
The Stroke/Rehab group recovered at PSD 16 (p=0.944) while control animals 
recovered at PSD 21 (p=1.00) (Figure 3.5A).  
On the vibrissae-stimulated placing test, there was a significant effect of group 
(F3,42 =32.4; p<0.0005), time (F7,287 =18.1; p<0.0005), and interaction of group x time 
(F20,287 =5.63; p<0.0005). Both stroke groups were significantly impaired following 
surgery. Rehabilitation animals remained impaired for the duration of the study 
(p=0.022), while control animals recovered at PSD 20 (p=0.122) (Figure 3.5B). 
 
3.3.2.2 Forelimb postural reflex test 
 
3ULRUWRVXUJHU\DOODQLPDOVKDGDQRUPDOVFRUHRIµ¶RQWKHIRUHOLPESRVWXUDO
reflex test. Following surgery, animals from both ischemia groups showed a significant 
deficit (p<0.001). There was a significant effect of group (F3,42 =28.7; p<0.0005), time 
(F10,80=9.58; p<0.0005), and interaction of group x time (F29,411 =4.12; p<0.0005).  
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Figure 3.5. Performance on the forelimb placing tests. (A) Tactile-stimulated 
forelimb placing was impaired in both stroke groups following endothelin-1 
administration. Animals undergoing forced use movement therapy recovered function 5 
days sooner than control therapy animals. (B) Similarly, vibrissae-stimulated forelimb 
placing was impaired in both groups following endothelin-1 injection. Control animals 
had spontaneously recovered by PSD 20, while Rehab animals remained impaired until 
PSD 21. *= Stroke/Control significantly different from sham; #= Stroke/Rehab 
significantly different from sham; p<0.05. n=11/stroke groups, n=12/sham groups. 
 
 
A. 
B. 
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Animals in the Stroke/Rehab group were impaired until PSD 19 (p=0.240) while those 
from the Stroke/Control group were impaired until PSD 20 (p=0.098) (Figure 3.6). 
 
3.3.2.3 Cylinder Test 
 
Before surgery, all animals used the contralesional forelimb for approximately 
50% of exploratory movement while rearing in the cylinder. Following surgery, there 
was a significant effect of group (F3,42 =13.2; p<0.0005), time (F4,185=4.56; p<0.0005), 
and interaction of group x time (F13,185 =4.97; p<0.0005). Stroke animals showed a 
significant decrease in the use of the contralateral limb on the first post-surgical day 
(p<0.01) that recovered by PSD 14 (p=0.100) in the Rehab group, while the deficit in 
control therapy animals recovered by PSD 21 (p=0.076; Figure 3.7). 
 
3.3.2.4 Horizontal ladder test 
 
Prior to surgery, all animals were able to cross the ladder with a minimal average 
number of foot slips (0.4±0.4). Following surgery, there was a significant effect of group 
(F3,42=3.01; p=0.041), time (F4,190=7.01; p<0.0005), and interaction of group x time 
(F4,190=3.33; p<0.0005). The average number of foot slips with the contralesional 
forelimb was significantly greater in both of the ischemia groups (p<0.01) (1.9±0.45 for 
Stroke/Control; 1.6±0.34 for Stroke/Rehab) relative to shams (0.33±0.13 for 
Sham/Control; 0.5±0.17 for Sham/Rehab). This impairment recovered by PSD 6 in 
Rehab animals (p=0.273), and recovered by PSD 10 in Control animals (p=0.057) 
(Figure 3.8). 
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Figure 3.6. Performance on the forelimb postural reflex test. The position of the 
impaired forelimb as the animal was suspended above the home cage was scored from 0 
(no deficit) to 2 (severe deficit). Following surgery, animals in the stroke group had a 
significant impairment. Animals in the Rehab group recovered by PSD 20; control 
animals recovered by PSD 21. *= Stroke/Control significantly different from sham; #= 
Stroke/Rehab significantly different from sham; p<0.05. n=11/stroke groups, 
n=12/sham groups. 
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Figure 3.7. Performance on the cylinder test. Following surgery, animals in both 
stroke groups used the impaired forelimb significantly less than sham controls. Rehab 
animals recovered by PSD 14; control animals recovered by PSD 21. *= Stroke/Control 
significantly different from sham; #= Stroke/Rehab significantly different from sham; 
p<0.05. n=11/stroke groups, n=12/sham groups. 
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Figure 3.8. Performance on the horizontal ladder test. Prior to surgery, all animals 
were able to cross the horizontal ladder with few foot slips. Following surgery, there was 
a significant deficit in both stroke groups. By PSD 6, the Rehab animals had recovered, 
while controls remained impaired until PSD 10. *= Stroke/Control significantly different 
from sham; #= Stroke/Rehab significantly different from sham; p<0.05. n=11/stroke 
groups, n=12/sham groups. 
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3.3.3 Infarct quantification 
 
Cresyl violet histology for infarct quantification revealed that there was no 
significant difference in the total infarct volume between groups. Animals receiving 
control therapy had similarly sized infarcts compared to animals receiving rehabilitation 
(12.2 ± 3.0 mm3 and 10.7 ± 2.0 mm3, respectively) (p=0.412) (Figure 3.9A). The infarct 
spread and volume at each stereotaxic level is presented in Figure 3.9B. 
 
3.3.4 Immunohistochemistry 
 
3.3.4.1 BDNF 
 
The proportion of cells expressing BDNF was determined from a total of 8 areas 
of interest encompassing both the ipsilesional and contralesional hemispheres (see 
Section 3.2.7). In the ipsilesional hemisphere of both stroke groups, there was an 
increase in the percent cells expressing BDNF (p<0.05), however this ratio remained 
unaffected by rehabilitative therapy (Figure 3.10B). In the contralesional hemisphere 
there were no significant differences in the percentage of cells expressing BDNF (data 
not shown). 
 
3.3.4.2 NOGOA 
 
The proportion of cells expressing NOGOA was determined from the same 
regions of interest as BDNF. There were no significant differences between the stroke  
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Figure 3.9. Infarct volume and spread. (A) Volume of the total infarct was the same in 
the animals that received Rehab and control therapy. (B) The distribution of the infarct 
across stereotaxic levels was similar between groups. n=11/group. 
A. 
B. 
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and sham groups in either the contralesional (data not shown) or ipsilesional 
hemispheres (Figure 3.11B). 
 
3.3.4.3 Neuroblasts 
 
The total number of Dcx+ cells was summed in each of the ipsi- and 
contralesional SVZ, cortex, and striatum. Animals in the both stroke groups exhibited 
significantly more ipsilesional Dcx+ cells than sham animals (p<0.02), however 
rehabilitation did not affect Dcx expression (Figure 3.12B). 
 
3.4 DISCUSSION  
 
While prophylactic lifestyle modifications and neuroprotection represent 
preventive measures for the damage resulting from stroke, current therapeutic options 
are severely limited, and many people continue to live with varying degrees of disability. 
As such, it is important to better understand how rehabilitation can influence 
neuroplasticity, and ultimately, improve function. Arm impairment following stroke 
represents one of the most common disabilities in stroke survivors (Jorgensen et al., 
1995a, 1995b; Kelly-Hayes et al., 1998). Forcing use of the impaired arm using CIMT 
can result in improved functional recovery in stroke patients. To better understand the 
mechanisms underlying CIMT-assisted recovery, a number of experimental studies have 
investigated forced use using animal models. Because of the intense but generally 
voluntary nature of clinical rehabilitation, animal models of rehabilitation are 
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challenging, and necessitate focus on particular aspects of clinical therapy (see Section 
1.7.2). Post-ischemic exposure of rats to various task-specific (Biernaskie and Corbett, 
2001; DeBow et al., 2003; Maldonado et al., 2008) or nonspecific (Johansson and 
Ohlsson, 1996; Ke et al., 2011; Marin et al., 2003; Ohlsson and Johansson, 1995) 
forelimb activity has been shown to improve function. However, forced use of the 
affected forelimb by plaster casting of the unaffected limb after photothrombotic 
ischemia did not accelerate motor recovery (Schabitz et al., 2004), Similarly, constraint 
of the intact forelimb as a singular approach following hemorrhagic stroke did not 
accelerate recovery, while the addition of exercises that further forced use of the 
unconstrained (impaired) forelimb resulted in improvement (DeBow et al., 2003). 
Notably, some experimental models of forced limb use in rodents have reported 
increased damage and worsened functional recovery as a result of rehabilitation (Bland 
et al., 2000; DeBow et al., 2004; Humm et al., 1998; Kozlowski et al., 1996). The 
reasons for these discrepancies are unclear, but could be due to (1) the use of stroke 
models that produce inconsistent infarcts (Carmichael, 2005), (2) the intensity of forced 
use rehabilitation employed (MacLellan et al., 2011), (3) varying behavioural pressures 
(DeBow et al., 2003), and in some cases, (4) animal stress (Kirkland et al., 2008). 
The present study evaluated the effects of a novel voluntary forced use therapy 
model on upper extremity function, lesion volume, and expression of proteins involved 
in neuroplasticity. This is the first time pet activity balls have been used in the context of 
post-stroke forelimb rehabilitation, although a similar protocol was employed by Moroz 
et al. (2004) to model mild exercise following 6-hydroxydopamine lesion. 
Several of the tests used in the present study were also used in the experiment 
described in Chapter 2. The ET-1 surgery resulted in a similar deficit on the vibrissae 
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and tactile stimulated forelimb placing tests, significant for 19 and 20 days in Chapter 2 
(see Figure 2.3) and 20 and 21 days in the present study (see Figure 3.5). The forelimb 
postural reflex test also resulted in a significant impairment, this time lasting up to 20 
days (see Figure 3.6) similar to the 21 days in Chapter 2 (see Figure 2.4). In the current 
study there was a significant deficit in performance on the cylinder test in both stroke 
groups. This test had not detected a deficit in Chapter 2 (see Figure 2.5). A possible 
explanation for this discrepancy is that in the present study, all testing was performed in 
the more active dark cycle, which may have increased the proportion of naturally 
elicited rears (see Section 2.4). An additional test added to the battery in this study was 
the horizontal ladder test, which revealed a significant stroke-induced deficit lasting up 
to PSD 10.  
Voluntary forced use rehabilitation caused a modest but significant acceleration 
in functional recovery using several assessments of forelimb function (Figures 3.3-3.6), 
without exacerbating damage (Figure 3.9). Interestingly, while rats spent most of the 
rehabilitation session moving earlier in the study, their engagement in activity ball usage 
declined throughout the duration of the study (Figure 3.2). This is surprising, as rats 
given free access to running wheels for several hours per day naturally increase their 
activity over time (Leasure and Grider, 2010; Makatsori et al., 2003; Persson et al., 
2004; Risedal et al., 2002; Shyu et al., 1984). Rehabilitation is believed to be most 
effective when it is of increasing intensity, both in clinical (Carr and Shepherd, 2011) 
and experimental (Ke et al., 2011) studies, thus declining participation in this 
experiment is a concern. It is possible that animals became increasingly accustomed to 
and disinterested in the rehabilitation over time. Increasing voluntary participation in the 
therapy may result in more marked improvement in recovery. During rehabilitation, 4-6 
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animals were placed in the arena at a time. An alternative approach would be to give 
each animal a single arena to move around, with other animals nearby, which may 
increase curiosity to explore and counteract the decline in voluntary engagement over 
time. 
As highlighted in Section 3.2.3, navigation of the ball around the arena requires 
the use of all four limbs. Interestingly, the amount of time spent rolling the exercise ball 
did not differ between ischemic and control rats (Figure 3.4). Thus, despite marked 
deficits on contralesional forelimb function on multiple tests (Figure 3.5-3.8) impaired 
rats continually used the limb during rehabilitation. A similar outcome was noted by 
Marin et al. (2003), who found that post-stroke voluntary wheel running was similar 
between animals with large infarcts and those with little or no damage. A possible 
explanation for the discrepancy in use of the impaired limb for activity ball movement 
versus behavioural testing may involve the engagement of central pattern generators 
(CPGs). CPGs involve neural networks in the spinal cord that can produce rhythmic 
movements such as walking, even when isolated from the brain (Grillner and Wallen, 
1985). The nervous system is capable of generating CPGs following complete 
deafferentation and paralysis (Mackay-Lyons, 2002). Thus, ball rolling movement may 
comprise both voluntary and automatic components, involving a combination of cerebral 
and spinal inputs.  
Stroke caused a significant increase in the proportion of ipsilesional cells 
expressing BDNF, similar to other reports (Béjot et al., 2011a, 2011b; Madinier et al., 
2009), but this proportion was not affected by rehabilitation (Figure 3.8). Other 
rehabilitative paradigms have been shown to increase the production of BDNF (Kim et 
al., 2005; MacLellan et al., 2011; Ploughman et al., 2009) using quantitative analyses 
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such as gene expression (Ploughman et al., 2009) or quantitative protein expression 
(Kim et al., 2005; MacLellan et al., 2011). While the proportion of BDNF-expressing 
cells in the present study was unaffected by rehabilitation, each cell may have increased 
absolute BDNF production. Analysis using protein quantification methods (e.g. Western 
blot) is required to investigate this possibility. 
Doublecortin is a protein required for neuronal migration of newly generated 
neurons, and is commonly examined when investigating neurogenesis (Komitova et al., 
2005; Plane et al., 2008; Wang et al., 2007). In this study, stroke resulted in an increase 
in the number of Dcx+ cells in the ipsilesional SVZ, cortex, and striatum compared to 
sham surgery. It has been shown by several groups that brain injury such as ischemia 
results in reactive neurogenesis (Carmichael, 2008; Gu et al., 2000; Jiang et al., 2001; 
Jin et al., 2001; Kernie and Parent, 2010; Leasure and Grider, 2010; Parent et al., 2002; 
Wang et al., 2007; Xiong et al., 2010; Zhang et al., 2001), and functional recovery can 
be attenuated if neurogenesis is impeded (Jin et al., 2010; Raber et al., 2004; Sun et al., 
2012). In the current study, rehabilitation did not further affect the number of Dcx+ cells 
(Figure 3.12B), while other rehabilitation paradigms have been shown to increase 
neurogenesis (Briones et al., 2005; Nilsson et al., 1999; Wurm et al., 2007). However, 
direct comparisons cannot be made between those results and the ones presented herein, 
due to the use of different techniques. Notably, studies examining neurogenesis usually 
use injection of bromodeoxyuridine (BrdU), a thymidine analogue that becomes 
incorporated into dividing cells, as a marker of neurogenesis. In the present study, 
however, the decision to look for evidence of neurogenesis was made after the tissue had 
been collected, thereby rendering BrdU injections impossible. Instead, evidence of 
immature neurons was investigated using Dcx labelling. This method is not directly 
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comparable to studies that incorporate BrdU for several reasons. Firstly, this method 
only provides a snapshot of the Dcx+ cells that were present at the time of sacrifice, 
while BrdU injection protocols usually examine neurogenesis over a window of time. 
Further, BrdU labels all phenotypes of newborn cells, including astrocytes. Therefore, an 
increase in the number of BrdU+ cells does not necessarily reflect the number of newly 
formed neurons. A study by Leasure and Grider (2010) highlighted the importance of 
considering the phenotype of newly born cells, by showing that nearly all of the BrdU+ 
cells in the peri-infarct region were either undifferentiated or non-neuronal in nature 
(Leasure and Grider, 2010). Lastly, while Dcx labelling is commonly used in 
combination with BrdU to confirm the identity and specificity of newly born cells 
(Breunig et al., 2007), it is not a sufficiently robust marker to prove neurogenesis, 
considering evidence that it can be expressed by mature neurons undergoing structural 
plasticity (Nacher et al., 2001). Nonetheless, the Dcx+ cells observed in the present 
study had characteristic morphology of migratory neuroblasts (long and thin, with few 
processes; see Figure 3.12), and were located almost exclusively between the SVZ and 
the areas of damage. Further confirmatory studies specifically aimed at investigating the 
role of neurogenesis following stroke, as well as long-term cell survival and integration, 
would be of interest. 
NOGOA is a protein that inhibits axonal outgrowth following CNS injury 
(Cheatwood et al., 2008), and treatment with anti-NOGOA enhances post-ischemic 
neuroplasticity and functional recovery (Papadopoulos et al., 2002). A detailed profile of 
NOGOA expression following MCAo revealed dynamic temporal and spatial changes in 
expression of the protein following ischemia (Cheatwood et al., 2008). Rehabilitation 
combined with a NOGOA antagonist, NEP 1-40, promotes functional recovery (Fang et 
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al., 2010), indicating that it may play an important role in post-ischemic neuroplastic 
events. In the present study, it was hypothesized that accelerated recovery of function 
following rehabilitation would be associated with a decrease in the expression of this 
growth-inhibiting protein. However, the proportion of cells expressing NOGOA in the 
chosen regions of interest was not affected in either hemisphere by either stroke or 
rehabilitation at PSD 21. The intricate temporal profile of NOGOA expression has not 
yet been characterized in the ET-1 model, so it is possible that examination at a different 
time point, or different region of the brain, may have revealed alterations. Furthermore, 
as highlighted in the discussion of BDNF expression (see above) it is impossible to 
surmise based on the technique used in this study whether there was a quantitative 
decrease in the amount of protein being expressed from the (unchanged) proportion of 
cells. 
In summary, the use of a novel approach to voluntary forced use therapy results 
in a modest acceleration in functional recovery on some tests, through mechanisms 
unrelated to increasing the proportion of BDNF-expressing cells or the number of new 
neurons. Further refinement of this method could prove useful in developing strategies 
to study and improve post-ischemic rehabilitation and neuroplasticity. 
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CHAPTER 4: 
EVALUATING A REFINED MODEL OF VOLUNTARY FORCED USE 
REHABILITATION ON POST-ISCHEMIC FUNCTIONAL RECOVERY AND 
MARKERS OF NEUROPLASTICITY 
 
 
 
 
 
 
 ³>&,07@LVDWHUULILFUHKDELOLWDWLRQ
therapy....and it speaks to the fact that the 
plastic capability of the brain...is even greater 
WKDQZHWKRXJKW´ 
 
Eric Kandel (1929-present) 
picture from http://www.rmanyc.org/events/load/1548
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SUMMARY 
 
Constraint induced movement therapy, which forces use of the impaired arm 
following unilateral stroke, improves functional recovery. Issues with animal motivation 
make modelling CIMT challenging. Chapter 3 described how a novel rehabilitative 
paradigm that appetitively engaged the impaired forelimb following ischemic injury led 
to a modest acceleration in recovery and did not affect lesion volume. The purpose of 
this study was to investigate the effects of a modified voluntary regimen on recovery 
profile, with the addition of a task specific reaching exercise. Adult male rats were 
subjected to stroke or sham surgery. Stroke animals were then assigned to either daily 
rehabilitation or control therapy beginning on PSD 3. Rehabilitation consisted of 30 
minutes of voluntary activity ball sessions (as evaluated in Chapter 3) followed by 30 
minutes of voluntary task-specific movement using reaching boxes. Animals were tested 
weekly to assess deficit and recovery of forelimb function for 28 days, including 
evaluation in a test of skilled reaching. At the end of the experiment, animals were 
euthanized and tissue was examined for infarct volume, BDNF expression, and Dcx+ 
cells. The modified voluntary rehabilitation resulted in acceleration of forelimb recovery 
using several tests, and a significant increase in the number of Dcx+ cells. There was no 
difference in the proportion of BDNF expressing cells, or the number of microglia at 
PSD 28. However, there was a shift in the cellular origin of the BDNF being expressed, 
resulting in significantly more non-neuronal/non-astrocytic BDNF, presumed to be of 
microglial origin.  
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4.1 INTRODUCTION 
 
Almost 850,000 North Americans experience a stroke each year (Heart and 
Stroke Foundation, 2012; Roger et al., 2011). Because of logistical constraints, many 
stroke patients do not receive the clot-dissolving drug tPA, leading to a high rate of 
impairment (Madden, 2002; Stemer and Lyden, 2010; Zhang and Chopp, 2009). As a 
result, it has been suggested that stroke has a greater disability impact than any other 
chronic disease (Adamson et al., 2004). Patients can remain chronically impaired for 
months to years following stroke, which vastly impacts quality of life for both survivors 
and caretakers (Burvill et al., 1997; Ramasubbu et al., 1998). As such, many stroke 
patients continue to rely critically on post-stroke rehabilitation, and continued efforts 
toward progression of rehabilitative techniques is warranted to improve treatment of the 
devastating effects of a stroke. 
Rehabilitation has traditionally focused on preventing functional impairment 
from worsening, and learning to compensate for loss of function (Sandin, 2012). 
+RZHYHU ZLWK DQ HYROYLQJ XQGHUVWDQGLQJ RI WKH EUDLQ¶V SRVW-injury potential to 
reorganize, emphasis has shifted toward the goal of neuroreparation. One rehabilitative 
approach that has been developed to improve function of the upper limb in survivors of 
VWURNH LV &,07 7KH WKHUDS\ GLVFRXUDJHV µOHDUQHG QRQ-XVH¶ D Shenomenon whereby 
movement is initially suppressed due to failure and adverse consequences encountered 
when a subject attempts to use the affected limb (Taub et al., 2006). This results in 
persistent compensatory behaviours and subsequent suppression of use of the impaired 
limb, even when function may eventually be possible (see Figure 1.7). Through 
constraint of the unaffected limb and subsequent forced use of the affected one, CIMT 
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HQFRXUDJHV SRVLWLYH IHHGEDFN DERXW WKH OLPE¶V IXQFWLRQDO SRWHQWLDO *HQHUDOO\ WKH
constraint device is worn for most waking hours during a two week period, and is 
accompanied by intensive RTP performed daily using the (unconstrained) impaired limb 
(Sawaki et al., 2011; Wittenberg et al., 2003). RTP and shaping exercises are designed 
to engage participants in meaningful functional activities, with measurable progressions 
for which they receive positive feedback.  
Chapter 3 described how a novel animal model of appetitive forced use of the 
impaired forelimb using commercial pet activity balls resulted in a modest acceleration 
of functional recovery. The purpose of this study was to further develop the model by 
the addition of an appetitively-motivated, task-specific component (similar to the RTP 
portion of CIMT). This study evaluated whether this modified model could result in 
accelerated functional recovery, as well as impact infarct volume, expression of BDNF, 
number of microglia, and number of Dcx+ cells after 28 days. 
 
4.2 METHODS 
 
4.2.1 Experimental animals 
 
Adult male Sprague-Dawley rats (N=32) were purchased from Charles River 
Laboratories (Montreal, Canada) and single housed on a 12 hr reverse light/dark cycle 
(lights off at 08:00, on at 20:00). As in Chapter 3, all procedures took place during the 
GDUNF\FOHDVDFWLYLW\OHYHOVDIIHFWHGDQLPDOV¶SDUWLFLSDWLRQLQWKHUHKDELOLtation. Unless 
otherwise stated, animals had ad libitum access to food and water, and weighed between 
300-350 g at the time of surgery. All procedures were conducted in accordance with the 
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guidelines of the Canadian Council for Animal Care and were approved in advance by 
the University of Prince Edward Island Animal Care Committee. 
 
4.2.2 Surgical procedure 
 
The ET-1 surgical procedure was performed as described in the previous 
Chapters (for full description, see Section 2.2.3). Briefly, rats were placed into an 
induction chamber pre-filled with isoflurane to induce anaesthesia, which was later 
maintained during surgery using 2% isoflurane in oxygen. Once deeply anesthetised, 
animals were mounted onto a stereotaxic apparatus (David Kopf Instruments, USA), and 
the scalp was incised and retracted with clamps. Small holes were drilled through the 
skull at each injection location (see Table 2.1) using a stereotaxically mounted drill 
(Stoelting Co., USA). In this study, lesions were made contralateral to the preferred paw, 
as determined by staircase test training (described below, in Section 4.2.4.1). 
Endothelin-1 (Calbiochem, Germany) was injected at each location at a flow rate of 
0.5µl/min. After the injections, the scalp was sutured and the incision was treated with 
topical anaesthetic. Body temperature was maintained at 36.0 ± 0.2°C for the duration of 
surgery using a heating pad. Following surgery, animals were given subcutaneous 
injections of butorphanol (2.0 mg/kg), returned to their home cage, and allowed to 
recover. A heating pad was placed under the cage for 1 hour. Sham-operated rats 
received the same surgical procedure up to but not including the drill holes, and 
remained anesthetised for the same amount of time as the ET-1 animals (n=5 sham; 
n=18 stroke). 
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4.2.3 Rehabilitation 
 
Following surgery, ischemia animals began either a modified rehabilitation 
therapy (Rehab; n=9) or Control therapy (n=9) on PSD 3. Daily rehabilitation sessions 
consisted of 30 minutes of activity ball movement, followed by 30 minutes of task 
specific movement. A similar rehabilitation program used in Chapter 3 had no effect on 
the performance or histology of sham animals (see Section 3.3), therefore to reduce the 
number of animals required for the present study, sham surgical controls remained 
untreated. Animals were trained to use the activity balls as described in Chapter 3 (see 
Section 3.2.3) and to perform the task specific reaching exercise described below. Those 
who would not engage in either portion of the rehabilitation following training were 
disqualified from the rehabilitation groups (n=6). 
 
4.2.3.1 Activity ball rehabilitation 
 
Prior to surgery, animals were trained as described in Chapter 3 to use 
commercially available clear plastic pet activity balls (29 cm diameter; Super Pet, USA) 
(Figure 4.1A). During the 30 minute daily rehabilitation sessions, animals were allowed 
to move around an enclosed 40 sq ft arena (1 animal per arena). Sessions were video 
recorded and a subset of time points (PSD 3, 14, 28) was analysed using ANY-maze© 
software (Stoelting Co., USA) to estimate rehabilitation intensity (as distance moved) 
and to assess group variability. Control therapy animals were placed in stationary balls 
for 30 minutes each day. 
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Figure 4.1. Modified forced use movement therapy model. Rehabilitation involved 
two components: (A) General movement therapy was modelled using clear plastic pet 
activity balls. Rehabilitation sessions lasted for 30 minutes daily, in a 40 sq ft arena. (B) 
Reaching boxes measured 7 cm wide x 3 cm deep x 7 cm tall, with the platform holding 
pellets at a height of 3 cm. Boxes were placed into the home cage, and filled on either 
the left or right side, such that the animal was prompted to reach voluntarily with his 
contralesional forepaw for up to 30 minutes/day. Control animals were placed into 
stationary balls for 30 minutes/day and given the equivalent number of pellets without 
having to reach. 
A. B. 
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4.2.3.2 Task specific rehabilitation 
 
Immediately following daily activity ball sessions, Stroke/Rehab animals were 
given a further 30 minutes of task-specific reaching rehabilitation. Reaching boxes filled 
with banana-IODYRXUHGVXFURVHSHOOHWVZHUHVHFXUHGLQWKHDQLPDOV¶KRPHFDJHV3ULRUWR
the initiation of the study, animals were acclimated to the reaching boxes with three 
exposures, and then the ability to use the boxes was verified. Reaching boxes were 
constructed from Plexiglas and measured 7 x 3 x 7 cm, with a central 1 cm wide gap to 
reach through and a 3 cm high platform for pellets (Figure 4.1B). For each animal, the 
ipsilesional side of the box (opposite the impaired forelimb) was filled with 100 pellets 
such that reaching was encouraged with the impaired side. Stroke/Control animals were 
provided with the average number of pellets consumed by the Stroke/Rehab animals 
each day, without requiring reaching. 
 
4.2.4 Behavioural testing 
 
For three weeks prior to surgery, animals were handled daily and acclimated to 
all tests, then pre-surgery scores were recorded. Following surgery, animals were tested 
weekly until PS'$VLQ WKHSUHYLRXVVWXGLHVµGHILFLW¶ZDVGHILQHGDVDPHDQSRVW-
VXUJLFDO SHUIRUPDQFH VLJQLILFDQWO\ ZRUVH WKDQ WKH VKDP JURXS DQG µUHFRYHU\¶ ZDV
considered the point at which the mean performance of animals in each experimental 
group returned to mean sham group performance. In any instance where animals had 
recovered at a particular time point, then had subsequent testing days with impaired 
SHUIRUPDQFHµUHFRYHU\¶ZDVFRQVLGHUHGWKHODWHVWWLPHSRLQWDWZKLFKWKH\FRQVLVWHQWO\
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performed at sham level. All performance evaluations were conducted by an 
experimenter blind to the surgical condition and, when possible, to post-surgical testing 
day. 
 Forelimb placing tests were performed as described in Chapter 2 (see Section 
2.2.4.1); the horizontal ladder test was performed as described in Chapter 3 (see Section 
3.3.2.4). Briefly, for TFP and VFP, the distal portion of the unrestrained forelimb or the 
corresponding vibrissae was gently brushed against the edge of a table, to measure the 
ability of the animal to respond by placing its forelimb onto the surface. Performance 
was determined based on the number of correct forelimb placements on the table top out 
of 5 attempts. For the horizontal ladder test, animals ran across a 1.5 m long ladder 
comprised of unevenly spaced rungs (1-3 cm apart) for 3 trials. The average number of 
foot slips made with the contralesional forelimb was determined by slow motion video 
analysis. 
 
4.2.4.1 Montoya staircase test 
 
The Montoya staircase test (Montoya et al., 1991) was used to assess deficit and 
recovery of skilled reaching in this study. Rats were first trained for 14 consecutive days 
prior to the experiment. During the training period, the test was administered as 
described below while animals were restricted to 4 hours/day ad libitum feeding (all 
DQLPDOV PDLQWDLQHG  ERG\ PDVV $Q\ DQLPDOV WKDW ZHUH XQDEOH WR SHUIRUP Whe 
staircase test following the training period were excluded from the study (n=8). 
Following the 14 day training period, rats were returned to regular ad libitum feeding. 
Training results were used to determine paw preference for each animal, as defined by 
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the paw with which the animal consistently reached more pellets on the last 3 days of 
training. 
To perform the test, animals were placed into a rodent motility staircase 
apparatus that consisted of a box and plinth (Campden Instruments, UK) (Figure 4.2). 
On either side of the plinth were 7 steps of increasing reaching difficulty, each baited 
with 3 banana-flavoured sucrose pellets, for a total of 21 pellets accessible to each 
forelimb. The animals were placed into the staircase apparatus for 15 minutes, after 
which the number of pellets remaining on each step was recorded, as well as the 
maximum step that had been reached (as evidenced by disturbed pellets).  
 
4.2.5 Histology and infarct quantification 
 
At PSD 30 rats were deeply anaesthetized with 4% isoflurane in oxygen. 
Following rapid decapitation, brains were extracted and post-fixed for 72 hours in 10% 
buffered neutral formalin + 30% (w/v) sucrose. Tissue was cryoprotected using 
Cryomatrix (Thermo Scientific, USA) and stored at -80oC until use. Tissue was 
sectioned using a Cryostat (Thermo Scientific, USA) at 50 µm throughout most of the 
brain; several sets of 10 µm sections were taken from the damaged brain region (+0.8 
mm from bregma) for immunohistochemical analysis.  
Sections (50 µm) from all animals in the two stroke groups were then stained 
with cresyl violet, placed on a standard lightbox, and photographed. Pictures of every 
VL[WK VHFWLRQ LH  ȝP DSDUW ZHUH DVVHVVHG IRU LQIDUFW GDPDJH XVLQJ ,PDJH -
software (NIH, USA). Ischemic injury was defined and estimated as described in the 
previous Chapters (see Sections 2.2.5, 3.2.5). 
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Figure 4.2. Staircase Test. Animals were tested for skilled reaching by being placed 
into the staircase apparatus for 15 minutes each testing day. The number of pellets 
consumed and the maximum step of 7 increasingly difficult levels was recorded. Steps 
were baited with banana flavoured sucrose pellets. 
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4.2.6 Immunohistochemistry 
 
Sections (10 µm) were processed for markers of neuroplasticity (n=4/group, 
unless otherwise stated). After rinsing in PBS, antigen retrieval was performed by 
heating the slides at 90oC for 20 minutes in sodium citrate buffer (pH 6.0). Slides were 
then cooled and rinsed in PBS, then used for immunofluoresence or immunochemistry 
as described below. Negative controls were prepared by omitting the primary antibodies. 
 
4.2.6.1 Immunofluoresence 
 
Immunofluoresence was performed to determine the co-localization of BDNF 
with cell phenotype markers. Sections were incubated in blocking solution (10% goat 
serum/1% BSA/0.1% Triton X-100 in PBS) for 2 hours, followed by a combination of 
primary antibodies overnight [1:250 mouse anti-NeuN, #AB377; 1:400 chicken anti-
GFAP, #AB5541; 1:100 rabbit anti-BDNF, #AB1779, Millipore, USA] at 4°C. Sections 
were washed 3 x 10 minutes in PBS+0.1% Tween. They were then incubated with the 
following Alexa Fluor conjugated secondary antibodies: Alexa 350 goat anti-mouse IgG 
(1:100), Alexa 594 goat anti-chicken IgG (1:200), and Alexa 488 goat anti-rabbit IgG 
(1:200; all from Invitrogen, USA) for 1 hour. Fluorescence signals were detected with a 
Zeiss AxioObserver.Z1 inverted fluorescent microscope with an Apotome system, 
VFDQQLQJ PLFURILQH VOLFHV  ȝP DW H[FLWDWLRQHPLVVLRQ ZDYHOHQJWKV RI 
585/615, and 470/505 nm for NeuN, GFAP, and BDNF labelling, respectively. 
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4.2.6.2 Diaminobenzidine Tetrachloride 
 
Sections were incubated in 3% H2O2 for 20 minutes, then in blocking solution 
(10% goat or horse serum/1% BSA/0.1% Triton X-100 in PBS) for 1 h at room 
temperature, followed by rabbit anti-BDNF (1:500, #AB1779; Millipore, USA), rabbit 
anti-Iba1 (1:500, #019-1974; Wako Chemicals, USA), or goat anti-Dcx (1:250, #c-18; 
Santa Cruz Biotechnologies, USA) antibodies at 4°C overnight. The following day, they 
were incubated in the presence of secondary antibody (1:200 biotinylated goat anti-
rabbit or horse anti-goat) for 1 hour, then ABC for 2 hours (all from Vector 
Laboratories, USA). Following washing, sections were visualized with a solution of 
DAB and H2O2 (Vector Laboratories, USA), and counterstained with hematoxylin to 
visualize cell nuclei (Dcx and BDNF only). Verification of microglial reaction in the 
infarct using anti-Iba1 was performed using n=4 for each stroke group with a single 
sham subject for comparison. 
 
4.2.7 Cell counting 
 
 The proportion of cells expressing BDNF [(# BDNF+ cells/total # cells) X 100] 
and the number of Iba1+ cells was determined in the ipsilesional and contralesional 
hemisphere (and corresponding regions of sham sections) using DAB-labelled sections. 
Counting was performed at 400 x magnification (each ROI measuring 0.35 x 0.25 mm) 
along the cortical lesion boundary, in the ipsilesional striatum, and in 2 equivalent 
regions of the contralesional hemisphere (Figure 4.3). The number of Dcx+ cells was 
determined by counting cells in ROIs on the lesion border, ipsilesional striatum and  
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Figure 4.3. Immunohistochemistry regions of interest. The proportion of Iba1+ cells 
and BDNF expressing cells, as well as triple labelling to determine the co-localization of 
BDNF with NeuN and GFAP, was determined from two ipsi- and two contralesional 
ROIs (0.70 x 0.56 mm). Scale bar= 100 µm. 
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SVZ, and corresponding contralesional cortex, striatum and SVZ. Counting was 
performed at 200 x magnification and ROIs measured 0.67 x 0.54 mm (see Figure 3.3B). 
For immunofluoresence, the number of immunopositive cell bodies was counted 
at the same four regions, at 200 x magnification (ROIs measured 0.70 x 0.56 mm). 
Counting was performed by an observer blinded to treatment group, using 
Zeiss Axiovision 4.7 image analysis software. A co-labeled BDNF+/phenotypic 
marker+ cell was defined as expressing both immunolabels within the same optical 
section.  
 
4.2.8 Statistical analyses 
 
Statistical analyses were performed using PAWS Statistics (v. 18; SPSS inc., 
Chicago, USA). Behavioural data were analysed using RM ANOVA. Where the 
assumptions of sphericity were violated (Mauchly's test; p<0.05) the Greenhouse±
Geisser correction was applied (see Section 2.2.6; degrees of freedom are reported to the 
nearest integer). When warranted, subsequent Bonferroni post-tests were used to 
determine differences between groups on specific days. Rehabilitation intensity and 
immunohistochemistry (with the exception of Iba1 analysis) were analysed using one 
way ANOVAs, with subsequent Bonferroni post-hoc tests to determine group 
differences. Infarct volumes and Iba1 expression were compared between groups using 
independent t-tests. Values are expressed as mean ± SEM. 
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4.3 RESULTS 
 
4.3.1 Rehabilitation 
 
The intensity of voluntary engagement in the activity ball paradigm was analysed 
from video recordings using a subset of early, middle, and late time points (PSD 3, 14, 
and 28). Mean performance (distance moved) of rats was not significantly different 
between days, averaging 160 meters/session (Figure 4.4A). The same subset of time 
points was used to assess participation in task-specific reaching. Animals consumed 
significantly fewer pellets on the first day of rehabilitation (p=0.001), but consumption 
was equal on days 14 and 28 (p=0.332) (Figure 4.4B). 
 
4.3.2 Behavioural tests 
 
4.3.2.1 Forelimb placing tests 
 
Following surgery, all ischemic animals had a significant contralesional 
functional deficit compared to controls when responding to tactile stimulation. Analysis 
revealed a significant effect of group (F2,20=12.2; p<0.0005), time (F3,48=15.8; 
p<0.0005), and an interaction of group x time (F5,48=3.52; p=0.009) beginning on PSD 1 
(p<0.001; Figure 4.5A). Rats that were receiving rehabilitation had recovered by PSD 14 
(p=0.169), compared to PSD 21 for control animals (p=0.112).  
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Figure 4.4. Rehabilitation intensity. A subset of time points were sampled to 
determined the intensity of voluntary rehabilitation engagement. (A) The average 
distance moved in the activity balls during 30 minute voluntary rehabilitation sessions 
was the same at all time points sampled. (B) On the first day of rehabilitation, animals 
reached fewer pellets in the RTP task, however this stabilized by the second post 
surgical week. n=9; *p<0.05. 
A. 
B. 
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Figure 4.5. Performance on forelimb placing tests. (A) Tactile-stimulated forelimb 
placing of animals in both stroke groups was significantly impaired compared to shams; 
this performance recovered earlier in animals receiving rehabilitation. (B) Similarly, 
vibrissae stimulated placing of animals in both stroke groups revealed a significant 
impairment which recovered earlier in the rehabilitation group. n=5/shams; 9/stroke 
groups; *= Stroke/Control significantly different from sham; #= Stroke/Rehab 
significantly different from sham; p<0.05. 
 
A. 
B. 
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Similarly, all animals that received stroke surgery had a significant functional 
deficit in vibrissae-stimulated forelimb placing following surgery. There was a 
significant effect of group (F2,20=12.9; p<0.0005), time (F3,65=13.9; p<0.0005), and an 
interaction of group x time (F6,65=3.43; p=0.004). Rats receiving rehabilitation had 
sustained deficits until PSD 14 (p=0.370) compared to control animals that had deficits 
until PSD 28 (p=0.084; Figure 4.5B). 
 
4.3.2.2 Horizontal ladder test 
 
Prior to surgery, all animals were able to cross the ladder with a small average 
number of foot slips (1.3 ± 0.11). On PSD 1, the number of foot slips with the 
contralesional forelimb was significantly greater in both ischemia groups (p<0.001). 
There was a significant effect of group (F2,20=4.27; p=0.029), time (F5,100=9.38; 
p<0.0005), and interaction of group x time (F10,100=2.39; p=0.014). Further analysis 
revealed that by PSD 7, both groups had recovered performance to Sham level (Figure 
4.6). 
 
4.3.2.3 Montoya staircase test 
 
On PSD 1, both ischemia groups had a significant deficit in reaching 
performance with respect to maximum step reached (p<0.001). There was a significant 
effect of group (F2,20=10.3; p=0.001), time (F5,100=6.19; p<0.0005), and interaction of 
group x time (F10,100=2.52; p=0.010). Animals that received rehabilitation recovered to 
sham performance by PSD 14, whereas control treatment animals had not recovered by  
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Figure 4.6. Performance on the horizontal ladder test. Animals in both stroke groups 
had a significant impairment in running performance, as defined by the number of foot 
slips while crossing the ladder on the first post-surgical day. This impairment recovered 
in both groups by the following testing day. n=5/shams; 9/stroke groups; *= 
Stroke/Control significantly different from sham; #= Stroke/Rehab significantly 
different from sham; p<0.05.  
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the end of the study (PSD 28 p=0.018; Figure 4.7A). Results are presented as percentage 
of pre-surgery performance. Following surgery, both ischemic groups also had a 
significant deficit with respect to the number of pellets consumed (p<0.001). Again, 
there was a significant effect of group (F2,20=15.2; p<0.0005), time (F3,60=12.1; 
p<0.0005), and a group x time interaction (F6,60=5.01; p<0.0005). However, further 
analysis revealed that neither stroke group recovered by the end of the study (p<0.0005; 
Figure 4.7B).  
 
4.3.3 Histology and infarct quantification 
 
Infarct volume was not significantly different between the two stroke groups 
(p=0.23), and measured 10.6 ± 5.7 mm3 (SEM) for animals receiving control therapy 
and 25.7 ± 8.6 mm3 for those receiving rehabilitation (Figure 4.8). 
 
4.3.4 Immunohistochemistry 
 
4.3.4.1 BDNF 
 
The proportion of cells expressing BDNF was determined in both the ipsilesional 
and contralesional hemispheres using immunohistochemistry. There were no significant 
differences between any of the groups in either hemisphere (p>0.05) (data not shown). 
The same regions were then examined for the cellular origin of BDNF by visualizing co-
localization of BDNF with NeuN (mature neurons) or GFAP (astrocytes), or by 
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Figure 4.7. Performance on the staircase test. (A) Maximum step reached. All 
animals that received stroke surgery had impaired reaching performance compared to 
shams. Those that received control therapy remained impaired for the duration of the 
study, while those receiving rehabilitation regained function on this test at 14 days. (B) 
Maximum number of pellets reached. All animals that received stroke surgery had 
impaired reaching performance compared to shams, which remained significant for the 
duration of the study. n=5/shams; 9/stroke groups; *= Stroke/Control significantly 
different from sham; #= Stroke/Rehab significantly different from sham; p<0.05. 
A. 
B. 
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Figure 4.8. Infarct volume. Total infarct volume (mm3) in stroke animals that received 
rehabilitation did not differ significantly from those receiving control therapy. 
n=9/group.
158 
 
observing single labelled BDNF+ cells (subsequently referred to aV³2WKHU´FHOO W\SH
Proportions were determined by calculating the percent of total BDNF that was co- 
localized with each cellular marker. Animals in the Stroke/Control group did not show 
altered BDNF expression compared to Shams. However, animals that received 
rehabilitation had significantly fewer BDNF+/NeuN+ cells (p=0.021), and significantly 
PRUH VLQJOH ODEHOOHG ³2WKHU´ %'1) FHOOV S  )LJXUH -4.10). There were no 
significant differences were found in the contralesional hemisphere (data not shown). 
 
4.3.4.2 Microglia 
 
 Microglia were visualized by labelling with anti-Iba1. Stroke caused a visible 
increase in the number of microglia present in the lesion border when compared to the 
Sham section (Figure 4.11), but there was no significant difference between the number 
of Iba1+ cells in the Stroke/Rehab group compared to the Stroke/Control group. No 
differences were found in the contralesional hemisphere. 
 
4.3.4.3 Neuroblasts 
 
Stroke/Control animals did not have significantly more Dcx+ cells in the 
ipsilesional SVZ, striatum, or cortex compared to the Sham group. Stroke/Rehab 
animals showed a significant increase in the number of Dcx+ cells in the SVZ and 
lesioned cortical areas (F2,13=3.95; p=0.050) (Figure 4.12).  
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Figure 4.9. Ipsilesional BDNF expression. Triple labelling immunofluoresence was 
performed to determine the cellular origin of existing BDNF. Stroke/Control animals 
were not significantly different form either the Sham or the Stroke/Rehab groups. 
Animals that received rehabilitation had significantly less BDNF co-labelled with NeuN 
and significantly more non-co-ODEHOOHG µ2WKHU¶ %'1) SXWDWLYHO\ PLFURJOia; see 
Discussion).  
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Figure 4.11. Presence of ipsilesional microglia. (A) Expression of microglia in Stroke 
groups was visibly increased compared to the Sham animal. In sham animals, the Iba1+ 
cells exhibited stellate morphology (solid arrowhead). In stroke animals, the Iba1+ cells 
were mostly ameboid, typical of activated microglia (empty arrowheads). Scale bar= 50 
µm. (B) Rehabilitation did not affect the number of Iba1+ cells in any brain region. The 
white bar represents one Sham animal that was used for comparison, while n=4 for the 
two stroke groups, which were included in the analysis. *p<0.05. 
A. 
B. 
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Figure 4.12. Ipsilesional Dcx expression (A) Normal expression of Dcx in sham animals (first row). Control therapy did not 
significantly increase the number of Dcx+ cells in the SVZ, nor in the ipsilesional striatum or cortex (second row and B). However, 
animals that underwent rehabilitation exhibited significantly more Dcx+ cells in the SVZ and in the ipsilesional cortex compared to 
either Sham or Control therapy animals (third row, and B), and the morphology of Dcx+ cells was long and thin (enlarged area). 
n=4/group; *p<0.05. Scale bar= 100 µm (enlarged area scale bar= 50µm). 
A. B. 
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4.4 DISCUSSION 
 
 Forced use of the paretic limb in stroke patients can enhance the recovery of 
motor function. However, animal models of forced use therapy have had varying success 
(Bland et al., 2000; Humm et al., 1998; Kozlowski et al., 1996). Encouragingly, post-
ischemia exposure of rats to task-specific (Biernaskie and Corbett, 2001; DeBow et al., 
2003; Maldonado et al., 2008) or non-specific (Johansson and Ohlsson, 1996; Ke et al., 
2011; Marin et al., 2003; Ohlsson and Johansson, 1995) forelimb activity can improve 
functional outcome. Herein, a rehabilitation paradigm comprised of two voluntary 
components [generalized movement (activity ball) and task-specific movement 
(reaching box)] was evaluated (see Figure 4.1). This appetitively-motivated 
rehabilitation resulted in accelerated recovery of forelimb function on several tests (see 
Figures 4.5-4.7), without significantly affecting the amount of damage (see Figure 4.8). 
Examination of the effect of rehabilitation on BNDF expression revealed that while the 
proportion of total cells expressing BDNF was not different between groups at PSD 28, 
there was an increase in the proportion of non-neuronal, non-astrocytic cells expressing 
BDNF (see Figure 4.10). Further, there was a significant increase in the presence of 
Dcx+ cells in the ipsilateral SVZ and cortex of the Stroke/Rehab animals (see Figure 
4.12).  
Voluntary participation in activity ball movement therapy was similar throughout 
the course of this study, and averaged 160 m per day. This is in contrast to the declining 
intensity observed over the course of the study presented in Chapter 3 (see Figure 3.2). 
A potential explanation for this may be that the setup of the rehabilitation room was 
altered for the present study. The use of ANY-maze© tracking software required the 
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placement of one animal at a time into each rehabilitation arena, as opposed to the 
multiple animals approach used in Chapter 3. Perhaps this alteration resulted in 
increased incentive and curiosity of each individual animal for the duration of the study.  
Prior to surgery, all animals used the intended contralesional limb to reach for 
pellets during the task-specific component of rehabilitation. In the days following 
surgery some animals behaved abnormally, for example by: 1) attempting to reach with 
the ipsilesional paw, 2) attempting to pull or knock over the reaching box to spill the 
pellets out, and 3) ignoring the reaching box. These behaviours mostly normalized (i.e. 
reaching with the contralesional paw resumed) within the first post surgical week. 
However, because these behaviours were occasionally observed, and because it often 
took multiple reach attempts to acquire pellets, the total number of pellets consumed is 
not indicative of the number of contralesional task-specific movements undertaken.  
Interestingly, the Montoya staircase test demonstrated that animals receiving 
rehabilitation recovered reaching distance (see Figure 4.7A), but not the dexterity 
required to successfully consume the pellets in the apparatus (see Figure 4.7B). This 
could be due to the nature of the task-specific portion of the rehabilitation. In order to 
obtain pellets through the 1 cm reaching slot (see Figure 4.1B), animals were required to 
reach into the box (at a maximum depth of 3 cm), then could simply slide and scoop 
pellets out. Thus, the successful grasp and delivery of the pellet directly to the mouth 
was not required; rather, the pellets were obtainable once on the floor of the cage. 
Vaynman and Gomez-Pinilla (2005) suggest that different types of recovery may be 
specific to the form of rehabilitation implemented, supporting this explanation that the 
type of movement required for the present task-specific rehabilitation may underlie the 
recovery in maximum step reached but not in number of pellets eaten.  
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In the current study, testing took place on a weekly basis, rather than the daily 
and twice weekly testing in Chapters 2 and 3. This weekly testing schedule was chosen 
based on the gradual recovery profile observed from the studies presented in the 
previous chapters, which took place over three to four weeks. Daily testing was deemed 
needlessly frequent, and as highlighted in Section 1.8, repeated testing can itself be 
rehabilitative (Kleim et al., 2007). However, some resolution of recovery profile was 
lost because of the weekly schedule employed in the present study. For example, 
horizontal ladder running performance was only impaired in stroke groups on the first 
post surgical day, and by PSD 7 performance had recovered to sham levels in both 
groups. Thus, it was impossible to determine whether rehabilitation resulted in 
accelerated functional recovery in the first post surgical week, or rather, if both groups 
had recovered simultaneously. It is unclear why performance on the ladder test was not 
impaired for a longer period of time, as was seen in Chapter 3.  
The volume of the infarct was not significantly affected by rehabilitation in this 
study, similar to previous reports (Biernaskie and Corbett, 2001; Biernaskie et al., 2004; 
Maldonado et al., 2008; Marin et al., 2003; Schabitz et al., 2004), although the mean 
volume in the rehabilitation group appeared greater than that of the control treatment 
group (25.7 ± 8.6 vs 10.6 ± 5.7 mm3; p=0.23). Lesion exacerbation due to rehabilitation 
has previously been reported following forced use (Bland et al., 2000; DeBow et al., 
2004; Humm et al., 1998) and enriched environment (Farrell et al., 2001) rehabilitation, 
perhaps related to timing and intensity of rehabilitation (Leasure and Schallert, 2004). 
Conversely, reduction in lesion volume has also been reported following exercise 
programs (Auriat and Colbourne, 2009; DeBow et al., 2003; Kim et al., 2005). The 
voluntary rehabilitation applied in this study likely exerts neural activation slightly 
166 
 
below the level required to result in significant damage, supporting the importance of 
low intensity, voluntary paradigms. It is possible that waiting until PSD 5 to initiate 
rehabilitation would have resulted in preservation of more tissue, as in Chapter 3. 
BDNF expression was examined by immunofluoresence to ascertain whether 
rehabilitation resulted in a shift in the cellular origin of the BDNF being expressed. In 
the present study, rehabilitation caused a shift in BDNF production away from the 
neuronal phenotype and toward non-neuronal/non-astrocytic phenotype; a phenomenon 
that has been reported previously in the peri-infarct area (Béjot et al., 2011). In addition 
to neurons and astrocytes, other cell types that can express BDNF include microglia, 
endothelial cells, and ependymal cells. Because endothelial cells and ependymal cells 
are relatively easily identified based on location, morphology, and arrangement (Béjot et 
al., 2011), the observed morphRORJ\ DQG ORFDWLRQ RI WKH µ2WKHU¶ %'1) FHOOV )LJXUH
4.10D) supports the hypothesis that they are microglial (Béjot et al., 2011). Therefore, 
further investigation was made into the presence of microglia in the perilesional areas.  
Historically thought to play a detrimental role in the injured brain, microglia are 
increasingly considered to have additional beneficial effects during post-ischemic 
neuroplasticity (Faustino et al., 2011; Iadecola and Anrather, 2011; Madinier et al., 
2009). Madinier et al. (2009) reported that decreased acute microglial activation was 
associated with a long term down-regulation of markers of neuroplasticity, including 
BDNF. Narantuya et al. (2010) demonstrated that transplantation of human microglial 
cells following MCAo in the rat reduced ischemic deficits and cellular apoptosis. 
However, Hewlett and Corbett (2006) reported that administration of minocycline, an 
antibiotic with anti-inflammatory effects, improved functional recovery and reduced 
infarct volume. In the present study, visualization of Iba1+ cells showed that stroke 
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caused a large increase in the number of microglia in the perilesional areas, as reported 
by others (Auriat et al., 2010; Madinier et al., 2009). In sham animals, the Iba1+ cells all 
exhibited stellate morphology. In stroke animals, the Iba1+ cells were mostly ameboid, 
typical of activated microglia (Nowicka et al., 2008) (see Figure 4.11A). However, there 
was no difference in the number of microglia between the Stroke/Control and 
Stroke/Rehab groups. Therefore, rehabilitation may cause a shift in the role of local 
microglia (to express more BDNF), without affecting the actual microglial reaction. To 
further investigate this hypothesis, subsequent experiments should examine co-
localization of BDNF and Iba1 (a process not possible in the present study due to 
insufficient tissue samples). In the absence of this confirmation, it is difficult to draw 
conclusions on the observed shift from neuronal to non-neuronal/non-astrocytic 
³2WKHU´ VRXUFHVRI%'1)7KHSRWHQWLDO LPSRUWDQFHRI WKLVPXVWQRWEHRYHUORRNHG
because the cellular source of BDNF has implications for potential target cell 
populations for post-stroke adjunctive therapies. If BDNF production is shifted 
significantly to microglial cells with rehabilitation, adjuvant therapies that inhibit 
microglial response could be counterproductive. 
Lastly, this study showed an increase in the number of Dcx+ cells, indicative of 
migrating neuroblasts, in the SVZ and cortex of animals that received rehabilitation 
compared to control therapy. Thus, rehabilitation may increase the proliferation and/or 
survival of new neurons that migrate to damaged brain areas. It has been shown by 
several groups that brain injury and rehabilitation (Auriat et al., 2010; Briones et al., 
2005; Leasure and Grider, 2010) result in reactive neurogenesis (Carmichael, 2008; Gu 
et al., 2000; Jiang et al., 2001; Jin et al., 2001; Kernie and Parent, 2010; Leasure and 
Grider, 2010; Parent et al., 2002; Wang et al., 2007; Xiong et al., 2010; Zhang et al., 
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2001). However, a major limitation in this study was the use of Dcx as a marker of 
neurogenesis instead of the traditional BrdU injections. The reason for, and limitations 
of, this are discussed in Chapter 3 (see Section 3.4). Rehabilitation increased the 
expression of Dcx in the present study, and as in Chapter 3, the Dcx+ cells observed had 
characteristic morphology of migratory neuroblasts (long and thin, with few processes; 
Figure 4.12) and were located almost exclusively between the SVZ and the areas of 
damage. Further confirmatory studies specifically aimed at investigating the role of 
neurogenesis following rehabilitation, as well as long-term cell survival and integration, 
are warranted. 
Modelling forced use using this appetitively-motivated paradigm appears to offer 
an alternative that overcomes some of the challenges associated with animal motivation 
and stress. This approach to voluntary forced use therapy results in modest acceleration 
of functional recovery using several tests, and may involve mechanisms related to 
BDNF expression and neurogenesis. Future studies should further investigate the 
involvement of microglia and neurogenesis in the post-ischemic neuroplastic process 
that result from this form of rehabilitation. 
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CHAPTER 5: 
GENERAL DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
³0LQGFDQRQO\EHUHJDUGHGIRU
scientific purposes, as the activity of 
the brain, and this should be mystery 
HQRXJKIRUDQ\RQH´ 
 
-Donald Hebb (1904-1985) 
picture from http://www.vetopsy.fr/comp/mem/mem_bn1.php
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5.1 GENERAL OVERVIEW AND COMPARISON OF STUDIES 
 
The discovery that the adult brain can undergo structural and functional changes 
following injury was truly a breakthrough in the field of brain repair. It has 
revolutionized the way in which we think about neurodegeneration and 
neurorehabilitation. While a few decades ago, rehabilitation revolved around learning 
FRPSHQVDWRU\IXQFWLRQLQRUGHUWRRSWLPL]HSDWLHQWV¶TXDOLW\RIOLIH WKHIRFXVKDVQRZ
shifted to driving positive, activity-dependent neuroplastic events to optimize recovery 
processes (Sandin, 2012). 
Stroke is a complex disease with a plethora of causes, manifestations, and 
outcomes. Because the MCA is so commonly affected in stroke, and this artery supplies 
blood to cortical and striatal motor regions, impairment of limb function is a prevalent 
disability in survivors of stroke, and upper extremity impairment is common (Kelly-
Hayes et al., 1998). The research described in this thesis aimed to address post-ischemic 
neuroplasticity following unilateral forelimb damage resulting from a temporary 
ischemic episode. 
A promising rehabilitation technique for treating hemiplegic patients is CIMT. 
By forcing use of the impaired arm (by constraining the unaffected arm), recovery can 
be improved (see Section 1.7.1). The mechanisms by which this occurs are not 
completely understood, although neurotrophins have been implicated (Clarkson et al., 
2011; Ke et al., 2011; MacLellan et al., 2011; Ploughman et al., 2007, 2009; Vaynman 
and Gomez-Pinilla, 2005). To better understand the effect of rehabilitation on 
neuroplasticity, animal models are required. The benefits of rehabilitation are greater 
when the patient is motivated to participate to the best of their abilities and at 
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increasingly progressive intensity (Carr and Shepherd, 2011). As such, clinical 
rehabilitation relies on patient willpower, clinician motivation, and family support. In 
animals, this presents a challenge. A novel approach intended to circumvent willpower 
and motivation issues while forcing use of the impaired forelimb was explored in the 
research described in this thesis. 
An additional challenge when studying rehabilitation in animals is the choice of 
stroke model. Each of the commonly employed stroke models described in Chapter 1 
(see Table 1.1) has a unique profile of benefits and disadvantages. The most commonly 
used model, MCAo, has the disadvantage of producing large and variable infarcts. While 
animals can survive surgical strokes that result in a large amount of damage, this may 
not represent a realistic model of the clinical condition, because humans are unlikely to 
survive such extensive tissue loss (Carmichael, 2005). Furthermore, the purpose of 
rehabilitation is to manipulate neuroplastic events in an activity-dependent manner. 
Neuroplasticity is known to occur at a cellular level, thus it is critical that sufficient 
brain tissue remains to form a substrate on which such changes can occur (Knieling et 
al., 2009; Teasell et al., 2005). 
The specific objectives of this research were 1) to refine a rat model of focal 
ischemia to produce consistent, reliable infarcts to forelimb motor regions of the brain 
accompanied by quantifiable forelimb impairments, 2) to evaluate a novel voluntary 
model of forcing use of the impaired limb using behavioural and biochemical measures, 
and 3) to evaluate a refined version of the voluntary forced use model. 
To address the first aim, an ET-1 intracerebral injection protocol was refined 
using a set of previously unpublished injection coordinates. This resulted in forelimb 
impairments lasting up to 3 weeks (see Section 2.3), and represented an improvement 
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over a previously established protocol in our laboratory. This refined protocol was then 
used for the remaining studies described in Chapters 3 and 4. 
With respect to the second aim, initial evaluation of a novel forced use 
movement therapy revealed a slight acceleration in recovery profile in animals receiving 
rehabilitation. In this study, rehabilitation consisted of 30 minutes/day of low intensity 
movement in pet activity balls, initiated at PSD 5. While this rehabilitation did 
accelerate functional recovery to sham group level of performance (see Section 3.3), the 
results were not as pronounced as expected. Recovery was accelerated by as little as one 
day, for example in the forelimb postural reflex test (see Figure 3.6). Rehabilitation did 
not exacerbate damage, as indicated by the similarity in lesion volume between the 
control and rehabilitation groups (see Figure 3.9). However, despite the modest 
improvement in recovery, rehabilitation did not alter the proportion of cells expressing 
BDNF, NOGOA, or the number of Dcx+ cells.  
To further refine the rehabilitation protocol used in Chapter 3, an additional 
component was added to the therapy for the experiment described in Chapter 4. Inspired 
by the RTP administered as part of CIMT in the clinic, a repetitive skilled reaching 
exercise protocol was added to the rehabilitation. Additionally, because rehabilitation 
initiated on PSD 5 had not negatively affected lesion volume in Chapter 3, rehabilitation 
was initiated sooner in the following study (at PSD 3), in an attempt to maximize early 
QHXURSODVWLF RSSRUWXQLWLHV ZKLOH UHPDLQLQJ LQ WKH µVDIH¶ WLPH IUDPH DFFRPSOLVKHG
previously. Further, testing of the modified rehabilitation study took place on a weekly, 
rather than daily or twice weekly, basis. Modified rehabilitation resulted in a more 
marked acceleration in functional recovery (between 1 and 3 weeks; see Section 4.3). 
This rehabilitation paradigm also caused a shift in the cellular origin of BDNF, and in 
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the number of Dcx+ cells, compared to sham control animals. Interestingly, the lesion 
volumes of animals receiving rehabilitation, while not significantly different from 
control animals, tended to be larger (Figure 4.8). Therefore, it appears that initiation of 
rehabilitation sooner than PSD 3 could lead to exacerbation of damage, which is 
consistent with previous findings (Bland et al., 2000). 
Because of the differences in study designs presented in Chapters 3 and 4 
(summarized in Table 5.1), it would be inappropriate to make direct comparisons 
between the respective rehabilitation regimens. Nonetheless, based on the use of some 
similar tests, and the lack of altered expression of neuroplastic markers observed in the 
initial rehabilitation study, it appears that the refined rehabilitation did result in the best 
recovery.  
 
5.2 STROKE MODEL: CONSIDERATIONS 
 
 Chapter 2 described a variation of the ET-1 model that resulted in consistent 
damage to forelimb motor regions and reasonably long-lasting deficits (Hume, 2009; 
Leasure and Schallert, 2004; Schallert et al., 2000). Because of putative post-ischemic 
events that take place on a cellular level, it was important to use a stroke model that left 
sufficient intact neural tissue to act as a substrate for plasticity. Furthermore, the lesions 
were well-confined to the forelimb motor regions of the brain, reducing the possibility of 
confounding deficits.  
While the variability between infarcts in each study was reasonable, there were 
large differences in the average infarct sizes between studies (Figures 2.6, 3.9, and 4.8). 
Efforts were made to preserve the integrity of reconstituted ET-1 within each study (see  
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 Chapter 3: initial evaluation 
of rehabilitation 
Chapter 4: evaluation of 
refined rehabilitation 
Duration of study 21 days 28 days 
Rehabilitation 
exercise 
30 minutes exercise ball 30 minutes exercise ball + 
30 minutes repetitive task 
training 
Initiation of rehab Post surgery day 5 Post surgery day 3 
Intensity of rehab Declined over time Remained constant (ball 
rolling);  
increased over first few days 
(pellet reaching) 
Test battery Forelimb placing tests (2) 
Horizontal ladder test 
Forelimb postural reflex 
Cylinder test 
Forelimb placing tests (2) 
Horizontal ladder test 
Montoya staircase test 
Test schedule Daily (TFP, VFP, postural 
reflex); every 3-5 days  
(cylinder and ladder) 
Weekly 
Control groups Surgical control (Sham); 
Rehabilitation control 
(Sham/Rehab) 
Surgical control only (Sham) 
 
Table 5.1. Contrasting rehabilitation studies. Summary of the major differences 
between rehabilitation studies performed in this thesis (for details, see Chapters 3 and 4). 
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Section 2.2.2). Thus, variations observed between studies may be due to ET-1 batch-to-
batch variations, which have been reported by others (Soylu et al., 2012). 
This research used exclusively male animals. This choice was based largely on 
previous work in the laboratory, as well as logistical challenges of using female animals 
in stroke research. Because estrogen and progesterone can affect infarct volume 
(Alkayed et al., 1998; Chen et al., 1999) and post-ischemic neuroplasticity (Woolley and 
McEwen, 1993), female animals must be monitored for estrous state throughout the 
experiment using cytological characterization of cervical smears (Maldonado et al., 
2008), a labour intensive process. Further, it may be necessary to perform stroke 
surgeries at various times; unfortunately, the short storage life of prepared ET-1 would 
make this difficult. Thus, it is important to recognize that the studies presented herein 
should be replicated in female animals before making broad conclusions regarding 
efficacy. The general lack of confirmatory studies using both genders in preclinical 
research is believed to be one factor contributing to the demise of experimentally 
promising treatments when tested in the clinical setting (STAIR, 1999). 
Another important point requiring emphasis is the age of the animals used in 
these studies. Because of a number of challenges surrounding the use of aged animals, 
this research focused exclusively on young adult rats (approximately 3-4 months of age 
at the time of surgery). Aside from additional housing costs, aged animals have a higher 
post-surgical mortality rate (Lindner et al., 2003; Pan et al., 2005), or require intensive 
post-operative care (Ryan et al., 2006). Furthermore, as rats grow larger, they become 
more difficult to handle properly and too large for some test apparatuses. These 
considerations make young adults a more attractive choice for short-term research 
projects. Nonetheless, the use of young animals is an increasingly criticized practice in 
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stroke research (Leasure and Grider, 2010; Lindner et al., 2003; Soleman et al., 2010; 
STAIR, 1999). As the majority of people who experience a stroke are elderly (Lloyd-
Jones et al., 2009), using young animals may not provide an accurate portrayal of the 
physiological processes that take place in the average post-stroke brain. Li and 
Carmichael (2006) showed that the post-ischemic expression patterns of various markers 
of neuroplasticity were different in the aged brain compared to young adults 
(Carmichael et al., 2006). Thus, the data presented in this thesis should not to be 
extrapolated to an elderly population. 
 
5.3 REHABILITATION: CONSIDERATIONS 
 
Fundamental parameters of rehabilitation, including optimal duration and 
intensity, remain poorly understood. Some studies suggest that rehabilitation may be 
dose-dependent, with better outcome after more intense therapy (Huang et al., 2009b; 
Kwakkel et al., 1999). It also appears that a critical threshold of rehabilitation intensity 
must be reached to observe functional benefit (MacLellan et al., 2011). 
It should be noted that like most post-stroke rehabilitation studies, the conditions 
in which animals were housed in the current work were considerably impoverished 
environments compared to the clinical setting, which further limits the translational 
relevance of results (Kleim et al., 2003). Even the most sedentary of stroke patients live 
in extremely complex environments, with regular cognitive, social, and environmental 
stimulation. This is in stark contrast to the institutional environment available to 
preclinical researchers, especially with the single-housing protocol used in the present 
research.  
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In Chapter 4, the use of ANY-maze© software allowed for the determination of 
WKH GLVWDQFH PRYHG GXULQJ WKH UHKDELOLWDWLRQ VHVVLRQV $QDO\VLV RI D VXEVHW RI µHDUO\¶
µPLGGOH¶DQGµODWH¶ WLPHSRLQWVUHYHDOHGWKDWDQLPDOVFRQVLVWHQWO\PRYHGDQDYHUDJHRI
160 m/session. This is relatively low compared to other voluntary and forced use 
paradigms that have been explored. Generally, access to running wheels has been used 
to model voluntary exercise, and results in daily walking/running distances of 200-7000 
m over the course of up to 23 hours (Ke et al., 2011; Maldonado et al., 2008; Mizutani 
et al., 2011). Forced exercise regimens, on the other hand, have involved daily distances 
of 82-1600 m, generally averaging 600 m over the course of an hour (Auriat et al., 2006; 
Kim et al., 2005; Leasure and Grider, 2010; Ploughman et al., 2007, 2009; Yanagita et 
al., 2007; Yang et al., 2003). Ke et al. (2011) measured corticosterone levels, indicative 
of stress, following voluntary running rehabilitation and found no difference from 
sedentary control animals, supporting tKH SUHVXPHG µPLOG¶ QDWXUH RI YROXQWDU\ IRUFHG
use. Further, Yanagita et al. (2007) demonstrated an increase in the presence of 
corticotrophin-releasing hormone neurons following forced, but not voluntary, exercise. 
Mizutani et al. (2011) demonstrated that similarly mild voluntary rehabilitation (200-400 
m/day) was sufficient to alter the expression of several proteins involved in 
neuroplasticity, supporting the hypothesis that the intensity observed in this thesis 
research could affect post-ischemic neuroplasticity. Without having directly measured 
stress levels, it is impossible to conclusively determine whether the paradigm of shorter 
periods of voluntary forced use used in this research evoked as little stress as other 
published voluntary paradigms. However, considering the fact that the rats were 
extensively and gradually familiarized with the activity balls prior to surgery, 
participation in the activity was optional, and animals could stop engaging during the 
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sessions if desired, it is likely that animals did not find the chosen activity level overly 
stressful. 
7KLVZRUNGLGQRW LQFOXGHDµGRVH¶-dependent investigation of the rehabilitation 
treatment; rather, there was a set 30 minute interval during which animals were able to 
participate in each component of rehabilitation. The voluntary nature of the 
rehabilitation being evaluated made a dose-dependent approach challenging. 
Retrospective analysis of self-governed rehabilitation intensity revealed that there was 
little variability between individuals with respect to participation, but no attempt was 
made to determine, for example, whether allowing animals 60 minutes of activity ball 
time (rather than 30) would lead to further functional improvement. Further evaluation 
in this area would be interesting, considering the importance of at least a minimum 
intensity required to elicit benefit (MacLellan et al., 2011). The issue of dose/intensity 
also remains challenging for clinical researchers. Although CIMT intensity can be 
controlled to a degree (by prescribing a particular daily constraint duration) research into 
the importance of intensity has yielded mixed results (Page et al., 2005; Richards et al., 
2006; Sterr et al., 2002). 
Chapter 3 described an initial evaluation of only generalized voluntary forced 
use, using activity balls. In Chapter 4, a task-specific shaping exercise was added to the 
rehabilitation, intended to model the RTP component of CIMT (Sawaki et al., 2008; 
Wittenberg et al., 2003). However, in the interest of reducing the number of animals 
required for this experiment, there was no inclusion of a group that had each 
rehabilitation component (activity ball, reaching) separately. While the study in Chapter 
3 allows for limited conjecture as to the value of activity ball alone, it is not possible to 
ascertain how much functional recovery might be observed by reaching alone. It may be 
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interesting to separate these components, to determine whether there is an additive or 
synergistic effect when combined. For example, Debow et al. (2003) found that 
following intracerebral hemorrhage, the application of either reaching alone or constraint 
alone (via the use of a constraint jacket) was not effective, while a combination therapy 
of both significantly improved recovery (DeBow et al., 2003).  
 
5.4 BEHAVIOURAL TESTING: CONSIDERATIONS 
 
As with all studies of post-stroke recovery, it is challenging to determine to what 
degree observed improvement represents recovery versus behavioural compensation. 
This is a concern that plagues both preclinical and clinical brain injury research (Duncan 
et al., 1992; Krakauer, 2005). When evaluating recovery, the perceived efficacy of a 
rehabilitation technique depends on the use of functional measures. However, 
behavioural outcome is the culmination of a number of processes that can be affected by 
numerous variables including recovery, compensatory strategies, stress, anxiety, and 
general well-being. This creates a complicated web of interactions that may confound 
results.  
To reduce the confounding factor of compensation, due consideration must be 
given to the use and interpretation of appropriate tests. For example, in the clinic, a 
commonly used assessment of deficit and recovery is a scale of performance on 
activities of daily living (ADL) (Jorgensen et al., 1995; MacKay-Lyons and Makrides, 
2002; Ramasubbu et al., 1998). However, a patient who has learned to perform activities 
of daily living by using the unaffected arm can exhibit an improved score on this test 
despite the absence of functional recovery in the impaired arm. To address this, the 
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present research consisted of a battery of tests in each study, targeting a variety of 
impaired behaviours (i.e. sensorimotor reflex, postural positioning, coordination, 
spontaneous movement, skilled reaching). These tests encompassed both similar and 
different movements to those induced by rehabilitation [i.e. ladder walking (similar to 
ball rolling) and staircase reaching (similar to repetitive pellet reaching)]. In the study 
presented in Chapter 4, performance on the Montoya staircase test (with respect to 
µQXPEHU RI SHOOHWV FRQVXPHG¶ GLG QRW UHWXUQ WR FRQWURO OHYHO VHH )LJXUH %
However, animals showed improved performance on other assessments used (tactile 
stimulated placing test, vibrissae stimulated placing test, and maximum step reached on 
the 0RQWR\DVWDLUFDVH7KXVLWLVSODXVLEOHWKDWODFNRIUHFRYHU\RQµQXPEHURISHOOHWV
FRQVXPHG¶ZDVGXHWRDPRUHSURIRXQGGHILFLWLQWKHcomplex function required for that 
task, rather than the animals exhibiting compensation on all other tests.  
Nonetheless, it is challenging to determine the best test battery to use for any 
study that will be appropriately sensitive to the nature of the deficit and also reduce the 
opportunity for compensatory performance. Several other forelimb functional tests 
popular in stroke and rehabilitation research were not used in this research, including 
adhesive removal (Leasure and Grider, 2010; Müller et al., 2008; Schallert et al., 2000; 
Soleman et al., 2010), beam traversing (Windle et al., 2006; Zhao et al., 2009), and 
single pellet reaching (MacLellan et al., 2006). Some tests that were used (e.g. the 
cylinder test in Chapter 3, and the ladder test in Chapter 4) were not sufficiently 
sensitive for this purpose. However, for each study, the test batteries were carefully 
chosen with the expectation that they would be appropriate based on previous 
experience and existing literature. Unfortunately, the use of too many or overly technical 
tests, frequent testing periods, and tests too similar to the rehabilitation being evaluated 
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can result in inadvertent rehabilitation (i.e. the performance of the test battery confounds 
the post-ischemic recovery process being investigated) (MacLellan et al., 2006), 
necessitating the use of concise test batteries. For future studies of this nature, the 
continued use of the forelimb placing tests (based on ease of use and sensitivity to 
significant changes) and the staircase task (based on the more profound and long-lasting 
deficit on this test, perhaps making it sensitive and suitable for even longer-term studies 
of rehabilitation) should be implemented. Also, more work should be done to investigate 
the discrepant ladder test results, which appeared sufficiently sensitive to injury in 
Chapter 3 (see Figure 3.8) but not Chapter 4 (see Figure 4.6). Other tests, such as those 
highlighted above and used by other investigators, have yet to be evaluated using the 
present surgical or rehabilitation protocols. 
An alternative approach to the measurement of functional outcome would be to 
implement more qualitative assessments. Rather than analysing whether the animals can 
do something (e.g. reach for pellets on the staircase), this approach would involve 
detailed analysis of how the animal performs a task. For example, qualitative analysis of 
limb movements during paw reaching (Gilmour et al., 2004; MacLellan et al., 2006; 
Whishaw, 2000) may provide more information about the nature of how animals 
receiving rehabilitation use the impaired forelimb compared to controls. Because such 
qualitative analyses have not yet been standardized for the staircase test (MacLellan et 
al., 2006), a separate, labour-intensive single pellet reaching task would be required 
(Auriat and Colbourne, 2009; MacLellan et al., 2006; Maldonado et al., 2008; Whishaw, 
2000).  
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5.5 MARKERS OF NEUROPLASTICITY: CONSIDERATIONS 
 
5.5.1 Growth-associated proteins 
  
The use of growth factors as therapeutants following stroke is generally hindered 
by poor permeability of the blood brain barrier, thus limiting bioavailability. Research 
into the use of delivery vectors (Wu, 2005) aims to overcome this obstacle; however, 
treatments that result in increased endogenous expression remain a promising 
alternative. 
The study presented in Chapter 3 demonstrated that surgical stroke resulted in an 
increase in the proportion of cells expressing BDNF in perilesional tissue (see Figure 
3.10), similar to other reports (Béjot et al., 2011a, 2011b; Johansson, 2000; Madinier et 
al., 2009). However, there was no increase in contralateral BDNF expression detected, 
contrary to Kim et al. (2005). In that experiment, BDNF expression was examined at 
PSD 16, rather than PSD 21. Due to the dynamic temporal profile of post-ischemic 
neuroplastic gene expression (see Section 1.4.3), it is possible that the rehabilitation 
evaluated herein caused earlier contralesional changes that were not detected on post 
mortem analysis. The potential impact of timing is further supported by the results 
described in Chapter 4. In that experiment, examination at PSD 28 revealed that there 
was no longer a change in the ipsilesional proportion of cells expressing BDNF. Thus, 
stroke may increase ipsilesional BDNF expression until sometime between PSD 21 and 
28. 
The lack of an increase in the proportion of BDNF-expressing cells in Chapter 4 
led to interest into whether or not there was a change in the cellular origin of the BDNF 
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being expressed in animals in the rehabilitation group. To determine this, co-labelling 
was performed to examine whether the BDNF-expressing cells were neurons, astrocytes, 
or neither. Interestingly, animals receiving rehabilitation had an increased expression of 
BDNF in cells that were not immunopositive for NeuN (neurons) or GFAP (astrocytes). 
As discussed in Section 4.4, the most likely source of µRWKHU¶ %'1) is microglia. 
Unfortunately, confirmatory analysis was not possible, due to a lack of remaining tissue 
samples. 
The BDNF antibody used in the current work, Millipore catalogue # AB1779 
rabbit anti-BDNF, does not allow distinction between pro-BDNF and the mature form of 
the neurotrophin. Therefore, there may be changes in the amount of either form that 
were not detected in the present research. Ultimately, discrimination of the two forms 
may be important, since the beneficial effect of this neurotrophin is believed to be 
restricted to its mature form (Greenberg et al., 2009; Lu et al., 2005). Antibodies 
specific to pro-BDNF are commercially available (e.g. Millipore catalogue #AB9042) 
and would be required for such an investigation. Recent work by Madinier et al. (2013) 
showed that peri-lesional expression of the two forms of BDNF are differentially 
induced following photothrombosis, wherein the level of mature BDNF shows an early 
increase, followed later by an increase in levels of pro-BDNF (Madinier et al., 2013). 
While BDNF is a commonly studied neurotrophin in rehabilitation research, it is 
certainly not the only interesting candidate for involvement in rehabilitation-induced 
neuroplasticity. A growing list of growth factors have been implicated in post-ischemic 
neuroplasticity, including FGF-2, epidermal growth factor (EGF), IGF-1, erythropoietin 
(EPO), stem cell factor (SCF), vascular endothelial growth factor (VEGF), GDNF, and 
NGF (Greenberg and Jin, 2006; Horinouchi et al., 2007). The following section will 
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highlight some interesting findings with respect to post-stroke growth factors; for an in-
depth review see Greenberg and Jin (2006). 
As stated in Section 1.4.3, NGF belongs to the same family of neurotrophins as 
BDNF (Lu, 2003). Interestingly, like BDNF, NGF is also released as a result of cellular 
depolarization (Zafra et al., 1990), making it a logical candidate for involvement in post-
ischemic neuroplasticity. Indeed, two groups recently reported that ischemia followed by 
forced or voluntary exercise resulted in upregulation of NGF (Matsuda et al., 2011; 
Mizutani et al., 2011). Unfortunately, NGF is clinically associated with hyperalgesia 
(Greenberg and Jin, 2006), which may hinder any therapeutic potential. 
Established functions of GDNF include neurite outgrowth and interference with 
apoptotic and necrotic pathways (Abe, 2000; Kitagawa et al., 1998; Zhang et al., 
2001b), potentially important in the post-ischemic brain environment. So named because 
of its original isolation from cultured glial cells, expression of GDNF is also induced in 
neurons following MCAo and photothrombotic stroke (Abe and Hayashi, 1997; 
Horinouchi et al., 2007). Post-stroke administration of GDNF is neuroprotective 
(Kitagawa et al., 1998; Zhang et al., 2001b, 2002). However, to date, the effects of 
rehabilitation on GDNF expression have not been examined. 
 
5.5.2 Growth inhibiting proteins 
 
The effect of the current model of rehabilitation on growth inhibition was also 
investigated by examining the expression of NOGOA. Because NOGOA has been 
implicated in post-ischemic recovery (Fang et al., 2010; Papadopoulos et al., 2002), it is 
plausible that rehabilitation that results in functional improvement may act in part by 
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reducing the expression of this growth-inhibiting protein. However, in the study 
described in Chapter 3, there was no difference in the proportion of NOGOA+ cells in 
either stroke group. Previous work has shown that the expression of NOGOA (measured 
by Western blot analysis) is higher in animals 7-14 days following stroke, although an 
extended time period was not analysed (Li and Carmichael, 2006). As discussed in the 
previous section, it is possible that by the time point chosen in Chapter 3 (PSD 21), 
NOGOA expression had normalized. Because expression was not different at that time, 
NOGOA analysis was not performed in the study presented in Chapter 4. 
The temporal expression profiles of several growth inhibitors have been 
characterized following MCAo (Carmichael et al., 2005; Li and Carmichael, 2006). 
There was an initial upregulation of several genes involved in growth inhibition in the 
first 14 days following injury, which were generally no longer significantly increased by 
PSD 28 (e.g. NOGO, ephrins A5 and B1) (Carmichael et al., 2005). Thus, there may be 
a critical time period after the first 2 weeks post-stroke in which expression of NOGOA 
changes significantly, but normalizes by PSD 21. However, it must be noted that the 
measurement of mRNA does not necessarily correlate with the expression of functional 
SURWHLQV DQG µPLVPDWFKHV¶ EHWZHHQ P51$ OHYHOV DQG SURWHLQ H[pression have been 
reported previously (Li and Carmichael, 2006).  
 
5.5.3 Doublecortin 
 
While it has long been recognized that many adult tissues have the capacity to be 
renewed through the production of stem cells, a major breakthrough in the study of 
neurodegenerative disease was the discovery that the adult brain²previously thought to 
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cease cell renewal following development²continually produces new cells (Altman, 
1962; Eriksson et al., 1998). Neural SCs are constantly being formed in SGZ and the 
SVZ, adjacent to the lateral ventricles. Under normal conditions, SCs from the SVZ 
migrate to the rostral olfactory lobe along the rostral migratory stream (RMS) (Lois and 
Alvarez-Buylla, 1994; Momma et al., 2000). Interestingly, following brain damage such 
as ischemia, increased neurogenesis can be observed (Arvidsson et al., 2002; Jin et al., 
2001; Liu et al., 2009; Zhang et al., 2001a). SCs originating from the SVZ are re-routed 
from the RMS toward the ischemic regions (Hicks et al., 2009; Ohab et al., 2006; Parent 
et al., 2002), potentially representing an endogenous repair mechanism. Analysis of 
Dcx+ cells in Chapters 3 and 4 suggested that the ET-1 stroke model promotes 
neurogenesis (see Figures 3.12 and 4.12; for discussion of the limitations of this 
analysis, see Section 3.4) and that the modified rehabilitation regimen used in Chapter 4 
further increased the number of migrating neuroblasts (see Figure 4.12).  
Chapter 3 demonstrated a mild functional benefit of rehabilitation without 
affecting the number of Dcx+ cells (see Figure 3.12). Chapter 4 revealed a more robust 
acceleration in functional recovery and an increase in the number of Dcx+ cells. This 
suggests that the migration of new neurons to damaged tissue may have a potentially 
positive impact on functional recovery. Nonetheless, neurogenesis is ultimately the 
culmination of several equally important cellular events: proliferation, migration, 
differentiation, and ultimately circuit integration and survival (Zhang and Chopp, 2009), 
processes not fully addressed in this work. Furthermore, there is some evidence that 
ischemia can lead to aberrant neurogenesis, raising concerns about the contribution of 
newly born neural cells to functional impairments (Niv et al., 2012). This aspect of 
rehabilitation would be interesting to pursue in greater detail.  
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5.6 TRANSLATIONAL CONSIDERATIONS 
 
While animal models remain critical to basic stroke research, there are 
limitations in the translation of research findings to clinical practice. As with other 
experimental conditions, stroke models represent a simplified version of an extremely 
complex human condition. Gender, age, pre-stroke condition, stroke severity, and co-
morbidities are highly variable in the clinical population, but tightly controlled in 
experimental studies. The amount of damage and subsequent severity of impairment are 
also disjointed between the animal and human population, as animals both require and 
can survive more severe neurological damage in order to produce detectable functional 
deficits.  
With the plethora of variables to consider at each step, modelling rehabilitation 
presents a major challenge and remains fundamentally different from rehabilitation in 
the clinical setting. Stroke patients undergoing CIMT receive supervised, assisted, and 
highly motivated treatment from trained experts. Experimental rehabilitation is largely 
hands-off, and animals are more difficult to motivate. Decisions must be made to best 
represent the validity of a model with respect to a particular aspect of the therapy. Such 
decisions may result in compromises in aspects of the therapy, for example intensity, in 
order to address stress and behavioural pressure.  
A further difficulty in attempting to translate findings from animal rehabilitation 
studies is that the number of exercise repetitions is typically quite high in animals 
compared to human stroke survivors. As shown in Figure 4.4B, for example, animals 
were reaching 70-80 pellets per 30 minute session, similar to the degree of engagement 
reported by others (DeBow et al., 2003; Maldonado et al., 2008). However, an 
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observation of clinical rehabilitation revealed that patients are required to perform 
considerably less (on average, 32 repetitions of an exercise during a session, divided 
between 2-4 separate tasks) (Lang et al., 2010). Thus, it is possible that current practices 
in rehabilitation are administering very low levels of rehabilitation (Nudo, 2011), an 
especially important consideration as there appears to be a threshold of rehabilitation 
below which functional improvements are not observed (MacLellan et al., 2011). A 
proof-of-concept study recently concluded that it is feasible to attain repetitions in 
human stroke patients that resemble those reported in the animal literature (Birkenmeier 
et al., 2010).  
Because the role of rehabilitation is to facilitate recovery processes after infarct 
development (rather than to provide neuroprotection), it is tempting to assume that it 
may translate to other neural injuries that result in forelimb hemiplegia. It is important to 
note that the mechanisms of injury following aspiration lesions and stab wounds differ 
substantially from those post-ischemia, with respect to the dynamics and distribution of 
inflammation, apoptotic cell death, free radical damage, and post-injury axonal and 
dendritic growth (Carmichael, 2006; Gonzalez and Kolb, 2003; Kempermann et al., 
2000). Nonetheless, clinical examinations of CIMT in other neuropathological 
paradigms have been promising. Following traumatic brain injury, hemiplegic patients 
responded well to CIMT (Shaw et al., 2005) and positive results have been reported 
following the use of CIMT in cerebral palsy patients (Huang et al., 2009a). Until the 
mechanisms underlying treatment induced recovery are fully understood, it is difficult to 
determine what other injury models might benefit. Perhaps variables like lesion size, 
remaining tissue, and patient demographics are more influential than the nature of the 
lesion. 
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5.7 FUTURE DIRECTIONS 
 
Future investigations should first attempt to further optimize the rehabilitation 
paradigm. Both rehabilitation studies presented in this thesis resulted in a statistically 
significant acceleration in functional recovery to control levels in a number of functional 
tests, supporting the use of voluntary forced forelimb use in a rat model. However, the 
magnitude of the effect was lower than expected, often only accelerating recovery by as 
little as one or two days (Chapter 3) or a week (Chapter 4). As highlighted in Section 
5.3, the duration of rehabilitation sessions was relatively constant throughout the studies. 
Some others have used rehabilitation paradigms that increase in intensity over time 
(Auriat et al., 2006; Maldonado et al., 2008; Ploughman et al., 2009), with varying 
success. In clinical rehabilitation, higher intensity therapeutic practice has a greater 
impact on task performance (Kwakkel, 2006), though at a certain point, increased 
intensity induces fatigue and counteracts the positive effect (Sterr and Saunders, 2006). 
Thus, the determination of how increasing the intensity of the rehabilitation, either over 
the duration of the study or as a constant delivery of higher intensity, would be of 
interest in exploring this model further. As previously described, a task-specific 
component was added to the voluntary forced use paradigm in Chapter 4, to more 
closely model clinical CIMT (see Section 4.2.3.2). The research presented in this thesis 
did not investigate separate general and task-specific components. Doing so may prove 
useful for investigating varying intensities of each component separately. 
As highlighted in Section 5.2, the use of young adult rats in stroke research is 
becoming increasingly criticized (Leasure and Grider, 2010; Lindner et al., 2003; 
Soleman et al., 2010; STAIR, 1999), and the aged brain responds differently than the 
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young adult brain following stroke (Li and Carmichael, 2006). Thus, it would be 
interesting to determine if the present approach to rehabilitation can accelerate 
functional recovery in older rats. While several logistical challenges would need to be 
overcome (described in Section 5.2), these barriers have hindered the implementation of 
this important variable for too long, likely contributing to the lack of translational value 
frequently observed in preclinical stroke research (STAIR, 1999). 
Evaluation of the efficacy of this model of therapy should examine the 
persistence (or further development) of functional recovery beyond the end of treatment. 
Clarke et al. (2009) showed that environmental enrichment rehabilitation resulted in a 
lasting functional benefit beyond the completion of treatment. Similarly, Taub et al. 
(2006) reported that following CIMT treatment, patients retained functional 
improvement at a four week follow-up assessment. However, some clinical 
rehabilitation regimens may show improvements in motor function that are lost upon 
discontinuation of the therapy (Kleim et al., 2007). The long-term effects of the 
rehabilitation examined in this thesis should be determined through future studies. 
Because of the heterogeneity of ischemic injury and subsequent repair 
mechanisms, a promising strategy for developing stroke treatments is to combine 
therapies (Ratan and Noble, 2009). For example, adjuvant treatment with a 
pharmacotherapy or natural health product along with voluntary forced use rehabilitation 
could prove more effective than either treatment alone. Enriched environment (Ramic et 
al., 2006), forced exercise (Sakakima et al., 2012), and skilled reaching (Fang et al., 
2010; Windle and Corbett, 2005) rehabilitation have been shown to increase the efficacy 
of D-amphetamine (Ramic et al., 2006), S-nitrosoglutathione (Sakakima et al., 2012), 
fluoxetine (Windle and Corbett, 2005), and NOGO receptor antagonist (Fang et al., 
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2010) treatments, resulting in better recovery than either the rehabilitation or drug alone. 
This suggests that activity-dependent rehabilitation may engage certain instructive cues 
that optimize the neuroplastic changes occurring in the post-stroke brain 
microenvironment. Thus, following further optimization of the voluntary forced use 
movement therapy, it may prove to be a useful adjuvant to treatment with promising 
pharmaceuticals and nutraceuticals. 
 
5.8 CONCLUSIONS 
 
Animal models will never perfectly mimic the human condition, but are intended 
to guide scientific understanding and provide insight into specific processes involved in 
post-ischemic recovery. As such, several studies have already been critical in identifying 
processes that may underlie the functional improvements resulting from CIMT. The 
novel voluntary forced use movement therapy rehabilitation model developed and 
evaluated in this thesis adds to this body of literature. This model resulted in accelerated 
functional recovery following ET-1 induced lesions to forelimb motor brain regions, 
while circumventing animal stress and behavioural pressure issues associated with some 
other forced use models. Further optimization may lead to increasingly robust 
acceleration in recovery. 
The importance of post-stroke activity-dependent neuroplasticity must be 
recognized. Stroke patients usually have diminished capacity for exercise (MacKay-
Lyons and Makrides, 2002), thus an understanding of post-stroke activity-dependent 
mechanisms, and how they might be enhanced, could prove crucial in developing 
improved therapies. The remaining challenge is to ensure that experimental research is 
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effectively translated to clinical practice in order to capitalize on existing knowledge, 
identify common findings, and ultimately ensure positive collaborations toward 
improving post-stroke recovery. 
 
³>7KHEUDLQ@LVZLWKRXWGRXEWWKHODVWIURQWLHURIVFLHQFH´ 
-Eric Kandel
198 
 
5.9 REFERENCES 
Abe, K. (2000). Therapeutic potential of neurotrophic factors and neural stem cells 
against ischemic brain injury. J Cereb Blood Flow Metab 20, 1393±1408. 
Abe, K., and Hayashi, T. (1997). Expression of the glial cell line-derived neurotrophic 
factor gene in rat brain after transient MCA occlusion. Brain Res 776, 230±234. 
Alkayed, N.J., Harukuni, I., Kimes, a. S., London, E.D., Traystman, R.J., Hurn, P.D., 
and Grady, P. a. (1998). Gender-Linked Brain Injury in Experimental Stroke. 
Stroke 29, 159±166. 
Altman, J. (1962). Are New Neurons Formed in the Brains of Adult Mammals? Science 
135, 1127±1128. 
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., and Lindvall, O. (2002). Neuronal 
replacement from endogenous precursors in the adult brain after stroke. Nat Med 
8, 963±970. 
Auriat, A.M., and Colbourne, F. (2009). Delayed rehabilitation lessens brain injury and 
improves recovery after intracerebral hemorrhage in rats. Brain Res 1251, 262±
268. 
Auriat, A.M., Grams, J.D., Yan, R.H., and Colbourne, F. (2006). Forced exercise does 
not improve recovery after hemorrhagic stroke in rats. Brain Res 1109, 183±191. 
Béjot, Y., Prigent-Tessier, A., Cachia, C., Giroud, M., Mossiat, C., Bertrand, N., 
Garnier, P., and Marie, C. (2011a). Time-dependent contribution of non neuronal 
cells to BDNF production after ischemic stroke in rats. Neurochem Int 58, 102±
111. 
Béjot, Y., Mossiat, C., Giroud, M., Prigent-Tessier, A., and Marie, C. (2011b). 
Circulating and brain BDNF levels in stroke rats. Relevance to clinical studies. 
PloS One 6, e29405. 
Birkenmeier, R.L., Prager, E.M., and Lang, C.E. (2010). Translating animal doses of 
task-specific training to people with chronic stroke in 1-hour therapy sessions: a 
proof-of-concept study. Neurorehabil Neural Repair 24, 620±635. 
Bland, S.T., Schallert, T., Strong, R., Aronowski, J., Grotta, J.C., and Feeney, D.M. 
(2000). Early exclusive use of the affected forelimb after moderate transient 
focal ischemia in rats: functional and anatomic outcome. Stroke 31, 1144±1152. 
Carmichael, S.T. (2005). Rodent models of focal stroke: size, mechanism, and purpose. 
NeuroRx 2, 396±409. 
199 
 
Carmichael, S.T. (2006). Cellular and molecular mechanisms of neural repair after 
stroke: making waves. Ann Neurol 59, 735±742. 
Carmichael, S.T., Archibeque, I., Luke, L., Nolan, T., Momiy, J., and Li, S. (2005). 
Growth-associated gene expression after stroke: evidence for a growth-
promoting region in peri-infarct cortex. Exp Neurol 193, 291±311. 
Carr, J.H., and Shepherd, R.B. (2011). Enhancing physical activity and brain 
reorganization after stroke. Neurol Res Int 1±7. 
Chen, J., Chopp, M., and Li, Y. (1999). Neuroprotective effects of progesterone after 
transient middle cerebral artery occlusion in rat. J Neurol Sci 171, 24±30. 
Clarke, J., Mala, H., Windle, V., Chernenko, G., and Corbett, D. (2009). The effects of 
UHSHDWHGUHKDELOLWDWLRQ³WXQH-XSV´RQIXQFWLRQDOUHFRYHU\DIWHUIRFDOLVFKHPLDLQ
rats. Neurorehabil Neural Repair 23, 886±894. 
Clarkson, A.N., Overman, J.J., Zhong, S., Mueller, R., Lynch, G., and Carmichael, S.T. 
(2011). AMPA receptor-induced local brain-derived neurotrophic factor 
signalling mediates motor recovery after stroke. J Neurosci 31, 3766±3775. 
DeBow, S.B., Davies, M.L. a, Clarke, H.L., and Colbourne, F. (2003). Constraint-
induced movement therapy and rehabilitation exercises lessen motor deficits and 
volume of brain injury after striatal hemorrhagic stroke in rats. Stroke 34, 1021±
1026. 
Duncan, P.W., Goldstein, L.B., Matchar, D., Divine, G.W., and Feussner, J. (1992). 
Measurement of motor recovery after stroke. Outcome assessment and sample 
size requirements. Stroke 23, 1084±1089. 
Eriksson, P., Perfilieva, E., Björk-Eriksson, T., Alborn, A., Nordborg, C., Peterson, D., 
and Gage, F. (1998). Neurogenesis in the adult human hippocampus. Nat Med 4, 
1313±1317. 
Fang, P.C., Barbay, S., Plautz, E.J., Hoover, E., Strittmatter, S.M., and Nudo, R.J. 
(2010). Combination of NEP 1-40 treatment and motor training enhances 
behavioral recovery after a focal cortical infarct in rats. Stroke 41, 544±549. 
*LOPRXU*,YHUVHQ6'2¶1HLOO0)DQG%DQQHUPDQ'07KHHIIHFWVRI
intracortical endothelin-1 injections on skilled forelimb use: implications for 
modelling recovery of function after stroke. Behav Brain Res 150, 171±183. 
Gonzalez, C.L., and Kolb, B. (2003). A comparison of different models of stroke on 
behaviour and brain morphology. Eur J Neurosci 18, 1950±1962. 
Greenberg, D., and Jin, K. (2006). Growth factors and stroke. NeuroRx 3, 458±465. 
200 
 
Greenberg, M.E., Xu, B., Lu, B., and Hempstead, B.L. (2009). New insights in the 
biology of BDNF synthesis and release: implications in CNS function. J 
Neurosci 29, 12764±12767. 
Hicks, A.U., Lappalainen, R.S., Narkilahti, S., Suuronen, R., Corbett, D., Sivenius, J., 
Hovatta, O., and Jolkkonen, J. (2009). Transplantation of human embryonic stem 
cell-derived neural precursor cells and enriched environment after cortical stroke 
in rats: cell survival and functional recovery. Eur J Neurosci 29, 562±574. 
Horinouchi, K., Ikeda, S., Harada, K., Ohwatashi, A., Kamikawa, Y., Yoshida, A., 
Nomoto, Y., Etoh, S., and Kawahira, K. (2007). Functional recovery and 
expression of GDNF seen in photochemically induced cerebral infarction. Int J 
Neurosci 117, 315±326. 
Huang, H., Chung, K., Lai, D., and Sung, S. (2009a). The impact of timing and dose of 
rehabilitation delivery on functional recovery of stroke patients. J Chin Med 
Assoc 72, 257±264. 
Huang, H., Fetters, L., Hale, J., and McBride, A. (2009b). Bound for success: a 
systematic review of constraint-induced movement therapy in children with 
cerebral palsy supports improved arm and hand use. Phys Ther 89, 1126±1141. 
Hume, A. (2009). Evaluation of NMDA receptor-mediated neuroprotection in the 
endothelin-1 model of upper extremity impairment in stroke. MSc Thesis, 
University of Prince Edward Island. 
Jin, K., Minami, M., Lan, J.Q., Mao, X.O., Batteur, S., Simon, R.P., and Greenberg, 
D.A. (2001). Neurogenesis in dentate subgranular zone and rostral subventricular 
zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A 98, 4710±
4715. 
Johansson, B.B. (2000). Brain Plasticity and Stroke Rehabilitation: The Willis Lecture. 
Stroke 31, 223±230. 
Jorgensen, H.S., Nakayama, H., Raaschou, H.O., Vive-Larsen, J., Stoier, M., and Olsen, 
T.S. (1995). Outcome and time course of recovery in stroke. Part II: Time course 
of recovery. The Copenhagen Stroke Study. Arch Phys Med Rehabil 76, 406±
412. 
Ke, Z., Yip, S.P., Li, L., Zheng, X.X., and Tong, K.Y. (2011). The effects of voluntary, 
involuntary, and forced exercises on brain-derived neurotrophic factor and motor 
function recovery: a rat brain ischemia model. PloS One 6, e16643. 
Kelly-Hayes, M., Robertson, J.T., Broderick, J.P., Duncan, P.W., Hershey, L.A., Roth, 
E.J., Thies, W.H., and Trombly, C.A. (1998). The American Heart Association 
Stroke Outcome Classification: Executive Summary. Circulation 97, 2474±2478. 
201 
 
Kempermann, G., Van Praag, H., and Gage, F.H. (2000). Activity-dependent regulation 
of neuronal plasticity and self repair. Prog Brain Res 127, 35±48. 
Kim, M.W., Bang, M.S., Han, T.R., Ko, Y.J., Yoon, B.W., Kim, J.H., Kang, L.M., Lee, 
K.M., and Kim, M.H. (2005). Exercise increased BDNF and trkB in the 
contralateral hemisphere of the ischemic rat brain. Brain Res 1052, 16±21. 
Kitagawa, H., Hayashi, T., Mitsumoto, Y., Koga, N., Itoyama, Y., Abe, K., and Kontos, 
H. (1998). Reduction of Ischemic Brain Injury by Topical Application of Glial 
Cell Line Derived Neurotrophic Factor After Permanent Middle Cerebral Artery 
Occlusion in Rats. Stroke 29, 1417±1422. 
Kleim, J., Jones, T., and Schallert, T. (2003). Motor enrichment and the induction of 
plasticity before or after brain injury. Neurochem Res 28, 1757±1769. 
Kleim, J.A., Boychuk, J.A., and Adkins, D.L. (2007). Rat models of upper extremity 
impairment in stroke. ILAR J 48, 374±384. 
Knieling, M., Metz, G. a, Antonow-Schlorke, I., and Witte, O.W. (2009). Enriched 
environment promotes efficiency of compensatory movements after cerebral 
ischemia in rats. Neuroscience 163, 759±769. 
Krakauer, J.W. (2005). Arm function after stroke: from physiology to recovery. Semin 
Neurol 25, 384±395. 
Kwakkel, G. (2006). Impact of intensity of practice after stroke: issues for consideration. 
Disabil Rehabil 28, 823±830. 
Kwakkel, G., Wagenaar, R.C., Twisk, J.W., Lankhorst, G.J., and Koetsier, J.C. (1999). 
Intensity of leg and arm training after primary middle-cerebral-artery stroke: a 
randomised trial. Lancet 354, 191±196. 
Lang, C.E., Macdonald, J.R., Reisman, D.S., Boyd, L., Kimberley, T.J., Schindler-ivens, 
S.M., Hornby, T.G., Ross, S.A., and Scheets, P.L. (2010). Observation of 
amounts of movement practice provided during stroke rehabilitation. Arch Phys 
Med Rehabil 90, 1692±1698. 
Leasure, J.L., and Grider, M. (2010). The effect of mild post-stroke exercise on reactive 
neurogenesis and recovery of somatosensation in aged rats. Exp Neurol 226, 58±
67. 
Leasure, J.L., and Schallert, T. (2004). Consequences of forced disuse of the impaired 
forelimb after unilateral cortical injury. Behav Brain Res 150, 83±91. 
202 
 
Li, S., and Carmichael, S.T. (2006). Growth-associated gene and protein expression in 
the region of axonal sprouting in the aged brain after stroke. Neurobiol Dis 23, 
362±373. 
Lindner, M.D., Gribkoff, V.K., Donlan, N.A., and Jones, T.A. (2003). Long-lasting 
functional disabilities in middle-aged rats with small cerebral infarcts. J Neurosci 
23, 10913±10922. 
Liu, Y.P., Lang, B.T., Baskaya, M.K., Dempsey, R.J., and Vemuganti, R. (2009). The 
potential of neural stem cells to repair stroke-induced brain damage. Acta 
Neuropathol 117, 469±480. 
Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T.B., Flegal, K., 
Ford, E., Furie, K., Go, A., Greenlund, K., et al. (2009). Heart disease and stroke 
statistics--2009 update: a report from the American Heart Association Statistics 
Committee and Stroke Statistics Subcommittee. Circulation 119, 480±486. 
Lois, C., and Alvarez-Buylla, A. (1994). Long-distance neuronal migration in the adult 
mammalian brain. Science 264, 1145±1148. 
Lu, B. (2003). BDNF and activity-dependent synaptic modulation. Learn Mem 10, 86±
98. 
Lu, B., Pang, P.T., and Woo, N.H. (2005). The yin and yang of neurotrophin action. Nat 
Rev Neurosci 6, 603±614. 
MacKay-Lyons, M.J., and Makrides, L. (2002). Cardiovascular stress during a 
contemporary stroke rehabilitation program: Is the intensity adequate to induce a 
training effect? Arch Phys Med Rehabil 83, 1378±1383. 
MacLellan, C.L., Gyawali, S., and Colbourne, F. (2006). Skilled reaching impairments 
follow intrastriatal hemorrhagic stroke in rats. Behav Brain Res 175, 82±89. 
MacLellan, C.L., Keough, M.B., Granter-Button, S., Chernenko, G. a, Butt, S., and 
Corbett, D. (2011). A critical threshold of rehabilitation involving brain-derived 
neurotrophic factor is required for poststroke recovery. Neurorehabil Neural 
Repair 25, 740±748. 
Madinier, A., Bertrand, N., Mossiat, C., Prigent-Tessier, A., Beley, A., Marie, C., and 
Garnier, P. (2009). Microglial involvement in neuroplastic changes following 
focal brain ischemia in rats. PloS One 4, e8101. 
Madinier, A., Bertrand, N., Rodier, M., Quirié, A., Mossiat, C., Prigent-Tessier, A., 
Marie, C., and Garnier, P. (2013). Ipsilateral versus contralateral spontaneous 
post-stroke neuroplastic changes: Involvement of BDNF? Neuroscience 231, 
169±181. 
203 
 
Maldonado, M.A., Allred, R.P., Felthauser, E.L., and Jones, T.A. (2008). Motor skill 
training, but not voluntary exercise, improves skilled reaching after unilateral 
ischemic lesions of the sensorimotor cortex in rats. Neurorehabil Neural Repair 
22, 250±261. 
Matsuda, F., Sakakima, H., and Yoshida, Y. (2011). The effects of early exercise on 
brain damage and recovery after focal cerebral infarction in rats. Acta Physiol 
201, 275±287. 
Mizutani, K., Sonoda, S., Yamada, K., Beppu, H., and Shimpo, K. (2011). Alteration of 
protein expression profile following voluntary exercise in the perilesional cortex 
of rats with focal cerebral infarction. Brain Res 1416, 61±68. 
Momma, S., Johansson, C.B., and Frisen, J. (2000). Get to know your stem cells. Curr 
Opin Neurobiol 10, 45±49. 
Müller, H.D., Hanumanthiah, K.M., Diederich, K., Schwab, S., Schäbitz, W.-R., 
Sommer, C., Muller, H.D., and Schabitz, W.R. (2008). Brain-derived 
neurotrophic factor but not forced arm use improves long-term outcome after 
photothrombotic stroke and transiently upregulates binding densities of 
excitatory glutamate receptors in the rat brain. Stroke 39, 1012±1021. 
Niv, F., Keiner, S., Krishna, K., Witte, O., Chichung Lie, D., and Redecker, C. (2012). 
Aberrant Neurogenesis After Stroke: a retroviral cell labeling study. Stroke 43, 
2468±2475. 
Nudo, R.J. (2011). Neural bases of recovery after brain injury. J Commun Disord 44, 
5155±5120. 
Ohab, J.J., Fleming, S., Blesch, A., and Carmichael, S.T. (2006). A neurovascular niche 
for neurogenesis after stroke. J Neurosci 26, 13007±13016. 
Page, S.J., Levine, P., and Leonard, A.C. (2005). Modified constraint-induced therapy in 
acute stroke: a randomized controlled pilot study. Neurorehabil Neural Repair 
19, 27±32. 
Pan, Y., Zhang, H., Acharya, A.B., Patrick, P.H., Oliver, D., and Morley, J.E. (2005). 
Effect of testosterone on functional recovery in a castrate male rat stroke model. 
Brain Res 1043, 195±204. 
3DSDGRSRXORV&07VDL6<$OVELHL72¶%ULHQ7(6FKZDE0(DQG.DUWMH
G.L. (2002). Functional recovery and neuroanatomical plasticity following 
middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. 
Ann Neurol 51, 433±441. 
204 
 
Parent, J.M., Vexler, Z.S., Gong, C., Derugin, N., and Ferriero, D.M. (2002). Rat 
forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann 
Neurol 52, 802±813. 
Ploughman, M., Granter-Button, S., Chernenko, G., Attwood, Z., Tucker, B. a, Mearow, 
K.M., and Corbett, D. (2007). Exercise intensity influences the temporal profile 
of growth factors involved in neuronal plasticity following focal ischemia. Brain 
Res 1150, 207±216. 
Ploughman, M., Windle, V., MacLellan, C.L., White, N., Dore, J.J., and Corbett, D. 
(2009). Brain-derived neurotrophic factor contributes to recovery of skilled 
reaching after focal ischemia in rats. Stroke 40, 1490±1495. 
Ramasubbu, R., Robinson, R.G., Flint, a J., Kosier, T., and Price, T.R. (1998). 
Functional impairment associated with acute poststroke depression: the Stroke 
Data Bank Study. J Neuropsychiatry Clin Neurosci 10, 26±33. 
5DPLF0(PHULFN$-%ROOQRZ052¶%ULHQ7(7VDL6DQG.DUWMH*/
(2006). Axonal plasticity is associated with motor recovery following 
amphetamine treatment combined with rehabilitation after brain injury in the 
adult rat. Brain Res 1111, 176±186. 
Ratan, R.R., and Noble, M. (2009). Novel multi-modal strategies to promote brain and 
spinal cord injury recovery. Stroke 40, S130±132. 
Richards, L., Gonzalez Rothi, L.J., Davis, S., Wu, S.S., and Nadeau, S.E. (2006). 
Limited dose response to constraint-induced movement therapy in patients with 
chronic stroke. Clin Rehabil 20, 1066±1074. 
Ryan, C.L., Doucette, T.A., Gill, D.A., Langdon, K.D., Liu, Y., Perry, M.A., and Tasker, 
R.A. (2006). An improved post-operative care protocol allows detection of long-
term functional deficits following MCAo surgery in rats. J Neurosci Methods 
154, 30±37. 
Sakakima, H., Khan, M., Dhammu, T.S., Shunmugavel, A., Yoshida, Y., Singh, I., and 
Singh, A.K. (2012). Stimulation of functional recovery via the mechanisms of 
neurorepair by S-nitrosoglutathione and motor exercise in a rat model of 
transient cerebral ischemia and reperfusion. Restor Neurol Neurosci 30, 383±
396. 
Sandin, K.J. (2012). New approaches to neurorehabilitiation: the increasing evidence 
base. Minn Med 95, 46±48. 
Sawaki, L., Butler, A.J., Xiaoyan, L., Wassenaar, P.A., Mohammad, Y.M., Blanton, S., 
Sathian, K., Nichols-Larsen, D.S., Wolf, S.L., Good, D.C., et al. (2008). 
205 
 
Constraint-Induced Movement Therapy Results in Increased Motor Map Area in 
Subjects 3 to 9 Months After Stroke. Neurorehabil Neural Repair 22, 505±513. 
Schallert, T., Fleming, S., Leasure, J., Tillerson, J., and Bland, S. (2000). CNS plasticity 
and assessment of forelimb sensorimotor outcome in unilateral rat models of 
stroke, cortical ablation, parkinsonism and spinal cord injury. 
Neuropharmacology 39, 777±787. 
Shaw, S.E., Morris, D.M., Uswatte, G., McKay, S., Meythaler, J.M., and Taub, E. 
(2005). Constraint-induced movement therapy for recovery of upper-limb 
function following traumatic brain injury. J Rehabil Res Dev 42, 769±778. 
Soleman, S., Yip, P., Leasure, J.L., and Moon, L. (2010). Sustained sensorimotor 
impairments after endothelin-1 induced focal cerebral ischemia (stroke) in aged 
rats. Exp Neurol 222, 13±24. 
Soylu, H., Zhang, D., Buist, R., Martin, M., Albensi, B.C., and Parkinson, F.E. (2012). 
Intracortical injection of endothelin-1 induces cortical infarcts in mice: effect of 
neuronal expression of an adenosine transporter. Exp Transl Stroke Med 4, 4. 
STAIR (1999). Recommendations for standards regarding preclinical neuroprotective 
and restorative drug development. Stroke 30, 2752±2758. 
Sterr, A., and Saunders, A. (2006). CI therapy distribution: theory, evidence and 
practice. NeuroRehabilitation 21, 97±105. 
Sterr, A., Elbert, T., Berthold, I., Kolbel, S., Rockstroh, B., and Taub, E. (2002). Longer 
versus shorter daily constraint-induced movement therapy of chronic 
hemiparesis: an exploratory study. Arch Phys Med Rehabil 83, 1374±1377. 
Taub, E., Uswatte, G., King, D.K., Morris, D., Crago, J.E., and Chatterjee, A. (2006). A 
placebo-controlled trial of constraint-induced movement therapy for upper 
extremity after stroke. Stroke 37, 1045±1049. 
Teasell, R., Bayona, N., and Bitensky, J. (2005). Plasticity and reorganization of the 
brain post stroke. Top Stroke Rehabil 12, 11±26. 
Vaynman, S., and Gomez-Pinilla, F. (2005). License to run: exercise impacts functional 
plasticity in the intact and injured central nervous system by using neurotrophins. 
Neurorehabil Neural Repair 19, 283±295. 
Whishaw, I.Q. (2000). Loss of the innate cortical engram for action patterns used in 
skilled reaching and the development of behavioral compensation following 
motor cortex lesions in the rat. Neuropharmacology 39, 788±805. 
206 
 
Windle, V., and Corbett, D. (2005). Fluoxetine and recovery of motor function after 
focal ischemia in rats. Brain Res 1044, 25±32. 
Windle, V., Szymanska, A., Granter-Button, S., White, C., Buist, R., Peeling, J., and 
Corbett, D. (2006). An analysis of four different methods of producing focal 
cerebral ischemia with endothelin-1 in the rat. Exp Neurol 201, 324±334. 
Wittenberg, G.F., Chen, R., Ishii, K., Bushara, K.O., Eckloff, S., Croarkin, E., Taub, E., 
Gerber, L.H., Hallett, M., and Cohen, L.G. (2003). Constraint-induced therapy in 
stroke: magnetic-stimulation motor maps and cerebral activation. Neurorehabil 
Neural Repair 17, 48±57. 
Woolley, C., and McEwen, B. (1993). Roles of estradiol and progesterone in regulation 
of hippocampal dendritic spine density during the estrous cycle in the rat. J 
Comp Neurol 336, 193±306. 
Wu, D. (2005). Neuroprotection in experimental stroke with targeted neurotrophins. 
NeuroRx 2, 120±128. 
Yanagita, S., Amemiya, S., Suzuki, S., and Kita, I. (2007). Effects of spontaneous and 
forced running on activation of hypothalamic corticotropin-releasing hormone 
neurons in rats. Life Sci 80, 356±363. 
Yang, Y.R., Wang, R.Y., and Wang, P.S. (2003). Early and late treadmill training after 
focal brain ischemia in rats. Neurosci Lett 339, 91±94. 
Zafra, F., Hengerer, B., Leibrock, J., Thoenen, H., and Lindholm, D. (1990). Activity 
dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is 
mediated by non-NMDA glutamate receptors. EMBO J 9, 3545±3550. 
Zhang, Z.G., and Chopp, M. (2009). Neurorestorative therapies for stroke: underlying 
mechanisms and translation to the clinic. Lancet Neurol 8, 491±500. 
Zhang, R.L., Zhang, Z.G., Zhang, L., and Chopp, M. (2001a). Proliferation and 
differentiation of progenitor cells in the cortex and the subventricular zone in the 
adult rat after focal cerebral ischemia. Neuroscience 105, 33±41. 
Zhang, W.R., Hayashi, T., Iwai, M., Nagano, I., Sato, K., Manabe, Y., and Abe, K. 
(2001b). Time dependent amelioration against ischemic brain damage by glial 
cell line-derived neurotrophic factor after transient middle cerebral artery 
occlusion in rat. Brain Res 903, 253±256. 
Zhang, W.R., Sato, K., Iwai, M., Nagano, I., Manabe, Y., and Abe, K. (2002). Short 
communication Therapeutic time window of adenovirus-mediated GDNF gene 
transfer after transient middle cerebral artery occlusion in rat. Brain Res 947, 
140±145. 
207 
 
Zhao, C., Wang, J., Zhao, S., and Nie, Y. (2009). Constraint-Induced Movement 
Therapy Enhanced Neurogenesis and Behavioral Recovery after Stroke in Adult 
Rats. Tohoku J Exp Med 218, 301±308.  
 
 
